Compound
L-arginine
An essential amino acid that is physiologically active in the L-form.
Studied for
24 endpoints · 33 findings · 20 papers · 19 null
- Necrotising enterocolitis incidencelowersEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.
- Tumour necrosis factor alpha concentrationno detected effectEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.
- Body massno detected effectEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.
- Interleukin-6 concentrationlowersEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.
- CD4+ T cell countraisesEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.
Structure
An L-α-amino acid that is the L-isomer of arginine.
Loading the model…
- Class
- Organic compound
- Formula
- C6H14N4O2
- Mass
- 174.204 g/mol
- Charge
- 0
- InChIKey
- ODKSFYDXXFIFQN-BYPYZUCNSA-N
- SMILES
- N=C(N)NCCC[C@H](N)C(=O)O
- Look it up
- ChEBIPubChemBy InChIKey
Identity from ChEBI, geometry from PubChem. Not evidence.
What the evidence says
How to read these marks33 findings · 24 endpoints · 20 papers · 19 null · by evidence strength
- Evidence strength
- Strong
- Moderate
- Limited
- Very limited
- Insufficient
| Endpoint | Lowered8 findings, 5 endpoints | No detected effect19 findings, 15 endpoints | Raised4 findings, 4 endpoints | Other2 findings, 2 endpoints |
|---|---|---|---|---|
| Necrotising enterocolitis incidence | ||||
| Interleukin-6 concentration | ||||
| CD4+ T cell count | ||||
| Maximal oxygen uptake | ||||
| Diastolic blood pressure (setting unspecified) | ||||
| Systolic blood pressure (setting unspecified) | ||||
| Activates SDHA | ||||
| Flow-mediated dilation | ||||
| Infectious complication rate | ||||
| Total antioxidant capacity | ||||
| Activates ARG1 | ||||
| Measured, and no finding detected an effect | ||||
| Tumour necrosis factor alpha concentration | ||||
| Body mass | ||||
| Fat mass | ||||
| Lean body mass | ||||
| C-reactive protein concentration | ||||
| Arginine-to-ornithine ratio | ||||
| Body mass index | ||||
| Glycated haemoglobin (HbA1c) | ||||
| HDL cholesterol | ||||
| HOMA-IR | ||||
| Hospital length of stay | ||||
| LDL cholesterol | ||||
| Total cholesterol (TC) | ||||
What moved
14 findings
Increases CD4+ T cell count
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.Finding“With regards to cellular immunity, the arginine group exhibited a substantial increase in the CD4+ T cell count (SMD = 1.03, 95% CI: 0.67-1.38) compared to the control group.”
Quoted verbatim from Arginine on immune function and post-operative obstructions in colorectal cancer patients: a meta-analysis.. - Study
- meta-analysis
- Population
- colorectal cancer patients undergoing surgery; overall pooled estimate
Arginine on immune function and post-operative obstructions in colorectal cancer patients: a meta-analysis.2024PMID:39223466Permalink
Decreases necrotising enterocolitis incidence
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.Findingreplicated ×2“L-arginine had a 59% reduction in the incidence of stage II and III NEC (RR 0.41, 95% CI 0.20 to 0.85, NNT = 9) compared with placebo (P = 0.02).”
Quoted verbatim from Arginine supplementation in prevention of necrotizing enterocolitis in the premature infant: an updated systematic review.. - Study
- meta-analysis
- Population
- preterm infants born at 34 weeks gestation or less with birth weight 1500 g or less; event definition is stage II and III NEC
Arginine supplementation in prevention of necrotizing enterocolitis in the premature infant: an updated systematic review.2014PMID:25205007Permalink
Decreases interleukin-6 concentration
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.Finding“Our analysis also showed that L-arginine had a noticeable impact on decreasing interleukin-6 (IL-6) levels (WMD = -7.72 pg/ml; 95% CI: -15.05, -0.39).”
Quoted verbatim from L-arginine impact on inflammatory and cardiac markers in patients undergoing coronary artery bypass graft: a systematic review and meta-analysis of randomized controlled trials.. - Study
- meta-analysis
- Population
- adults undergoing coronary artery bypass grafting; overall pooled estimate
L-arginine impact on inflammatory and cardiac markers in patients undergoing coronary artery bypass graft: a systematic review and meta-analysis of randomized controlled trials.2024PMID:39538180Permalink
Increases maximal oxygen uptake
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.Finding“This meta-analysis indicated that supplementation with L-arginine could increase VO2 max in healthy people.”
Quoted verbatim from The effect of L-arginine supplementation on maximal oxygen uptake: A systematic review and meta-analysis.. - Study
- meta-analysis
- Population
- healthy people; overall pooled estimate across 11 randomized clinical trials
The effect of L-arginine supplementation on maximal oxygen uptake: A systematic review and meta-analysis.2021PMID:33587327Permalink
Decreases systolic blood pressure (setting unspecified)
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Finding“The pooled analysis demonstrated significant decreases in SBP (WMD = -6.40 mmHg; 95% CI: -8.74, -4.05; P < 0.001) and DBP (WMD = -2.64 mmHg; 95% CI: -3.94, -1.40; P < 0.001) after l-arginine supplementation.”
Quoted verbatim from Effect of l-Arginine Supplementation on Blood Pressure in Adults: A Systematic Review and Dose-Response Meta-analysis of Randomized Clinical Trials.. - Study
- meta-analysis
- Population
- adults; overall pooled estimate across all trials, not a dose or duration stratum
Effect of l-Arginine Supplementation on Blood Pressure in Adults: A Systematic Review and Dose-Response Meta-analysis of Randomized Clinical Trials.2022PMID:34967840Permalink
Decreases diastolic blood pressure (setting unspecified)
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Findingreplicated ×1“The pooled analysis demonstrated significant decreases in SBP (WMD = -6.40 mmHg; 95% CI: -8.74, -4.05; P < 0.001) and DBP (WMD = -2.64 mmHg; 95% CI: -3.94, -1.40; P < 0.001) after l-arginine supplementation.”
Quoted verbatim from Effect of l-Arginine Supplementation on Blood Pressure in Adults: A Systematic Review and Dose-Response Meta-analysis of Randomized Clinical Trials.. - Study
- meta-analysis
- Population
- adults; overall pooled estimate across all trials, not a dose or duration stratum
Effect of l-Arginine Supplementation on Blood Pressure in Adults: A Systematic Review and Dose-Response Meta-analysis of Randomized Clinical Trials.2022PMID:34967840Permalink
Show the remaining 8
Increases total antioxidant capacity
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Finding“After 30 and 60 days, significant increases in NO and TAS levels (p<0.001), as well as extended PFWD (p<0.001), were observed across all subgroups receiving L-arginine compared with controls.”
Quoted verbatim from Assessment of the effectiveness and safety of two-month oral supplementation with L-arginine depending on the type of lipid metabolism disorder in patients with atherosclerotic lower limb ischemia.. - Study
- RCT
- Dose
- 6 g/day, oral, for 30 and 60 days
- Population
- Patients over 50 years of age with Fontaine stage II atherosclerotic lower limb ischemia (hypertriglyceridemia, hypercholesterolemia and mixed hyperlipidemia subgroups)
Assessment of the effectiveness and safety of two-month oral supplementation with L-arginine depending on the type of lipid metabolism disorder in patients with atherosclerotic lower limb ischemia.2025PMID:41364169Permalink
Increases flow-mediated dilation
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Finding“Only l-arginine supplementation did improve postprandial FMD, but effects were not different from those of tree nuts and groundnuts.”
Quoted verbatim from Effects of tree nut and groundnut consumption compared with those of l-arginine supplementation on fasting and postprandial flow-mediated vasodilation: Meta-analysis of human randomized controlled trials.. - Study
- meta-analysis
- Dose
- 3-15 g/day (daily range across pooled RCTs)
- Population
- Adults; meta-analysis of human RCTs of l-arginine supplementation on postprandial flow-mediated dilation of the brachial artery, alongside separate RCTs of tree nut and groundnut consumption
Effects of tree nut and groundnut consumption compared with those of l-arginine supplementation on fasting and postprandial flow-mediated vasodilation: Meta-analysis of human randomized controlled trials.2021PMID:32980186Permalink
Decreases necrotising enterocolitis incidence
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Findingreplicated ×2“There was a statistically significant reduction in the risk of developing NEC (any stage) in the arginine group compared with the placebo group [RR 0.24 (95% CI 0.10, 0.61), RD -0.21 (95% CI -0.32, -0.09)].”
Quoted verbatim from Arginine supplementation for prevention of necrotising enterocolitis in preterm infants.. - Study
- meta-analysis
- Population
- preterm neonates given enteral or parenteral arginine supplementation vs placebo or no treatment, pooled from the single eligible trial identified by this review
Effect 0.24 risk ratio, 95% CI 0.1 to 0.61
Arginine supplementation for prevention of necrotising enterocolitis in preterm infants.2007PMID:17636753Permalink
Activates SDHA
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Finding“L-Arginine induces the expression of the regulator of mitochondrial biogenesis (PGC1 α) and genes encoding for complex I proteins such as Succinate Dehydrogenase A (SDHA), while genes of complex III (cytochrome B and ubiquinol cytochrome C1 reductase) were not affected.”
Quoted verbatim from Effects of Chronic Supplementation of L-Arginine on Physical Fitness in Water Polo Players.. - Study
- in vitro · not in humans
- Dose
- 500 μM L-Arginine, 24 hours
- Population
- human HEK-293 fibroblasts
Effects of Chronic Supplementation of L-Arginine on Physical Fitness in Water Polo Players.2021PMID:33815657Permalink
Decreases necrotising enterocolitis incidence
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Findingreplicated ×2“There was a statistically significant reduction in the risk of developing NEC (any stage) in the arginine group compared with the placebo group (RR 0.24 [95% CI 0.10, 0.61], RD -0.21 [95% CI -0.32, -0.09]).”
Quoted verbatim from Arginine supplementation for prevention of necrotising enterocolitis in preterm infants.. - Study
- meta-analysis
- Population
- preterm neonates given enteral or parenteral arginine supplementation vs placebo or no treatment, pooled from the single eligible trial identified by this review
Effect 0.24 risk ratio, 95% CI 0.1 to 0.61
Arginine supplementation for prevention of necrotising enterocolitis in preterm infants.2004PMID:15495101Permalink
Decreases infectious complication rate
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Finding“Meta-analysis showed that the L-arginine supplement group had a significantly greater CD4⁺ T-cell proliferation response (MD 5.03; 95% CI 1.11, 8.95; p<0.05), and that the incidence of infectious complications was lower (OR 0.40; 95% CI 0.17, 0.95; p<0.05) than control.”
Quoted verbatim from Effect of L-arginine on immune function: a meta-analysis.. - Study
- meta-analysis
- Population
- patients
Effect 0.4 odds ratio, 95% CI 0.17 to 0.95
Effect of L-arginine on immune function: a meta-analysis.2014PMID:25164444Permalink
Decreases diastolic blood pressure (setting unspecified)
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Findingreplicated ×1“This study demonstrates L-arginine supplementation is superior to placebo in lowering diastolic pressure and prolonging pregnancy in patients with gestational hypertension with or without proteinuria, but the effect on lowering systolic pressure and increasing neonatal weight was not statistically significant.”
Quoted verbatim from Arginine supplementation for improving maternal and neonatal outcomes in hypertensive disorder of pregnancy: a systematic review.. - Study
- meta-analysis
- Population
- patients with gestational hypertension with or without proteinuria
Arginine supplementation for improving maternal and neonatal outcomes in hypertensive disorder of pregnancy: a systematic review.2014PMID:23435582Permalink
Activates ARG1
InsufficientEvidence strength: insufficient. Mechanistic inference, no evidence found, or evidence weakened below very limited.Finding“Furthermore, L-arginine increased the activity of arginase-1 (Arg-1), while Arg-1 inhibitor abolished the protection of arginine against LPS-induced inflammation and oxidative stress.”
Quoted verbatim from L-Arginine Inhibited Inflammatory Response and Oxidative Stress Induced by Lipopolysaccharide via Arginase-1 Signaling in IPEC-J2 Cells.. - Study
- in vitro · not in humans
- Population
- IPEC-J2 porcine intestinal epithelial cells challenged with lipopolysaccharide
L-Arginine Inhibited Inflammatory Response and Oxidative Stress Induced by Lipopolysaccharide via Arginase-1 Signaling in IPEC-J2 Cells.2019PMID:30979040Permalink
What did not
19 findings
No detected effect on body mass
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.FindingNull resultreplicated ×1“Six weeks of l-arginine supplementation did not influence body weight, BMI, fat mass or lean mass in either of the ethnic groups (Table 2).”
Quoted verbatim from Effect of L-arginine on energy metabolism, skeletal muscle and brown adipose tissue in South Asian and Europid prediabetic men: a randomised double-blinded crossover study.. - Study
- crossover
- Duration
- 6 weeks
- Dose
- 9 g/day L-arginine, divided over three servings
- Population
- Prediabetic overweight South Asian and Europid men
Effect of L-arginine on energy metabolism, skeletal muscle and brown adipose tissue in South Asian and Europid prediabetic men: a randomised double-blinded crossover study.2019PMID:30377712Permalink
No detected effect on tumour necrosis factor alpha concentration
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.FindingNull resultreplicated ×2“However, we found no considerable impact of L-arginine treatment on creatine phosphokinase-MB (CPK-MB), tumor necrosis factor-alpha (TNF-α), and troponin I compared to the placebo groups.”
Quoted verbatim from L-arginine impact on inflammatory and cardiac markers in patients undergoing coronary artery bypass graft: a systematic review and meta-analysis of randomized controlled trials.. - Study
- meta-analysis
- Population
- adults undergoing coronary artery bypass grafting; overall pooled estimate
L-arginine impact on inflammatory and cardiac markers in patients undergoing coronary artery bypass graft: a systematic review and meta-analysis of randomized controlled trials.2024PMID:39538180Permalink
No detected effect on lean body mass
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.FindingNull result“Six weeks of l-arginine supplementation did not influence body weight, BMI, fat mass or lean mass in either of the ethnic groups (Table 2).”
Quoted verbatim from Effect of L-arginine on energy metabolism, skeletal muscle and brown adipose tissue in South Asian and Europid prediabetic men: a randomised double-blinded crossover study.. - Study
- crossover
- Duration
- 6 weeks
- Dose
- 9 g/day L-arginine, divided over three servings
- Population
- Prediabetic overweight South Asian and Europid men
Effect of L-arginine on energy metabolism, skeletal muscle and brown adipose tissue in South Asian and Europid prediabetic men: a randomised double-blinded crossover study.2019PMID:30377712Permalink
No detected effect on fat mass
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.FindingNull result“Six weeks of l-arginine supplementation did not influence body weight, BMI, fat mass or lean mass in either of the ethnic groups (Table 2).”
Quoted verbatim from Effect of L-arginine on energy metabolism, skeletal muscle and brown adipose tissue in South Asian and Europid prediabetic men: a randomised double-blinded crossover study.. - Study
- crossover
- Duration
- 6 weeks
- Dose
- 9 g/day L-arginine, divided over three servings
- Population
- Prediabetic overweight South Asian and Europid men
Effect of L-arginine on energy metabolism, skeletal muscle and brown adipose tissue in South Asian and Europid prediabetic men: a randomised double-blinded crossover study.2019PMID:30377712Permalink
No detected effect on glycated haemoglobin (HbA1c)
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull result“However, the effects of l-arginine supplementation on HOMA-IR and HbA1c were not significant.”
Quoted verbatim from Effects of l-arginine supplementation on glycemic profile: Evidence from a systematic review and meta-analysis of clinical trials.. - Study
- meta-analysis
- Population
- Adults; pooled analysis of RCTs (search to 5 May 2018) of l-arginine supplementation on glycemic profile
Effects of l-arginine supplementation on glycemic profile: Evidence from a systematic review and meta-analysis of clinical trials.2020PMID:32561357Permalink
No detected effect on interleukin-6 concentration
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull result“Results indicated that L-arginine supplementation had no significant effect on inflammatory biomarkers including CRP, IL-6 and TNFα.”
Quoted verbatim from Effect of l-arginine supplementation on C-reactive protein and other inflammatory biomarkers: A systematic review and meta-analysis of randomized controlled trials.. - Study
- meta-analysis
- Population
- participants in randomised controlled trials of L-arginine supplementation
Effect of l-arginine supplementation on C-reactive protein and other inflammatory biomarkers: A systematic review and meta-analysis of randomized controlled trials.2019PMID:31780028Permalink
Show the remaining 13
No detected effect on HOMA-IR
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull result“However, the effects of l-arginine supplementation on HOMA-IR and HbA1c were not significant.”
Quoted verbatim from Effects of l-arginine supplementation on glycemic profile: Evidence from a systematic review and meta-analysis of clinical trials.. - Study
- meta-analysis
- Population
- Adults; pooled analysis of RCTs (search to 5 May 2018) of l-arginine supplementation on glycemic profile
Effects of l-arginine supplementation on glycemic profile: Evidence from a systematic review and meta-analysis of clinical trials.2020PMID:32561357Permalink
No detected effect on LDL cholesterol
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull result“Compared with the Placebo groups, there was no significant effect on low-density lipoprotein cholesterol (LDL-c), total cholesterol (TC), and high-density lipoprotein cholesterol (HDL-c) after L-Arginine treatment.”
Quoted verbatim from Effect of L-Arginine supplementation on lipid profiles and inflammatory markers: A systematic review and meta-analysis of randomized controlled trials.. - Study
- meta-analysis
- Population
- humans
Effect of L-Arginine supplementation on lipid profiles and inflammatory markers: A systematic review and meta-analysis of randomized controlled trials.2019PMID:31442577Permalink
No detected effect on total cholesterol (TC)
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull result“Compared with the Placebo groups, there was no significant effect on low-density lipoprotein cholesterol (LDL-c), total cholesterol (TC), and high-density lipoprotein cholesterol (HDL-c) after L-Arginine treatment.”
Quoted verbatim from Effect of L-Arginine supplementation on lipid profiles and inflammatory markers: A systematic review and meta-analysis of randomized controlled trials.. - Study
- meta-analysis
- Population
- humans
Effect of L-Arginine supplementation on lipid profiles and inflammatory markers: A systematic review and meta-analysis of randomized controlled trials.2019PMID:31442577Permalink
No detected effect on HDL cholesterol
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull result“Compared with the Placebo groups, there was no significant effect on low-density lipoprotein cholesterol (LDL-c), total cholesterol (TC), and high-density lipoprotein cholesterol (HDL-c) after L-Arginine treatment.”
Quoted verbatim from Effect of L-Arginine supplementation on lipid profiles and inflammatory markers: A systematic review and meta-analysis of randomized controlled trials.. - Study
- meta-analysis
- Population
- humans
Effect of L-Arginine supplementation on lipid profiles and inflammatory markers: A systematic review and meta-analysis of randomized controlled trials.2019PMID:31442577Permalink
No detected effect on tumour necrosis factor alpha concentration
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull resultreplicated ×2“Results indicated that L-arginine supplementation had no significant effect on inflammatory biomarkers including CRP, IL-6 and TNFα.”
Quoted verbatim from Effect of l-arginine supplementation on C-reactive protein and other inflammatory biomarkers: A systematic review and meta-analysis of randomized controlled trials.. - Study
- meta-analysis
- Population
- participants in randomised controlled trials of L-arginine supplementation
Effect of l-arginine supplementation on C-reactive protein and other inflammatory biomarkers: A systematic review and meta-analysis of randomized controlled trials.2019PMID:31780028Permalink
No detected effect on body mass
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull resultreplicated ×1“However, L-arginine intervention had not elicited a significant effect on BMI (WMD: -0.51 kg/m2; 95% CI: -1.11 to .08, P = 0.09) and body weight (WMD: -0.57 kg; 95% CI: -1.77 to 0.61, P = 0.34).”
Quoted verbatim from The effect of L-arginine supplementation on obesity-related indices: A systematic review and meta-analysis of randomized clinical trials.. - Study
- meta-analysis
- Population
- humans
Effect -0.57 mean difference, 95% CI -1.77 to 0.61
The effect of L-arginine supplementation on obesity-related indices: A systematic review and meta-analysis of randomized clinical trials.2021PMID:30982445Permalink
No detected effect on hospital length of stay
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull result“There was no significant difference in hospital length of stay (4.1 ± 01.8 versus 4.8 ± 2.5 days, P=0.34), although a trend favored the arginine arm, and total opioid use was strongly correlated with the duration of the admission (r=0.86, P<0.0001).”
Quoted verbatim from A randomized, placebo-controlled trial of arginine therapy for the treatment of children with sickle cell disease hospitalized with vaso-occlusive pain episodes.. - Study
- RCT
- Dose
- L-arginine 100 mg/kg three times daily for 5 days or until discharge, versus placebo
- Population
- Children with sickle cell disease hospitalised with vaso-occlusive pain episodes (38 children, 56 episodes)
A randomized, placebo-controlled trial of arginine therapy for the treatment of children with sickle cell disease hospitalized with vaso-occlusive pain episodes.2013PMID:23645695Permalink
No detected effect on body mass index
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull result“However, L-arginine intervention had not elicited a significant effect on BMI (WMD: -0.51 kg/m2; 95% CI: -1.11 to .08, P = 0.09) and body weight (WMD: -0.57 kg; 95% CI: -1.77 to 0.61, P = 0.34).”
Quoted verbatim from The effect of L-arginine supplementation on obesity-related indices: A systematic review and meta-analysis of randomized clinical trials.. - Study
- meta-analysis
- Population
- humans
Effect -0.51 mean difference, 95% CI -1.11 to 0.08
The effect of L-arginine supplementation on obesity-related indices: A systematic review and meta-analysis of randomized clinical trials.2021PMID:30982445Permalink
No detected effect on C-reactive protein concentration
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull resultreplicated ×1“Results indicated that L-arginine supplementation had no significant effect on inflammatory biomarkers including CRP, IL-6 and TNFα.”
Quoted verbatim from Effect of l-arginine supplementation on C-reactive protein and other inflammatory biomarkers: A systematic review and meta-analysis of randomized controlled trials.. - Study
- meta-analysis
- Population
- participants in randomised controlled trials of L-arginine supplementation
Effect of l-arginine supplementation on C-reactive protein and other inflammatory biomarkers: A systematic review and meta-analysis of randomized controlled trials.2019PMID:31780028Permalink
No detected effect on arginine-to-ornithine ratio
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull result“Pharmacodynamic analysis confirmed increased plasma arginine levels but showed no significant change in the arginine-to-ornithine ratio.”
Quoted verbatim from Arginine therapy in sickle cell disease: A systematic review and meta-analysis of clinical outcomes.. - Study
- meta-analysis
- Population
- Sickle cell disease patients with vaso-occlusive crises; meta-analysis of 8 RCTs (n=830) of L-arginine vs placebo or standard care; pharmacodynamic sub-analysis
Arginine therapy in sickle cell disease: A systematic review and meta-analysis of clinical outcomes.2026PMID:41534622Permalink
No detected effect on C-reactive protein concentration
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull resultreplicated ×1“According to the results of the present systematic review and meta-analysis, L-Arginine does not significantly affect CRP and TNFα indices.”
Quoted verbatim from Effect of L-Arginine supplementation on lipid profiles and inflammatory markers: A systematic review and meta-analysis of randomized controlled trials.. - Study
- meta-analysis
- Population
- humans
Effect of L-Arginine supplementation on lipid profiles and inflammatory markers: A systematic review and meta-analysis of randomized controlled trials.2019PMID:31442577Permalink
No detected effect on tumour necrosis factor alpha concentration
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull resultreplicated ×2“According to the results of the present systematic review and meta-analysis, L-Arginine does not significantly affect CRP and TNFα indices.”
Quoted verbatim from Effect of L-Arginine supplementation on lipid profiles and inflammatory markers: A systematic review and meta-analysis of randomized controlled trials.. - Study
- meta-analysis
- Population
- humans
Effect of L-Arginine supplementation on lipid profiles and inflammatory markers: A systematic review and meta-analysis of randomized controlled trials.2019PMID:31442577Permalink
No detected effect on systolic blood pressure (setting unspecified)
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull result“This study demonstrates L-arginine supplementation is superior to placebo in lowering diastolic pressure and prolonging pregnancy in patients with gestational hypertension with or without proteinuria, but the effect on lowering systolic pressure and increasing neonatal weight was not statistically significant.”
Quoted verbatim from Arginine supplementation for improving maternal and neonatal outcomes in hypertensive disorder of pregnancy: a systematic review.. - Study
- meta-analysis
- Population
- patients with gestational hypertension with or without proteinuria
Arginine supplementation for improving maternal and neonatal outcomes in hypertensive disorder of pregnancy: a systematic review.2014PMID:23435582Permalink
What it touches on the way
Mechanistic reach
25 entities
25 entities reached.
0 reported hops25 assembled from the scaffold
- NOS2ProteinUNIPROT:P35228substrate ofInferred only459 paths152 endpoints
- NOS3ProteinUNIPROT:P29474substrate ofInferred only216 paths72 endpoints
- SLC7A7ProteinUNIPROT:Q9UM01transported byInferred only160 paths16 endpoints
- NOS1ProteinUNIPROT:P29475substrate ofInferred only153 paths51 endpoints
- SLC7A9ProteinUNIPROT:P82251transported byInferred only148 paths9 endpoints
- SLC25A29ProteinUNIPROT:Q8N8R3transported byInferred only144 paths24 endpoints
- SLC3A2ProteinUNIPROT:P08195transported byInferred only132 paths12 endpoints
- ARG1ProteinUNIPROT:P05089activates, substrate ofInferred only59 paths32 endpoints
- RARS1ProteinUNIPROT:P54136substrate ofInferred only52 paths26 endpoints
- SLC7A6ProteinUNIPROT:Q92536transported byInferred only48 paths2 endpoints
- ASLProteinUNIPROT:P04424substrate ofInferred only42 paths21 endpoints
- GATMProteinUNIPROT:P50440substrate ofInferred only40 paths8 endpoints
Show the remaining 13
- SLC7A1ProteinUNIPROT:P30825transported byInferred only38 paths19 endpoints
- CHRNA7ProteinUNIPROT:P36544transported byInferred only34 paths34 endpoints
- SLC7A5ProteinUNIPROT:Q01650transported byInferred only32 paths8 endpoints
- L-citrullineCompoundCHEBI:16349converted toInferred only27 paths6 endpoints
- SLC7A2ProteinUNIPROT:P52569transported byInferred only26 paths13 endpoints
- ARG2ProteinUNIPROT:P78540substrate ofInferred only18 paths9 endpoints
- SLC3A1ProteinUNIPROT:Q07837transported byInferred only14 paths1 endpoint
- IL4I1ProteinUNIPROT:Q96RQ9substrate ofInferred only6 paths6 endpoints
- RARS2ProteinUNIPROT:Q5T160substrate ofInferred only4 paths4 endpoints
- AGMATProteinUNIPROT:Q9BSE5substrate ofInferred only4 paths4 endpoints
- SLC6A14ProteinUNIPROT:Q9UN76transported byInferred only4 paths2 endpoints
- SLC38A4ProteinUNIPROT:Q969I6transported byInferred only2 paths2 endpoints
- CLTRNProteinUNIPROT:Q9HBJ8transported byInferred only1 path1 endpoint
What the reference databases state
Chemical structure
- CHEBI:15816 is the enantiomer of L-arginineCompoundChEBI CHEBI:15816Inferred only
Statements
202 statements
202 statements · 2 reference databases · Subject: L-arginine · Sources: Human-GEM, Rhea
- 5-guanidino-2-oxopentanoate is converted to L-arginineCompoundRhea RHEA:78819Inferred only
- L-arginine is converted to 5-guanidino-2-oxopentanoateCompoundRhea RHEA:47636Inferred only
- L-arginine is converted to 5-guanidino-2-oxopentanoateCompoundRhea RHEA:47632Inferred only
- 5-guanidino-2-oxopentanoate is converted to L-arginineCompoundRhea RHEA:47632Inferred only
- L-arginine is converted to 5-guanidino-2-oxopentanoateCompoundRhea RHEA:78819Inferred only
- 5-guanidino-2-oxopentanoate is converted to L-arginineCompoundRhea RHEA:47636Inferred only
- L-arginine is converted to 5-guanidino-2-oxopentanoateCompoundRhea RHEA:51404Inferred only
- L-arginine is converted to agmatineCompoundHuman-GEM MAR04191Inferred only
- L-arginine is converted to agmatineCompoundRhea RHEA:17641Inferred only
- agmatine is converted to L-arginineCompoundRhea RHEA:17641Inferred only
- L-arginine is converted to D-arginineCompoundRhea RHEA:18069Inferred only
- D-arginine is converted to L-arginineCompoundRhea RHEA:18069Inferred only
Show the remaining 190
- L-citrulline is converted to L-arginineCompoundRhea RHEA:79571Inferred only
- L-arginine is converted to L-citrullineCompoundRhea RHEA:79571Inferred only
- L-citrulline is converted to L-arginineCompoundRhea RHEA:19597Inferred only
- L-arginine is converted to L-citrullineCompoundHuman-GEM MAR03832Inferred only
- L-arginine is converted to L-citrullineCompoundRhea RHEA:19597Inferred only
- L-arginine is converted to L-ornithineCompoundRhea RHEA:78779Inferred only
- L-ornithine is converted to L-arginineCompoundRhea RHEA:78779Inferred only
- N(5)-[(Z)-amino(hydroxyimino)methyl]ornithine is converted to L-arginineCompoundHuman-GEM MAR04190Inferred only
- L-arginine is converted to N(5)-[(Z)-amino(hydroxyimino)methyl]ornithineCompoundHuman-GEM MAR04190Inferred only
- N(omega)-hydroxy-L-arginine is converted to L-arginineCompoundRhea RHEA:24660Inferred only
- L-arginine is converted to N(omega)-hydroxy-L-arginineCompoundRhea RHEA:33939Inferred only
- L-arginine is converted to N(omega)-hydroxy-L-arginineCompoundRhea RHEA:24660Inferred only
- N(omega)-hydroxy-L-arginine is converted to L-arginineCompoundRhea RHEA:33939Inferred only
- N(omega)-methyl-L-arginine is converted to L-arginineCompoundRhea RHEA:59756Inferred only
- L-arginine is converted to N(omega)-methyl-L-arginineCompoundRhea RHEA:59756Inferred only
- L-arginine is a substrate of AGMATProteinRhea RHEA:20569Inferred only
- L-arginine is a substrate of ARG1ProteinHuman-GEM MAR03816Inferred only
- L-arginine is a substrate of ARG1ProteinRhea RHEA:20569Inferred only
- L-arginine is a substrate of ARG2ProteinHuman-GEM MAR08426Inferred only
- L-arginine is a substrate of ARG2ProteinRhea RHEA:20569Inferred only
- L-arginine is a substrate of ASLProteinHuman-GEM MAR03813Inferred only
- L-arginine is a substrate of ASLProteinRhea RHEA:24020Inferred only
- L-arginine is a substrate of GATMProteinHuman-GEM MAR04582Inferred only
- L-arginine is a substrate of GATMProteinRhea RHEA:75939Inferred only
- L-arginine is a substrate of GATMProteinRhea RHEA:75943Inferred only
- L-arginine is a substrate of GATMProteinRhea RHEA:75947Inferred only
- L-arginine is a substrate of GATMProteinRhea RHEA:13201Inferred only
- L-arginine is a substrate of IL4I1ProteinRhea RHEA:51404Inferred only
- L-arginine is a substrate of NOS1ProteinHuman-GEM MAR04190Inferred only
- L-arginine is a substrate of NOS1ProteinHuman-GEM MAR02023Inferred only
- L-arginine is a substrate of NOS1ProteinRhea RHEA:19897Inferred only
- L-arginine is a substrate of NOS2ProteinRhea RHEA:19897Inferred only
- L-arginine is a substrate of NOS2ProteinHuman-GEM MAR02023Inferred only
- L-arginine is a substrate of NOS2ProteinHuman-GEM MAR04190Inferred only
- L-arginine is a substrate of NOS3ProteinHuman-GEM MAR02023Inferred only
- L-arginine is a substrate of NOS3ProteinHuman-GEM MAR04190Inferred only
- L-arginine is a substrate of NOS3ProteinRhea RHEA:19897Inferred only
- L-arginine is a substrate of RARS1ProteinHuman-GEM MAR05132Inferred only
- L-arginine is a substrate of RARS1ProteinRhea RHEA:20301Inferred only
- L-arginine is a substrate of RARS2ProteinRhea RHEA:20301Inferred only
- L-arginine is transported by CHRNA7ProteinRhea RHEA:32143Inferred only
- L-arginine is transported by CLTRNProteinHuman-GEM MAR09871Inferred only
- L-arginine is transported by SLC25A15ProteinHuman-GEM MAR06307Inferred only
- L-arginine is transported by SLC25A15ProteinHuman-GEM MAR06308Inferred only
- L-arginine is transported by SLC25A15ProteinHuman-GEM MAR06323Inferred only
- L-arginine is transported by SLC25A15ProteinHuman-GEM MAR00079Inferred only
- L-arginine is transported by SLC25A15ProteinRhea RHEA:34991Inferred only
- L-arginine is transported by SLC25A2ProteinHuman-GEM MAR06308Inferred only
- L-arginine is transported by SLC25A2ProteinHuman-GEM MAR06312Inferred only
- L-arginine is transported by SLC25A2ProteinRhea RHEA:72811Inferred only
- L-arginine is transported by SLC25A2ProteinRhea RHEA:32143Inferred only
- L-arginine is transported by SLC25A2ProteinHuman-GEM MAR06311Inferred only
- L-arginine is transported by SLC25A2ProteinHuman-GEM MAR06299Inferred only
- L-arginine is transported by SLC25A2ProteinHuman-GEM MAR06310Inferred only
- L-arginine is transported by SLC25A2ProteinHuman-GEM MAR06300Inferred only
- L-arginine is transported by SLC25A2ProteinHuman-GEM MAR06323Inferred only
- L-arginine is transported by SLC25A2ProteinHuman-GEM MAR06307Inferred only
- L-arginine is transported by SLC25A2ProteinHuman-GEM MAR00079Inferred only
- L-arginine is transported by SLC25A2ProteinHuman-GEM MAR06309Inferred only
- L-arginine is transported by SLC25A29ProteinRhea RHEA:70827Inferred only
- L-arginine is transported by SLC25A29ProteinRhea RHEA:34991Inferred only
- L-arginine is transported by SLC25A29ProteinRhea RHEA:72799Inferred only
- L-arginine is transported by SLC25A29ProteinRhea RHEA:72803Inferred only
- L-arginine is transported by SLC25A29ProteinRhea RHEA:71063Inferred only
- L-arginine is transported by SLC25A29ProteinRhea RHEA:32143Inferred only
- L-arginine is transported by SLC38A4ProteinHuman-GEM MAR05068Inferred only
- L-arginine is transported by SLC38A8ProteinRhea RHEA:32143Inferred only
- L-arginine is transported by SLC3A1ProteinHuman-GEM MAR05932Inferred only
- L-arginine is transported by SLC3A1ProteinHuman-GEM MAR05928Inferred only
- L-arginine is transported by SLC3A1ProteinHuman-GEM MAR05938Inferred only
- L-arginine is transported by SLC3A1ProteinHuman-GEM MAR05937Inferred only
- L-arginine is transported by SLC3A1ProteinHuman-GEM MAR05936Inferred only
- L-arginine is transported by SLC3A1ProteinHuman-GEM MAR05935Inferred only
- L-arginine is transported by SLC3A1ProteinHuman-GEM MAR05934Inferred only
- L-arginine is transported by SLC3A1ProteinHuman-GEM MAR05933Inferred only
- L-arginine is transported by SLC3A1ProteinHuman-GEM MAR05929Inferred only
- L-arginine is transported by SLC3A1ProteinHuman-GEM MAR05923Inferred only
- L-arginine is transported by SLC3A1ProteinHuman-GEM MAR05924Inferred only
- L-arginine is transported by SLC3A1ProteinHuman-GEM MAR05931Inferred only
- L-arginine is transported by SLC3A1ProteinHuman-GEM MAR05925Inferred only
- L-arginine is transported by SLC3A1ProteinHuman-GEM MAR05930Inferred only
- L-arginine is transported by SLC3A1ProteinHuman-GEM MAR05926Inferred only
- L-arginine is transported by SLC3A1ProteinHuman-GEM MAR05927Inferred only
- L-arginine is transported by SLC3A2ProteinHuman-GEM MAR06863Inferred only
- L-arginine is transported by SLC3A2ProteinHuman-GEM MAR05873Inferred only
- L-arginine is transported by SLC3A2ProteinHuman-GEM MAR07102Inferred only
- L-arginine is transported by SLC3A2ProteinHuman-GEM MAR07153Inferred only
- L-arginine is transported by SLC3A2ProteinHuman-GEM MAR11804Inferred only
- L-arginine is transported by SLC3A2ProteinHuman-GEM MAR07189Inferred only
- L-arginine is transported by SLC3A2ProteinHuman-GEM MAR05578Inferred only
- L-arginine is transported by SLC3A2ProteinHuman-GEM MAR07105Inferred only
- L-arginine is transported by SLC3A2ProteinHuman-GEM MAR07151Inferred only
- L-arginine is transported by SLC3A2ProteinHuman-GEM MAR11810Inferred only
- L-arginine is transported by SLC3A2ProteinHuman-GEM MAR06897Inferred only
- L-arginine is transported by SLC6A14ProteinHuman-GEM MAR09592Inferred only
- L-arginine is transported by SLC6A14ProteinRhea RHEA:71287Inferred only
- L-arginine is transported by SLC6A18ProteinHuman-GEM MAR09871Inferred only
- L-arginine is transported by SLC7A1ProteinHuman-GEM MAR05068Inferred only
- L-arginine is transported by SLC7A1ProteinRhea RHEA:32143Inferred only
- L-arginine is transported by SLC7A2ProteinHuman-GEM MAR05068Inferred only
- L-arginine is transported by SLC7A2ProteinRhea RHEA:32143Inferred only
- L-arginine is transported by SLC7A3ProteinHuman-GEM MAR05068Inferred only
- L-arginine is transported by SLC7A3ProteinRhea RHEA:32143Inferred only
- L-arginine is transported by SLC7A5ProteinHuman-GEM MAR05582Inferred only
- L-arginine is transported by SLC7A5ProteinHuman-GEM MAR05578Inferred only
- L-arginine is transported by SLC7A5ProteinHuman-GEM MAR05583Inferred only
- L-arginine is transported by SLC7A5ProteinHuman-GEM MAR05584Inferred only
- L-arginine is transported by SLC7A6ProteinHuman-GEM MAR05928Inferred only
- L-arginine is transported by SLC7A6ProteinHuman-GEM MAR05927Inferred only
- L-arginine is transported by SLC7A6ProteinHuman-GEM MAR05929Inferred only
- L-arginine is transported by SLC7A6ProteinHuman-GEM MAR05926Inferred only
- L-arginine is transported by SLC7A6ProteinHuman-GEM MAR05925Inferred only
- L-arginine is transported by SLC7A6ProteinHuman-GEM MAR05930Inferred only
- L-arginine is transported by SLC7A6ProteinHuman-GEM MAR11810Inferred only
- L-arginine is transported by SLC7A6ProteinHuman-GEM MAR05924Inferred only
- L-arginine is transported by SLC7A6ProteinHuman-GEM MAR05931Inferred only
- L-arginine is transported by SLC7A6ProteinHuman-GEM MAR05923Inferred only
- L-arginine is transported by SLC7A6ProteinHuman-GEM MAR05903Inferred only
- L-arginine is transported by SLC7A6ProteinHuman-GEM MAR05932Inferred only
- L-arginine is transported by SLC7A6ProteinHuman-GEM MAR05898Inferred only
- L-arginine is transported by SLC7A6ProteinHuman-GEM MAR05893Inferred only
- L-arginine is transported by SLC7A6ProteinHuman-GEM MAR05933Inferred only
- L-arginine is transported by SLC7A6ProteinHuman-GEM MAR05888Inferred only
- L-arginine is transported by SLC7A6ProteinHuman-GEM MAR05883Inferred only
- L-arginine is transported by SLC7A6ProteinHuman-GEM MAR05934Inferred only
- L-arginine is transported by SLC7A6ProteinHuman-GEM MAR05878Inferred only
- L-arginine is transported by SLC7A6ProteinHuman-GEM MAR05863Inferred only
- L-arginine is transported by SLC7A6ProteinHuman-GEM MAR05935Inferred only
- L-arginine is transported by SLC7A6ProteinHuman-GEM MAR05873Inferred only
- L-arginine is transported by SLC7A6ProteinHuman-GEM MAR05868Inferred only
- L-arginine is transported by SLC7A6ProteinHuman-GEM MAR05936Inferred only
- L-arginine is transported by SLC7A6ProteinHuman-GEM MAR05858Inferred only
- L-arginine is transported by SLC7A6ProteinHuman-GEM MAR05853Inferred only
- L-arginine is transported by SLC7A6ProteinHuman-GEM MAR05937Inferred only
- L-arginine is transported by SLC7A6ProteinHuman-GEM MAR07189Inferred only
- L-arginine is transported by SLC7A6ProteinHuman-GEM MAR05848Inferred only
- L-arginine is transported by SLC7A6ProteinHuman-GEM MAR05938Inferred only
- L-arginine is transported by SLC7A6ProteinHuman-GEM MAR05843Inferred only
- L-arginine is transported by SLC7A6ProteinHuman-GEM MAR05838Inferred only
- L-arginine is transported by SLC7A6ProteinHuman-GEM MAR05833Inferred only
- L-arginine is transported by SLC7A6ProteinHuman-GEM MAR05828Inferred only
- L-arginine is transported by SLC7A6ProteinHuman-GEM MAR05584Inferred only
- L-arginine is transported by SLC7A6ProteinHuman-GEM MAR05583Inferred only
- L-arginine is transported by SLC7A6ProteinHuman-GEM MAR05582Inferred only
- L-arginine is transported by SLC7A6ProteinHuman-GEM MAR05578Inferred only
- L-arginine is transported by SLC7A6ProteinRhea RHEA:70827Inferred only
- L-arginine is transported by SLC7A6ProteinRhea RHEA:70831Inferred only
- L-arginine is transported by SLC7A6ProteinHuman-GEM MAR06863Inferred only
- L-arginine is transported by SLC7A6ProteinRhea RHEA:70835Inferred only
- L-arginine is transported by SLC7A6ProteinRhea RHEA:70839Inferred only
- L-arginine is transported by SLC7A6ProteinHuman-GEM MAR06897Inferred only
- L-arginine is transported by SLC7A6ProteinRhea RHEA:70843Inferred only
- L-arginine is transported by SLC7A6ProteinRhea RHEA:70847Inferred only
- L-arginine is transported by SLC7A6ProteinHuman-GEM MAR07102Inferred only
- L-arginine is transported by SLC7A6ProteinHuman-GEM MAR07153Inferred only
- L-arginine is transported by SLC7A6ProteinHuman-GEM MAR07151Inferred only
- L-arginine is transported by SLC7A6ProteinHuman-GEM MAR07105Inferred only
- L-arginine is transported by SLC7A7ProteinHuman-GEM MAR07189Inferred only
- L-arginine is transported by SLC7A7ProteinHuman-GEM MAR05873Inferred only
- L-arginine is transported by SLC7A7ProteinHuman-GEM MAR06863Inferred only
- L-arginine is transported by SLC7A7ProteinHuman-GEM MAR06897Inferred only
- L-arginine is transported by SLC7A7ProteinHuman-GEM MAR07102Inferred only
- L-arginine is transported by SLC7A7ProteinHuman-GEM MAR07105Inferred only
- L-arginine is transported by SLC7A7ProteinHuman-GEM MAR07151Inferred only
- L-arginine is transported by SLC7A7ProteinHuman-GEM MAR07153Inferred only
- L-arginine is transported by SLC7A7ProteinHuman-GEM MAR11804Inferred only
- L-arginine is transported by SLC7A7ProteinRhea RHEA:70831Inferred only
- L-arginine is transported by SLC7A9ProteinHuman-GEM MAR05927Inferred only
- L-arginine is transported by SLC7A9ProteinHuman-GEM MAR05926Inferred only
- L-arginine is transported by SLC7A9ProteinHuman-GEM MAR05935Inferred only
- L-arginine is transported by SLC7A9ProteinHuman-GEM MAR05934Inferred only
- L-arginine is transported by SLC7A9ProteinHuman-GEM MAR05933Inferred only
- L-arginine is transported by SLC7A9ProteinHuman-GEM MAR05937Inferred only
- L-arginine is transported by SLC7A9ProteinHuman-GEM MAR05932Inferred only
- L-arginine is transported by SLC7A9ProteinHuman-GEM MAR05931Inferred only
- L-arginine is transported by SLC7A9ProteinHuman-GEM MAR05938Inferred only
- L-arginine is transported by SLC7A9ProteinRhea RHEA:71075Inferred only
- L-arginine is transported by SLC7A9ProteinRhea RHEA:71071Inferred only
- L-arginine is transported by SLC7A9ProteinRhea RHEA:71067Inferred only
- L-arginine is transported by SLC7A9ProteinHuman-GEM MAR05925Inferred only
- L-arginine is transported by SLC7A9ProteinHuman-GEM MAR05930Inferred only
- L-arginine is transported by SLC7A9ProteinHuman-GEM MAR05929Inferred only
- L-arginine is transported by SLC7A9ProteinHuman-GEM MAR05928Inferred only
- L-arginine is transported by SLC7A9ProteinRhea RHEA:71063Inferred only
- L-arginine is transported by SLC7A9ProteinRhea RHEA:71059Inferred only
- L-arginine is transported by SLC7A9ProteinRhea RHEA:70827Inferred only
- L-arginine is transported by SLC7A9ProteinHuman-GEM MAR05923Inferred only
- L-arginine is transported by SLC7A9ProteinHuman-GEM MAR05936Inferred only
- L-arginine is transported by SLC7A9ProteinHuman-GEM MAR05924Inferred only
- L-arginine is transported by SLCO4C1ProteinRhea RHEA:32143Inferred only
Reactions
256 reactions
L-alanine+L-arginine+L-asparagine+L-aspartate+CHEBI:1307929+a cholesterol ester+a cardiolipin+MAM01602c+L-cysteine+MAM01721n+MAM01722n+L-glutamate(1-)+L-glutamine+glycine+CHEBI:15971+L-isoleucine+L-leucine+MAM02392c+CHEBI:18019+L-methionine+L-phenylalanine+phosphatidic acid+1-phosphatidyl-1D-myo-inositol+CHEBI:17203+MAM02847c+L-seryl residue+a sphingomyelin+CHEBI:16857+L-tryptophan+CHEBI:17895+L-valine+MAM03161cMAM03970c
Reaction pageBlockedBalance undeterminablecytosol, endoplasmic reticulum, nucleus
Human-GEM MAR00021CC BY 4.0Reference data
L-arginine+protonL-arginine+proton
Transported by SLC25A15 or SLC25A2
Reaction pageReversibleBalancedEC 4.3.2.1cytosol, mitochondrial matrix
Human-GEM MAR00079CC BY 4.0Reference data
L-arginine+2NADPH(4-)+2dioxygenL-citrulline+2water+2NADP(3-)+nitric oxide
Catalysed by NOS2 or NOS1 or NOS3
Reaction pageLeft to rightUnbalancedEC 1.14.13.39cytosol
Human-GEM MAR02023CC BY 4.0Reference data
L-arginine+fumaric acid2-(N(omega)-L-arginino)succinate
Catalysed by ASL
Reaction pageReversibleBalancedEC 4.3.2.1cytosol
Human-GEM MAR03813CC BY 4.0Reference data
L-arginine+waterL-ornithine+urea
Catalysed by ARG1
Reaction pageLeft to rightBalancedEC 3.5.3.1cytosol
Human-GEM MAR03816CC BY 4.0Reference data
L-arginine+waterL-citrulline+proton+ammonium
Reaction pageLeft to rightBalancedEC 3.5.3.6cytosol
Human-GEM MAR03832CC BY 4.0Reference data
L-arginine+proton+NADPH(4-)+dioxygenwater+N(5)-[(Z)-amino(hydroxyimino)methyl]ornithine+NADP(3-)
Catalysed by NOS2 or NOS1 or NOS3
Reaction pageReversibleBalancedEC 1.14.13.39cytosol
Human-GEM MAR04190CC BY 4.0Reference data
L-arginine+protonagmatine+carbon dioxide
Reaction pageLeft to rightBalancedEC 4.1.1.19mitochondrial matrix
Human-GEM MAR04191CC BY 4.0Reference data
0.505626L-alanine+0.35926L-arginine+0.279425L-asparagine+0.352607L-aspartate+20.704451ATP+0.020401CHEBI:1307929+0.011658a cardiolipin+0.039036CHEBI:17677+0.046571L-cysteine+0.013183CHEBI:16284+0.009442dCTP+0.009898CHEBI:16497+0.013091dTTP+0.275194D-glucopyranose 6-phosphate+0.385872L-glutamate(1-)+0.325996L-glutamine+0.538891glycine+0.036117GTP+20.650823water+0.126406CHEBI:15971+0.286078L-isoleucine+0.545544L-leucine+0.592114CHEBI:18019+0.153018L-methionine+0.1544631,2-diacyl-sn-glycero-3-phosphocholine(1+)+0.055374phosphatidylethanolamine+0.002914MAM02715c+0.259466L-phenylalanine+0.0233151-phosphatidyl-1D-myo-inositol+0.412484CHEBI:17203+0.005829phosphatidyl-L-serine+0.392525L-seryl residue+0.017486a sphingomyelin+0.31269CHEBI:16857+0.013306L-tryptophan+0.159671CHEBI:17895+0.053446UTP+0.352607L-valine20.650823ADP+20.650823proton+20.650823phosphate(3-)+MAM03970c
Reaction pageBlockedBalance undeterminablecytosol, nucleus
Human-GEM MAR04413CC BY 4.0Reference data
L-arginine+glycineguanidinoacetate+L-ornithine
Catalysed by GATM
Reaction pageReversibleBalancedEC 2.1.4.1cytosol
Human-GEM MAR04582CC BY 4.0Reference data
Reaction pageLeft to rightBalancedlysosome, cytosol
Human-GEM MAR05048CC BY 4.0Reference data
Transported by SLC7A2 or SLC38A4 or SLC7A1 or SLC7A3
Reaction pageLeft to rightBalancedextracellular space, cytosol
Human-GEM MAR05068CC BY 4.0Reference data
On the label
Labelled products
1,024 products
Source: NIH DSLD · Ingredient: L-arginine · 1,024 products · Declared amount per serving: 0.45–7,000 mg (865 products) · Showing 1,000 of 1,024
972 labels state an amount28 do not
- 21st CenturyL-Arginine 1000 mgL-Arginine Hydrochloride · L-Arginine (Form: from L-Arginine Hydrochloride)1,000 mgper 1 Tablet(s)DSLD:206642
- A1 Top World ProductsDoctor's Super Man Power300 mgper 2 Capsule(s)DSLD:25838
- Absorb HealthL-Arginine 400 mg400 mgper 1 Capsule(s)DSLD:215936
- Absorb HealthN-Acetyl Cysteine 600 mg600 mgper 1 Capsule(s)DSLD:306967
- Advantage PharmaceuticalsNoxySurge100 mgper 2 Capsule(s)DSLD:36533
- AdvocareCatalyst100 mgper 3 Capsule(s)DSLD:60518
- AdvoCareArginine Extreme Citrus2.5 Gram(s)per 13 Gram(s)DSLD:265495
- AdvoCareCatalyst100 mgper 3 Capsule(s)DSLD:265036
- AdvoCareMNS CL-Arginine Hydrochloride · L-Arginine (Form: as L-Arginine HCl)200 mgper 2 Packet(s)DSLD:207148
- AdvoCareMNS EL-Arginine Hydrochloride · L-Arginine (Form: as L-Arginine HCl)200 mgper 1 Packet(s)DSLD:177964
- AdvoCareNighttime RecoveryL-Arginine Hydrochloride400 mgper 1 Caplet(s)DSLD:318412
- Allergy Research GroupAmino Acid Neurotransmitter Formula80 mgper 4 Gram(s)DSLD:54247
Show the remaining 1,012
- Allergy Research GroupEstroPrimeamount not statedper 2 Tablet(s)DSLD:56015
- Allergy Research GroupL-Arginine500 mgper 1 Capsule(s)DSLD:233159
- Allergy Research GroupL-Arginine500 mgper 1 Capsule(s)DSLD:258241
- Allergy Research GroupNO Inducers125 mgper 3 Capsule(s)DSLD:233303
- Allergy Research GroupSteady On110 mgper 20 Gram(s)DSLD:54474
- Allergy Research GroupSteady On110 mgper 20 Gram(s)DSLD:54482
- Allergy Research GroupTake Heart II Without Hormones480 mgper 20 Gram(s)DSLD:54484
- Allergy Research GroupTake Heart II Without Hormones480 mgper 20 Gram(s)DSLD:54477
- ALLMAXAnabolinex104 mgper 2 Tablet(s)DSLD:326013
- ALLMAXImpact Igniter Sport Peach MangoL-Arginine Alpha-Ketoglutarate · L-arginine (as L-arginine AKG 2:1)167 mgper 6.4 Gram(s)DSLD:325807
- ALLMAXVitastack Orange104 mgper 8.3 Gram(s)DSLD:264245
- ALLMAX ESSENTIALSAgmatine + ArginineArginine Hydrochloride210 mgper 1004 mgDSLD:325772
- ALLMAX ESSENTIALSArginine HCl5 Gram(s)per 5 Gram(s)DSLD:296134
- Amazing HerbsHorny Goat Express +L-Arginine Hydrochloride20 mgper 2 Capsule(s)DSLD:272866
- Amazing MuscleL-Arginine 1000 mgL-Arginine Hydrochloride · L-Arginine (Form: as L-Arginine HCl)1,000 mgper 1 Tablet(s)DSLD:251154
- Amazing MuscleL-Arginine 500 mgL-Arginine Note: free form500 mgper 1 Capsule(s)DSLD:251842
- Amazing MuscleL-Arginine 500 mgL-Arginine Note: free form500 mgper 1 Capsule(s)DSLD:251159
- Amazing MuscleL-Arginine L-Citrulline 1000 mgL-Arginine Hydrochloride · L-Arginine (Form: as L-Arginine HCl)750 mgper 1 Tablet(s)DSLD:251162
- Amazing MuscleL-Arginine UnflavoredL-Arginine Note: free form4,600 mgper 4.6 Gram(s)DSLD:251161
- AmvilabJuvextraL-Arginine Hydrochloride20 mgper 2 Capsule(s)DSLD:298153
- AN Amazing Nutrition Amazing FormulasL-Arginine 1,000 mgL-Arginine Hydrochloride · L-Arginine (Form: as L-Arginine HCl)1,000 mgper 1 Capsule(s)DSLD:256039
- AN Amazing Nutrition Amazing FormulasL-Arginine 500 mgL-Arginine Note: free form500 mgper 500 mgDSLD:251356
- AN Amazing Nutrition Amazing FormulasL-Arginine 500 mgL-Arginine Note: free-form500 mgper 1 Capsule(s)DSLD:251922
- AN Amazing Nutrition Amazing FormulasL-Arginine 500 mgfree-form500 mgper 1 Capsule(s)DSLD:314675
- AN Amazing Nutrition Amazing FormulasL-Arginine L-Ornithine 1,500 mgfree-form1,000 mgper 2 Capsule(s)DSLD:314677
- AN Amazing Nutrition Amazing FormulasL-Arginine/L-Citrulline Complex 1000 mgL-Arginine Hydrochloride · L-Arginine (Form: as L-Arginine HCl)750 mgper 1 Tablet(s)DSLD:251920
- AN Amazing Nutrition Amazing FormulasL-Arginine/L-Citrulline Complex 1000 mgL-Arginine Hydrochloride750 mgper 1 Tablet(s)DSLD:314676
- ANTIAGING Institute of CaliforniaEnhanced Function for Men20 mgper 2 Capsule(s)DSLD:210646
- ANTIAGING Institute of CaliforniaFunction for Women250 mgper 1 Capsule(s)DSLD:210475
- APOPTOSIS NutraceuticalsMe No Pausebase100 mgper 2 Capsule(s)DSLD:323259
- APOPTOSIS NutraceuticalsSuccessFuel250 mgper 2 Tablet(s)DSLD:323263
- Approved ScienceFeminyl +BioPerine200 mgper 1 Capsule(s)DSLD:319754
- Approved ScienceGABA + L-Theanine & L-Arginine300 mgper 1 Capsule(s)DSLD:319760
- Arazo NutritionAlpha Maxx250 mgper 2 Capsule(s)DSLD:236946
- Arazo NutritionAlphaMAXX250 mgper 2 Capsule(s)DSLD:250811
- Arazo NutritionHorny Goat Weedbase20 mgper 2 Capsule(s)DSLD:285701
- Arazo NutritionL-Argininebase400 mgper 2 Capsule(s)DSLD:309472
- ArbonneSport Workout Fuel Orange Pineapple Flavor3,000 mgper 16.4 Gram(s)DSLD:335886
- ArbonneTrueSport Workut Fuel Orange Pineapple Flavor3,000 mgper 16.4 Gram(s)DSLD:256770
- AST Sports ScienceMyo-D500 mgper 2 Softgel(s)DSLD:21458
- Atlantis NutritionTest Testosterone Booster for Men10 mgper 2 Gummy(ies)DSLD:316104
- Axis LabsHemodrauliX1:11,000 mgper 6 Capsule(s)DSLD:306543
- Axis LabsNE2 Arginine Ethyl Ester2,250 mgper 2 Capsule(s)DSLD:19005
- Baby BeanFemale EnhancementBase100 mgper 2 Capsule(s)DSLD:334272
- Basic VitaminsL-Arginine 500 mg500 mgper 1 Capsule(s)DSLD:250016
- BeachbodyP90X Results And Recovery Formula Smooth Orange700 mgper 60 Gram(s)DSLD:43543
- Best NaturalsArginine N.O. Booster Triple Strength400 mgper 2 Vegetarian Capsule(s)DSLD:269232
- Best NaturalsL-Arginine 1000 mg1,000 mgper 1 Tablet(s)DSLD:270597
- Best NaturalsL-Arginine 500 mg500 mgper 1 Capsule(s)DSLD:269784
- Best NaturalsL-Arginine L-Citrulline Complex 1000 mg750 mgper 1 Tablet(s)DSLD:269786
- Best NaturalsL-Arginine L-Citrulline Complex 1000 mg750 mgper 1 Tablet(s)DSLD:270600
- Best NaturalsL-Arginine L-Ornithine750 mgper 2 Tablet(s)DSLD:306003
- Best NaturalsL-Arginine Pure Powder4,600 mgper 4.6 Gram(s)DSLD:269789
- Best NaturalsSuper Horny Goat Weed 1000 mg20 mgper 2 Capsule(s)DSLD:269702
- Best NaturalsSuper Horny Goat Weed 1000 mg20 mgper 2 Capsule(s)DSLD:270582
- Best NaturalsTri-Amino1,448 mgper 4 Tablet(s)DSLD:270193
- Beverly InternationalMuscle Synergybase7,000 mgper 16 Tablet(s)DSLD:332849
- Bio NutritionBlood Pressure Wellness75 mgper 2 Tablet(s)DSLD:200557
- Bio-Tech PharmacalArginine 600 mg600 mgper 1 Capsule(s)DSLD:217062
- BiosteelAdvanced Recovery Formula Vanilla553 mgper 36 Gram(s)DSLD:30899
- BioSteelAdvanced Recovery Formula Chocolate553 mgper 36 Gram(s)DSLD:30953
- BioSteelWhey Protein Isolate Chocolate455 mgper 32 Gram(s)DSLD:30990
- BioSteelWhey Protein Isolate Vanilla455 mgper 32 Gram(s)DSLD:30993
- Biotics Research CorporationAmino Sport73 mgper 3 Capsule(s)DSLD:21470
- Biotics Research CorporationImmuno-gG60 mgper 2 Capsule(s)DSLD:21891
- Biotics Research CorporationL-ArginineL-Arginine HCl Note: Nonhydrolyzed, naturally produced, free-form L-Amino acid700 mgper 1 Capsule(s)DSLD:21916
- BIOVEAHorny Goat Weed Plus 500 mg20 mgper 2 Vegetarian Capsule(s)DSLD:249210
- BIOVEAL-Arginine 500 mg500 mgper 1 Vegetarian Capsule(s)DSLD:207078
- BIOVEAL-Arginine L-Citrulline Complex 1000 mgL-Arginine Hydrochloride · L-Arginine (Form: as L-Arginine HCl)750 mgper 2 Vegetarian Capsule(s)DSLD:249236
- BIOVEAL-Arginine L-Citrulline Complex 1000 mgL-Arginine Hydrochloride · L-Arginine (Form: as L-Arginine HCl)750 mgper 1 Tablet(s)DSLD:66021
- BIOVEAL-Arginine L-Ornithine 750 mg500 mgper 1 Vegetarian Capsule(s)DSLD:207497
- BIOVEA Natural FoodsSilk Brown Rice Protein2,190 mgper 4 TbspDSLD:65970
- BlisqueNitric Oxide +300 mgper 3 Capsule(s)DSLD:321708
- BluebonnetL-Arginine 1000 mgfree-form3,000 mgper 3 Caplet(s)DSLD:279898
- BluebonnetL-Arginine 1000 mgfree-form1,000 mgper 1 Caplet(s)DSLD:314802
- BluebonnetL-Arginine 1000 mgfree-form1,000 mgper 1 Caplet(s)DSLD:316422
- BluebonnetL-Arginine 500 mggree-form500 mgper 1 Capsule(s)DSLD:314803
- BluebonnetL-Arginine 500 mgfree-form500 mgper 1 Capsule(s)DSLD:316423
- BluebonnetL-Arginine 500 mg L-Ornithine 250 mgFree-Form500 mgper 1 Capsule(s)DSLD:279535
- BluebonnetL-Arginine 500 mg L-Ornithine 250 mgFree-form500 mgper 1 Capsule(s)DSLD:279536
- Bluebonnet Intimate EssentialsFor Her Conception Formula Vegetable CapsulesL-Arginine · L-Arginine Note: Free-form, L-Arginine Alpha-Ketoglutarate Note: 2:1250 mgper 2 Capsule(s)DSLD:279974
- Bluebonnet Intimate EssentialsFor Her Sexual Response & Libido Boostfree-form200 mgper 2 Capsule(s)DSLD:332509
- Bluebonnet Intimate EssentialsFor Her Sexual Response & Libido Boost CapsulesFree-Form200 mgper 2 Capsule(s)DSLD:315072
- Bluebonnet Intimate EssentialsFor Him Conception Formula Vegetable CapsulesL-Arginine · as L-arginine (free-form), L-arginine alpha ketoglutarate 2:1500 mgper 2 Capsule(s)DSLD:279973
- Bluebonnet Intimate EssentialsFor Him Testosterone & Libido Boostfree-form500 mgper 2 Capsule(s)DSLD:332510
- Bluebonnet Intimate EssentialsFor Him Testosterone & Libido Boostfree-form500 mgper 2 Capsule(s)DSLD:332511
- Bluebonnet Intimate EssentialsNitroArginine Silicate Inositol300 mgper 1 Capsule(s)DSLD:332648
- Bluebonnet Targeted ChoiceBlood Pressure Supportfree-form250 mgper 2 Capsule(s)DSLD:314965
- Bluebonnet Targeted ChoiceBlood Pressure Supportfree-form250 mgper 2 Capsule(s)DSLD:316448
- Body AttackAttack 3.1 Cassis FlavourL-Arginine2,000 mgper 40 Gram(s)DSLD:329534
- Body AttackAttack 3.1 Green Apple FlavourL-Arginine2,000 mgper 40 Gram(s)DSLD:334177
- Body Attack Sports Nutrition100% Whey Protein ApfelstrudelAmino Acid Profile4.81 Gram(s)per 30 Gram(s)DSLD:329523
- Body Attack Sports NutritionArginine Zero PowderL-Arginine5,000 mgper 5 Gram(s)DSLD:329530
- Body Attack Sports NutritionCreatine Protein Chocolate Flavour1,000 mgper 50 Gram(s)DSLD:329546
- Body BasicsEncode Wild Berry Flavor5,000 mgper 10 Gram(s)DSLD:73633
- Body KitchenHydrolyzed Protein Collagen Decadent Chocolate1.24 Gram(s)per 22 Gram(s)DSLD:241118
- Bodybuilding.com SignatureAmino Plus Energy Blue Raspberry500 mgper 10.2 Gram(s)DSLD:199956
- Bodybuilding.com SignatureAmino Plus Energy Blueberry Lemonade500 mgper 10 Gram(s)DSLD:202969
- Bodybuilding.com SignatureAmino Plus Energy Grape500 mgper 10.4 Gram(s)DSLD:199983
- Bodybuilding.com SignatureAmino Plus Energy Green Apple500 mgper 10.4 Gram(s)DSLD:199991
- Bodybuilding.com SignatureAmino Plus Energy Tropical Pineapple500 mgper 11 Gram(s)DSLD:203201
- Bodybuilding.com SignatureAmino Plus Energy Watermelon Lime500 mgper 10 Gram(s)DSLD:203202
- BodyLogixNatural Pre-Workout Green AppleL-Arginine Alpha-Ketoglutarate1,000 mgper 8.6 Gram(s)DSLD:314860
- BodyTechLongJaX MHT with ArginineL-Arginine Hydrochloride · L-Arginine (Form: as L-Arginine HCl)500 mgper 2 Tablet(s)DSLD:204654
- BodyTechTribulus Pro with Arginine HCl750 mgper 3 Capsule(s)DSLD:184515
- BodyTech EliteNitrulline Powder Mango1,000 mgper 9.5 Gram(s)DSLD:207950
- BodyTech EliteNitrulline Powder Watermelon1,000 mgper 9.5 Gram(s)DSLD:204920
- BodyTech ElitePrimalJaxL-Arginine Hydrochloride · L-Arginine (Form: as L-Arginine HCl)250 mgper 2 Capsule(s)DSLD:207821
- Botanic ChoiceUltra Kidney Complex200 mgper 2 Capsule(s)DSLD:77986
- Bricker LabsAmino Supreme131 mgper 5 Tablet(s)DSLD:3182
- Bricker LabsMacabido Men's Formula50 mgper 1 Tablet(s)DSLD:45821
- Bricker LabsMacabido Women's Formula50 mgper 1 Tablet(s)DSLD:45829
- BronsonBeet Root + L-Arginine 2000 mg1,000 mgper 2 Capsule(s)DSLD:317304
- BronsonL-Arginine 500 mgL-Arginine Hydrochloride500 mgper 1 Capsule(s)DSLD:257544
- Bronson LaboratoriesAll Insurance Vitamin Powder92 mgper 8.76 Gram(s)DSLD:25265
- Brutal ForceIbuta Lean20 mgper 1 Veggie Capsule(s)DSLD:273562
- Bucked UpPump Ocalypse Yuzu & Peach1,000 mgper 13.1 Gram(s)DSLD:333986
- Bucked UpPump-Ocalypse Apple1,000 mgper 12.8 Gram(s)DSLD:269522
- Bucked UpPump-Ocalypse Blue Raz1,000 mgper 12 Gram(s)DSLD:282492
- Built By NatureL-Arginine Extra Strength 2662 mgbase800 mgper 4 Capsule(s)DSLD:328627
- Built By NatureNitric Oxidebase800 mgper 4 Capsule(s)DSLD:328630
- BulkSupplements.comAAKG (L-Arginine Alpha-Ketoglutarate)1,761 mgper 2500 mgDSLD:312823
- BulkSupplements.comAAKG (L-Arginine Alpha-Ketoglutarate)1,761 mgper 2500 mgDSLD:312824
- BulkSupplements.comAAKG (L-Arginine Alpha-Ketoglutarate)1,761 mgper 2500 mgDSLD:312825
- BulkSupplements.comAAKG (L-Arginine Alpha-Ketoglutarate)1,761 mgper 2500 mgDSLD:312826
- BulkSupplements.comL-Arginine 1000 mg Capsules1,000 mgper 2 Capsule(s)DSLD:312911
- BulkSupplements.comL-Arginine Base1,000 mgper 1000 mgDSLD:312078
- BulkSupplements.comL-Arginine Base1,000 mgper 1000 mgDSLD:312079
- BulkSupplements.comL-Arginine Base1,000 mgper 1000 mgDSLD:312080
- BulkSupplements.comL-Arginine Base1,000 mgper 1000 mgDSLD:312081
- BulkSupplements.comL-Arginine Base 1000 mg1,000 mgper 2 Capsule(s)DSLD:312082
- BulkSupplements.comL-Arginine Base 1000 mg1,000 mgper 2 Capsule(s)DSLD:312083
- BulkSupplements.comL-Arginine Base 500 mgL-Arginine base500 mgper 1 Capsule(s)DSLD:252589
- BulkSupplements.comL-Arginine Base 500 mgL-Arginine Base500 mgper 1 Capsule(s)DSLD:252590
- BulkSupplements.comL-Arginine Capsules 5000mg5,000 mgper 8 Capsule(s)DSLD:330018
- BulkSupplements.comL-Arginine HCl1,000 mgper 1000 mgDSLD:312084
- BulkSupplements.comL-Arginine HCl1,000 mgper 1000 mgDSLD:312085
- BulkSupplements.comL-Arginine HCl1,000 mgper 1000 mgDSLD:312086
- BulkSupplements.comL-Arginine HCl1,000 mgper 1000 mgDSLD:312087
- BulkSupplements.comL-Arginine HCL Capsules 5000 mg5,000 mgper 8 Capsule(s)DSLD:331158
- California Academy of HealthWhey Protein Gold Isolate Plus Natural Chocolate Flavor663 mgper 44 Gram(s)DSLD:191162
- California Academy of HealthWhey Protein Gold Isolate Plus Natural Vanilla Flavor677 mgper 6 TbspDSLD:197375
- California Gold NutritionL-Arginine 500 mg500 mgper 1 Capsule(s)DSLD:318841
- CarlsonCardio CompleteL-Arginine Hydrochloride60 mgper 3 Tablet(s)DSLD:306134
- CarlsonCardio CompleteL-Arginine Hydrochloride60 mgper 3 Tablet(s)DSLD:304730
- CarlsonHeartbeat EliteL-Arginine Hydrochloride · L-Arginine (Form: from L-Arginine HCl)60 mgper 3 Tablet(s)DSLD:54542
- CarlsonHeartbeat EliteL-Arginine Hydrochloride · L-Arginine (Form: from L-Arginine HCl)60 mgper 3 Tablet(s)DSLD:54544
- CarlsonL-Arginine 1,350 mg1,350 mgper 2 Capsule(s)DSLD:265611
- CarlsonL-Arginine Powder3,000 mg3 Gram(s)per 3 Gram(s)DSLD:304804
- CarlsonL-Arginine Powder3,000 mg3 Gram(s)per 3 Gram(s)DSLD:309268
- CarlsonRhythm Rite50 mgper 2 Softgel(s)DSLD:209334
- CarlsonRhythm Rite50 mgper 2 Softgel(s)DSLD:242123
- CarlsonRhythm Rite50 mgper 2 Softgel(s)DSLD:242128
- CellShock ResearchN'JECTNO3-T1 Gram(s)per 4 Capsule(s)DSLD:206767
- CellucorNO3 Black Chrome1,250 mgper 3 Capsule(s)DSLD:3676
- CellucorNO3 Black Chrome1,250 mgper 3 Capsule(s)DSLD:3677
- CellucorNo3 Chrome1,250 mgper 3 Capsule(s)DSLD:18972
- Centurion LabzOut of Rage XXX3,000 mgper 11.7 Gram(s)DSLD:201411
- Century SystemsHeart Miracle100 mgper 6 Capsule(s)DSLD:3262
- CGM LabsOnce A Day Albumin Complex30 mgper 1 Chewable Tablet(s)DSLD:301440
- Clean NutraceuticalsPulseplex 360400 mgper 3 Capsule(s)DSLD:336260
- Coast ScienceCoast MSHS Male Sexual Health Support200 mgper 2 Capsule(s)DSLD:241264
- Combat NutraWillie Pete15 mgper 3 Tablet(s)DSLD:249739
- Complete AscentialsAfterburn Complete6X/12X/30Xamount not statedper 3 Spray(s)DSLD:315948
- Complete H2O MineralsComplete Vitamin +0.45 mgper 0.5 Vial(s)DSLD:19121
- Complete H2O MineralsComplete Vitamins Plus0.45 mgper 2 mLDSLD:19127
- Complete NutritionElite Gold NX6250 mgper 3 Tablet(s)DSLD:320079
- Confidence USAFe-Mon-9500 mgper 2 Capsule(s)DSLD:246710
- Country LifeAction Max For Men XxxtremeL-Arginine Hydrochloride · L-Arginine (Form: as L-Arginine Hydrochloride)500 mgper 1 Tablet(s)DSLD:35697
- Country LifeL-Arginine Caps 500 mgL-Arginine Note: free form500 mgper 1 Capsule(s)DSLD:13021
- Country LifeL-Arginine Caps 500 mgL-Arginine Note: free form500 mgper 1 Capsule(s)DSLD:201839
- Country LifeL-Arginine Capsules 500 mgfree form500 mgper 1 Capsule(s)DSLD:333200
- Country LifeL-Arginine L-Ornithine Hydrochloride CapsL-Arginine Note: free form625 mgper 1 Capsule(s)DSLD:201840
- Country LifeL-Arginine L-Ornithine Hydrochloride CapsL-Arginine Note: free form625 mgper 1 Capsule(s)DSLD:201845
- Country LifeL-Arginine L-Ornithine Hydrochloride CapsL-Arginine Note: free form625 mgper 1 Capsule(s)DSLD:201877
- Country LifeMax-Amino Caps with Vitamin B6L-Arginine Note: free form amino acid50 mgper 4 Capsule(s)DSLD:208012
- Country LifeMax-Amino Caps with Vitamin B6L-Arginine Note: free form amino acid50 mgper 4 Capsule(s)DSLD:208016
- CrazyBulkIbuta 677550 mgper 4 Capsule(s)DSLD:288560
- Custom Health CentersFemaleBase100 mgper 2 Capsule(s)DSLD:272693
- CytoSportCytomax Fast Twitch Fruit Punch2 Gram(s)per 8 tspDSLD:73682
- D-Bal MaxD-Bal Max Version 2500 mgper 4 Capsule(s)DSLD:300247
- Daily SpraysPassionL-Arginine Hydrochloride · L-Arginine (Form: as L-Arginine HCl)10 mgper 0.47 mLDSLD:247949
- DaVinci Benefits LineNitro Benefits3,000 mgper 10.3 Gram(s)DSLD:322192
- DaVinci LaboratoriesAmino 2122.5 mgper 1 Capsule(s)DSLD:322151
- DaVinci LaboratoriesCocoa HGH1,000 mgper 15.5 Gram(s)DSLD:322159
- DaVinci LaboratoriesMaxi-HGH1,000 mgper 10.95 Gram(s)DSLD:322183
- DCArginine 500500 mgper 1 Capsule(s)DSLD:244614
- DCArginine Ornithine Lysine1,447 mgper 4 Tablet(s)DSLD:266724
- DCFree-Form Aminos115.5 mgper 1 Tablet(s)DSLD:245133
- DCL-Arginine 1000 mgArginine Hydrochloride · L-Arginine (Form: as Arginine Hydrochloride)1,000 mgper 1 Tablet(s)DSLD:265849
- DCMusketal50 mgper 2 Vegetable Capsule(s)DSLD:245024
- DCMusketal50 mgper 2 Vegetable Capsule(s)DSLD:266928
- DCMusketal50 mgper 2 Vegetable Capsule(s)DSLD:266931
- DCMusketal50 mgper 2 Vegetable Capsule(s)DSLD:266935
- DCMusketal50 mgper 2 Vegetable Capsule(s)DSLD:266938
- DCMusketal50 mgper 2 Vegetable Capsule(s)DSLD:266939
- DCMusketal50 mgper 2 Vegetable Capsule(s)DSLD:266940
- DCTri-Amino1,450 mgper 5 Capsule(s)DSLD:244729
- DCTri-Amino1,450 mgper 5 Capsule(s)DSLD:266004
- DCTri-Amino1,450 mgper 5 Capsule(s)DSLD:266725
- Designs for HealthAmino Acid Synergy300 mgper 4 Capsule(s)DSLD:22323
- Designs for HealthArginine750 mgper 1 Capsule(s)DSLD:22262
- Do VitaminsPumpPillsL-Arginine (Alt. Name: Kyowa Hakko)1,000 mgper 4 Capsule(s)DSLD:269526
- Do VitaminsPurePump LemonAjiPure500 mgper 4.48 Gram(s)DSLD:269537
- Do VitaminsPurePump UnflavoredAjiPure500 mgper 3.8 Gram(s)DSLD:269534
- Doctor Recommended SupplementsCardio Complete Mixed Berry Flavor5,000 mgper 15.9 Gram(s)DSLD:258386
- Doctor Recommended SupplementsCardio Heart Health5,000 mgper 15.9 Gram(s)DSLD:206297
- Doctor Recommended SupplementsCardio Heart Health5,000 mgper 15.9 Gram(s)DSLD:315556
- Doctor Recommended SupplementsHorny Goat Weed300 mgper 3 Capsule(s)DSLD:206343
- Doctor's BestPure L-Arginine Powder6 Gram(s)per 6 Gram(s)DSLD:203218
- Doctor's BestSustained plus Immediate Release L-Arginine 500 mgL-Arginine Alpha-Ketoglutarate1,000 mgper 2 Tablet(s)DSLD:302709
- Dorado NutritionGH Forcel-arginine base400 mgper 2 Capsule(s)DSLD:320078
- Dorado NutritionHorny Goat Weed20 mgper 2 Capsule(s)DSLD:229747
- Douglas Cooper Co.L-Arginine 500 mgfree-form (1 g)1,000 mgper 2 Capsule(s)DSLD:275238
- Douglas LaboratoriesAmino Gram ForteL-Arginine Note: One of 10 essential Amino Acids.39 mgper 1 Tablet(s)DSLD:57724
- Douglas LaboratoriesCardio-StolixL-Arginine Hydrochloride · L-Arginine (Form: as L-Arginine HCl)150 mgper 4 Vegetarian Capsule(s)DSLD:245225
- Douglas LaboratoriesCardio-StolixL-Arginine Hydrochloride · L-Arginine (Form: as L-Arginine HCl)150 mgper 4 Vegetarian Capsule(s)DSLD:31047
- Douglas LaboratoriesCysto Renew250 mgper 4 Capsule(s)DSLD:232584
- Douglas LaboratoriesFemale X Booster500 mgper 2 Vegetarian Capsule(s)DSLD:232969
- Douglas LaboratoriesJoint, Tendon, Ligament I400 mgper 3 Vegetarian Capsule(s)DSLD:261203
- Douglas LaboratoriesL-Arginine700 mgper 1 Capsule(s)DSLD:237159
- Douglas LaboratoriesL-Arginine 500 mg500 mgper 1 Capsule(s)DSLD:232446
- Douglas LaboratoriesTri-Amino1,200 mgper 4 Vegetarian Capsule(s)DSLD:232543
- Douglas LaboratoriesUltra Protein Plus Natural Vanilla Bean Flavor1,620 mgper 31.6 Gram(s)DSLD:30694
- Dr. Clark Research Association Dr. Clark ZentrumArginine 500 mg500 mgper 1 Capsule(s)DSLD:223367
- Dr. Clark StoreArginine 500 mg500 mgper 1 Capsule(s)DSLD:219771
- Dr. LaMar's ProductsArginol Citrus Flavor5,000 mgper 1 Ounce(s)DSLD:180307
- Dr. LaMar's ProductsArginol Fusion5,000 mgper 1 Scoop(s)DSLD:180265
- Dr. Martin's NutritionHorny Goat WeedL-Arginine Hydrochloride20 mgper 2 Capsule(s)DSLD:317087
- Dr. Rico PerezAmino Complex18 mgper 1 Capsule(s)DSLD:321008
- Dr. Rico PerezR.P.M.L-Arginine Hydrochloride600 mgper 1 Tablet(s)DSLD:321030
- Dr. Rico PerezRico-Amor20 mgper 2 Vegetarian Capsule(s)DSLD:321033
- Dr. Seth's Vitamin VibrationsPower HGH1,000 mgper 15.5 Gram(s)DSLD:315824
- Dr. Seth's Vitamin VibrationsPower Nitro Blood Vessels3,000 mgper 10.3 Gram(s)DSLD:315831
- Dr. SinatraNattoPlusL-Arginine Hydrochloride · L-Arginine (Form: as L-Arginine HCl)500 mgper 2 Capsule(s)DSLD:201842
- Dr. TobiasHorny Goat Weed 1000 mgL-Arginine Hydrochloride20 mgper 2 Capsule(s)DSLD:73104
- Dr. Venessa's FormulasBlood Pressure SupportL-Arginine Hydrochloride · L-Arginine (Form: as L-Arginine HCl)300 mgper 2 Tablet(s)DSLD:45216
- Dr. Venessa's FormulasTestrong20 mgper 4 Tablet(s)DSLD:45215
- dr.boHorny Goat Weed20 mgper 2 Capsule(s)DSLD:328673
- Drucker LabsintraMAX 2.0 Peach Mango Flavoramount not statedper 1 fl. Oz.DSLD:236722
- Earthborn ElementsL-Arginine1,060 mgper 2 Capsule(s)DSLD:319601
- Elements of Health CareL-Arginine Plus Grape5,110 mgper 12.7 Gram(s)DSLD:239623
- Endurance Products CompanyL-Arginine 350 mgL-Arginine Alpha-Ketoglutarate · L-Arginine (Form: as Arginine Alpha-Ketoglutarate)1,050 mgper 3 Tablet(s)DSLD:177918
- Endurance Products CompanyL-Arginine 350 mgL-Arginine Alpha-Ketoglutarate · L-Arginine (Form: as Arginine Alpha-Ketoglutarate)1,050 mgper 3 Tablet(s)DSLD:217236
- Enriching GiftsAmino Acids114 mgper 2 Capsule(s)DSLD:228176
- Envy NutritionL-Arginine400 mgper 2 Capsule(s)DSLD:241849
- Esmond NaturalMagic Strong Plus25 mgper 1 Tablet(s)DSLD:230777
- Esmond NaturalMen's Vitality Complex50 mgper 1 Tablet(s)DSLD:230788
- Everyday DoseMushroom Coffee+383 mgper 7 Gram(s)DSLD:315153
- Everyday DoseMushroom Matcha+412 mgper 7 Gram(s)DSLD:317537
- Everyday HealthHorny Goatweed Extreme50 mgper 1 Capsule(s)DSLD:306085
- Everyday HealthL-Arginine Pure1,100 mgper 2 Capsule(s)DSLD:306091
- Everyday HealthMuslemax Xtreme60 mgper 3DSLD:306098
- Everyday HealthNiagra400 mgper 2 Capsule(s)DSLD:306101
- Everyday HealthNympho Max50 mgper 2 Capsule(s)DSLD:306103
- Everyday HealthNZ-Men Forte140 mgper 2 Capsule(s)DSLD:306109
- Everyday HealthSpermo Max140 mgper 2 Capsule(s)DSLD:306122
- Evlution NutritionL-Arginine+ L-Citrulline Unflavored1,000 mgper 2 Gram(s)DSLD:320074
- Evlution NutritionL-Arginine15001,500 mgper 2 Capsule(s)DSLD:302118
- Evlution NutritionL-Arginine5000 Unflavored5,000 mgper 5 Gram(s)DSLD:326400
- Exeltis USAEvolution 60L-Arginine Note: free form30 mgper 1 Packet(s)DSLD:208914
- eXplicit SupplementsHorny Goat Weed Complex 1560 mg20 mgper 2 Veggie Capsule(s)DSLD:310036
- Fairhaven HealthFH PRO for Men350 mgper 6 Capsule(s)DSLD:260611
- femMEDLibidoL-Arginine Hydrochloride200 mgper 1 Capsule(s)DSLD:323191
- FINAFLEXEAA Psycho Peach500 mgper 13.4 Gram(s)DSLD:333668
- Finest NutritionMen's Daily Pack20 mgper 1 Packet(s)DSLD:44742
- FitLineMunogen396 mgper 2 Capsule(s)DSLD:181763
- FitLineMunogen396 mgper 2 Capsule(s)DSLD:321596
- FNXL-Arginine Complete Mixed Berry Flavor5,000 mgper 10 Gram(s)DSLD:71392
- FNXReinforce Blue Raspberry5 Gram(s)per 10 Gram(s)DSLD:244975
- FoodScience of VermontAmino Max 2122.5 mgper 1 Capsule(s)DSLD:74925
- ForeverForever Multi-Maca150 mgper 2 Tablet(s)DSLD:13177
- FortifyHeart Support300 mgper 6 Capsule(s)DSLD:283916
- Foster RegalL-Arginine 500500 mgper 1 Capsule(s)DSLD:259940
- Fully FloraBlood Circulation & Vein Support50 mgper 1 Capsule(s)DSLD:295306
- Fully FloraTotal TestL-Arginine Hydrochloride20 mgper 2 Capsule(s)DSLD:282466
- FuturebioticsBeet Root + L-Arginine1,000 mgper 2 Capsule(s)DSLD:319844
- Garden of LifeRaw Organic Fit Chocolate Flavor2,370 mgper 45.5 Gram(s)DSLD:297638
- GATTestrol Anabolic & Potency ActivatorL-Arginine Hydrochloride · L-Arginine (Form: as L-Arginine HCl)150 mgper 2 Tablet(s)DSLD:34175
- GAT SportJetMASS Strawberry Lemonade100 mgper 23.6 Gram(s)DSLD:276597
- GAT SportTESTROL OriginalL-Arginine Hydrochloride150 mgper 2 Tablet(s)DSLD:276599
- GenesaTotal Amino SolutionL-Arginine · Arginine (Form: as L-Arginine)75 mgper 3 Vegi-Capsule(s)DSLD:205996
- Genestra BrandsHMB Complex Natural Citrus FlavorL-Arginine Hydrochloride · L-Arginine (Form: as L-Arginine Hydrochloride)7 Gram(s)per 33.6 Gram(s)DSLD:231724
- GleeFull SupplementsOver 30 Hormone Supportbase100 mgper 2 Capsule(s)DSLD:320389
- GN GnarlyGnarly Pump Cranberry5 Gram(s)per 18 Gram(s)DSLD:218104
- GN GnarlyGnarly Pump Orange Mango5 Gram(s)per 18 Gram(s)DSLD:218110
- GNCArginMax3000 mg3 Gram(s)per 3 Caplet(s)DSLD:304331
- GNCL-Arginine & L-CitrullineL-Arginine Hydrochloride · L-Arginine (Form: as L-Arginine Hydrochloride)500 mgper 1 Caplet(s)DSLD:224677
- GNCL-Arginine 1000 mg1,000 mgper 1 Capsule(s)DSLD:224675
- GNCL-Arginine 1000 mg1,000 mgper 1 Caplet(s)DSLD:224678
- GNCL-Arginine 1000 mg1,000 mgper 1 Caplet(s)DSLD:224689
- GNCL-Arginine 500 mg500 mgper 1 Capsule(s)DSLD:318194
- GNCL-Arginine 5000 mg Orange5,000 mgper 9 Gram(s)DSLD:63792
- GNCMultivitaminL-Arginine Monohydrate50 mgper 2 Beige Caplet(s)DSLD:260119
- GNC AMP Advanced Muscle PerformanceN.O. Charger & Circulatory PumpL-Arginine1.5 Gram(s)per 2 Light Yellow Caplet(s)DSLD:312704
- GNC AMP Advanced Muscle PerformanceN.O. Charger & Circulatory PumpL-Arginine1.5 Gram(s)per 2 Light Yellow Caplet(s)DSLD:317649
- GNC Beyond RawRare VanillaBeef Peptides, Hydrolyzed · Arginine (Form: as hydrolyzed Beef peptide, Potato protein)1.5 gramsper 37.2 Gram(s)DSLD:37217
- GNC Beyond RawRe-Grow Double ChocolateL-Arginine, Micronized · Arginine (Form: As Micronized L-Arginine, Micronized Whey Protein Concentrate, Whey Protein Concentrate, Whey Protein Isolate, Milk Protein Concentrate, Milk Protein Isolate, Hydrolyzed Whey Peptides)3 gper 114 Gram(s)DSLD:12834
- GNC Beyond RawRe-Grow Vanilla Ice CreamL-Arginine, Micronized · Arginine (Form: As Micronized L-Arginine, Micronized Whey Protein Concentrate, Whey Protein Concentrate, Whey Protein Isolate, Milk Protein Concentrate, Milk Protein Isolate, Hydrolyzed Whey Peptides)3 gper 114 Gram(s)DSLD:19499
- GNC Beyond Raw Chemistry LabsL-Arginine 3 Grams3 Gram(s)per 4.18 Gram(s)DSLD:69292
- GNC Mega Men50 Plus100 mgper 2 Caplet(s)DSLD:27160
- GNC Mega Men50 PlusL-Arginine Hydrochloride100 mgper 2 Caplet(s)DSLD:304603
- GNC Mega Men50 PlusL-Arginine Hydrochloride100 mgper 2 Caplet(s)DSLD:304604
- GNC Mega Men50 Plus100 mgper 2 Caplet(s)DSLD:779
- GNC Mega Men50 Plus MultivitaminL-Arginine Monohydrochloride100 mgper 2 Caplet(s)DSLD:323511
- GNC Mega MenCirculatory Health250 mgper 1 White Capsule(s)DSLD:259818
- GNC Mega MenCirculatory Health250 mgper 1 White Capsule(s)DSLD:315841
- GNC Mega MenDHEA Prostate & Virility200 mgper 2 Green Caplet(s)DSLD:66427
- GNC Mega MenDHEA Prostate & Virility200 mgper 2 Green Caplet(s)DSLD:69270
- GNC Mega MenL-Arginine1,000 mgper 2 White Capsule(s)DSLD:33554
- GNC Mega MenL-Arginine1,000 mgper 2 Capsule(s)DSLD:5880
- GNC Mega MenL-Arginine & L-CitrullineL-Arginine Hydrochloride · L-Arginine (Form: as L-Arginine Hydrochloride)500 mgper 1 Caplet(s)DSLD:5887
- GNC Mega MenMaximum Nutrition Milk ChocolateDi-Arginine Malate · L-Arginine (Form: as DiArginine Malate, and Whey Protein Concentrate)1,000 mgper 34 Gram(s)DSLD:31063
- GNC Mega MenMega Men 50 Plus100 mgper 2 Caplet(s)DSLD:15713
- GNC Mega MenMega Men 50 Plus100 mgper 2 Beige Caplet(s)DSLD:33620
- GNC Mega MenMega Men 50 Plus MultivitaminL-Arginine Hydrochloride100 mgper 2 Beige Caplet(s)DSLD:259831
- GNC Mega MenMuscle Recovery & Support500 mgper 1 White Caplet(s)DSLD:315849
- GNC Mega MenProstate & VirilityL-Arginine Hydrochloride10 mgper 2 Caplet(s)DSLD:315845
- GNC Mega MenSport Milk ChocolateL-Arginine Note: Includes amounts in the protein naturally.1,000 mgper 36 Gram(s)DSLD:1060
- GNC Mega MenSport Vanilla BeanL-Arginine Note: Includes amounts in the protein naturally.1,000 mgper 36 Gram(s)DSLD:1061
- GNC Mega MenStaminol50 mgper 1 Capsule(s)DSLD:69538
- GNC Men'sArginMax3000 mg3 Gram(s)per 3 Caplet(s)DSLD:304332
- GNC Men'sArginMax3,000 mg3 Gram(s)per 3 Caplet(s)DSLD:315301
- GNC Men'sMaca Man1 Gram(s)per 3 Caplet(s)DSLD:213586
- GNC Men'sMaca Man1,000 mgper 3 Caplet(s)DSLD:315303
- GNC Men'sMen's Sexual Health100 mgper 2 Capsule(s)DSLD:243055
- GNC Men'sNitric Oxide Maximizer1 Gram(s)per 2 Beige Capsule(s)DSLD:191085
- GNC Men'sSexual Health100 mgper 2 Capsule(s)DSLD:82384
- GNC Men'sStaminol Ultra1,000 mgper 2 Caplet(s)DSLD:243499
- GNC Preventive NutritionHealthy Blood Pressure Formula250 mgper 3 Capsule(s)DSLD:315307
- GNC Pro PerformanceArginine & Ornithine1,500 mgper 4 Tablet(s)DSLD:69592
- GNC Pro PerformanceCreatine Plus 5950 Unflavored100 mgper 6 Gram(s)DSLD:66883
- GNC Pro PerformanceHybrid Creatine Complex Fruit Punch1,500 mgper 48.17 Gram(s)DSLD:25606
- GNC Pro PerformanceHybrid Creatine Complex Unflavored1,500 mgper 48.64 Gram(s)DSLD:27358
- GNC Pro PerformanceL-Arginine L-Ornithine 25001,500 mgper 4 Tablet(s)DSLD:44591
- GNC Pro PerformanceRapidDrive Arginine 50005,000 mgper 4 Tablet(s)DSLD:2725
- GNC Pro PerformanceRapidDrive Arginine 5000 Fruit Punch5,000 mgper 10 Gram(s)DSLD:2721
- GNC Pro PerformanceRapidDrive Arginine 5000 Unflavored5,000 mgper 5 Gram(s)DSLD:2720
- GNC Pro PerformanceRapidDrive Post-Workout Amino Complex Fruit Punch1,000 mgper 17 Gram(s)DSLD:2723
- GNC Pro PerformanceRapidDrive Pre-Workout Amino Complex Fruit Punch1,000 mgper 15.5 Gram(s)DSLD:2722
- GNC Pro PerformanceUltra Amino Complex Fruit Punch100 mgper 14.07 Gram(s)DSLD:16385
- GNC Pro PerformanceUltra Amino Complex Fruit Punch100 mgper 14.07 Gram(s)DSLD:207201
- GNC Pro PerformanceUltra Amino Complex Watermelon100 mgper 13.98 Gram(s)DSLD:25704
- GNC Pro Performance AMPAmplified Endurance Booster Blue Raspberry200 mgper 60 Gram(s)DSLD:18529
- GNC Pro Performance AMPAmplified Endurance Booster Blue Raspberry200 mgper 60 Gram(s)DSLD:5862
- GNC Pro Performance AMPAmplified Endurance Booster Orange200 mgper 61 Gram(s)DSLD:5864
- GNC Pro Performance AMPAmplified Maxertion N.O. Advanced1,650 mgper 4 Tablet(s)DSLD:74788
- GNC Pro Performance AMPAmplified N.O. Charger & Circulatory PumpL-Arginine · L-Arginine (Form: as L-Arginine Hydrochloride, and L-Arginine Free Base)1.5 Gram(s)per 2 Yellow Caplet(s)DSLD:67290
- GNC Pro Performance AMPAmplified Wheybolic Extreme 60 Fruit PunchArginine, Micronized · Arginine (Form: as micronized Arginine, and Whey Protein isolate)amount not statedper 79 Gram(s)DSLD:4796
- GNC Pro Performance AMPEnergy Enhancer N.O.1,500 mgper 3 Tablet(s)DSLD:5819
- GNC Pro Performance AMP Advanced Muscle PerformanceAmplified Wheybolic Extreme 60 Fruit PunchArginine, Micronized · Arginine (Form: as micronized Arginine, and Whey Protein isolate)amount not statedper 79 Gram(s)DSLD:4797
- GNC Women'sArginMax2.5 Gram(s)per 3 Caplet(s)DSLD:243744
- GNC Women'sArginMax2.5 Gram(s)per 6 Caplet(s)DSLD:74797
- Golden After 50BP-Activate350 mgper 2 Capsule(s)DSLD:336545
- Great Lakes Gelatin Co.Collagen Hydrolysate Apple + Cucumber Flavored924 mgper 13 Gram(s)DSLD:230087
- Greens First FemaleConceEVE250 mgper 3 Capsule(s)DSLD:312880
- H-E-BL-Arginine 500 mgL-Arginine Note: 1g1,000 mgper 2 Capsule(s)DSLD:75929
- Hard RhinoL-Arginine3 Gram(s)per 3 Gram(s)DSLD:71939
- Hard RhinoL-Arginine3,000 mgper 3 Gram(s)DSLD:72433
- Hard RhinoL-Arginine3,000 mgper 3 Gram(s)DSLD:72435
- Hard RhinoL-Arginine 1000 mg1,000 mgper 2 Capsule(s)DSLD:72430
- Hard RhinoPure L-Arginine L-Pyroglutamate Powder2 Gram(s)per 1500 mgDSLD:34523
- Havasu NutritionBeet Root Powder+ Black Cherry Flavor350 mgper 1 Scoop(s)DSLD:257488
- Havasu NutritionHorny Goat Weed 20 mgper 2 Capsule(s)DSLD:275891
- Havasu NutritionHorny Goat Weed Extra StrengthL-Arginine Hydrochloride20 mgper 2 Capsule(s)DSLD:230664
- Havasu NutritionL-Arginine400 mgper 2 Capsule(s)DSLD:320076
- Havasu NutritionL-Arginine Extra Strength400 mgper 2 Capsule(s)DSLD:292638
- Havasu NutritionL-Arginine Extra Strength400 mgper 2 Capsule(s)DSLD:326584
- Havasu NutritionSaw Palmetto + L-Arginine500 mgper 2 Capsule(s)DSLD:288357
- HealFastPost-Op & Injury Recovery Support Formula600 mgper 4 Tablet(s)DSLD:176433
- HealFastPre-Op Healing Optimization Formula600 mgper 3 Tablet(s)DSLD:176426
- Health Nutrition NaturalsHorny Goat Weed 1000 mgL-Arginine Hydrochloride20 mgper 2 Capsule(s)DSLD:276854
- Health Research InstituteViritenz125 mgper 1 Capsule(s)DSLD:271670
- Health Solution PrimeLongjack ComplexArginine Hydrochloride20 mgper 2 Capsule(s)DSLD:323706
- Health Solution USASuper Maca Blend500 mgper 2 Tablet(s)DSLD:323707
- Health Thru NutritionCelluRex 640 mgL-Arginine Hydrochloride400 mgper 2 Vegecap(s)DSLD:268167
- HerbadietL-ArginineFree Form1,000 mgper 2 Capsule(s)DSLD:257708
- HerbadietL-ArginineFree-Form1,000 mgper 2 Capsule(s)DSLD:293667
- HerbadietL-Arginine Powderstandardized for herb/extract ratio of 10:1750 mgper 750 mgDSLD:293729
- HerbadietTri-Aminofree-form550 mgper 3 Capsule(s)DSLD:258210
- HerbadietTri-Aminofree-form550 mgper 3 Capsule(s)DSLD:293685
- HerbadietYohimbe Bark99%120 mgper 1 Capsule(s)DSLD:258251
- Herbalife 24Prepare Tropical Mango3,000 mgper 16 Gram(s)DSLD:335030
- Herbalife 24Prepare Watermelon3,000 mgper 16 Gram(s)DSLD:335031
- HerbaMeBlood Flow Care50 mgper 1 Capsule(s)DSLD:293627
- HerbaMeFull VitalityL-Arginine400 mgper 2 Capsule(s)DSLD:291592
- HerbaMeHeart Vitality300 mgper 2 Capsule(s)DSLD:293443
- HerbaMeHeart Vitality300 mgper 6 Capsule(s)DSLD:304588
- HerbTonicsNitric Oxide1,200 mgper 4 Capsule(s)DSLD:287061
- High LevelHorny Goat Weed20 mgper 2 Capsule(s)DSLD:287449
- Higher NatureArginine3,000 mgper 3 Capsule(s)DSLD:223328
- Higher NatureCardio Heart Nutrients480 mgper 2 Capsule(s)DSLD:223389
- Higher NatureCardio Heart Nutrients480 mgper 2 Capsule(s)DSLD:304532
- Higher NatureCardio Heart Nutrients480 mgper 2 Capsule(s)DSLD:40820
- Higher NatureCardio Heart Nutrients480 mgper 2 Capsule(s)DSLD:40987
- Higher NatureCardio Heart Nutrients480 mgper 2 Capsule(s)DSLD:41749
- Higher NatureConcentration Support Tangy Lemon and Lime100 mgper 1 Tablet(s)DSLD:228892
- Higher NatureEnergy & Focus Lemon & Lime Flavour90 mgper 1 Tablet(s)DSLD:275922
- Higher NatureSx3,000 mgper 4 Capsule(s)DSLD:228555
- Higher NatureSX3,000 mgper 4 Capsule(s)DSLD:245877
- Higher NatureSX For Great Sex3,000 mgper 3 Capsule(s)DSLD:217207
- HormifyHormifybase100 mgper 2 Capsule(s)DSLD:316114
- HTLTWhey Protein Vanilla Peanut Butter619 mgper 32 Gram(s)DSLD:265454
- Huge NutritionExalt Mixed Berries2,500 mgper 11.7 Gram(s)DSLD:299804
- ILN Iron Labs NutritionArginine2,600 mgper 4 Capsule(s)DSLD:286929
- ILN Iron Labs NutritionArginine XXL2,600 mgper 4 Capsule(s)DSLD:286930
- ILN Iron Labs NutritionPCT Xtreme360 mgper 2 Capsule(s)DSLD:286926
- Indiana Botanic GardensL-Arginine 500 mgL-Arginine Hydrochloride · L-Arginine (Form: as L-Arginine HCl)500 mgper 1 Tablet(s)DSLD:77945
- Indiana Botanic GardensManatoneL-Arginine Note: (USP Grade) (free form)2,500 mgper 4 Capsule(s)DSLD:77310
- Indiana Botanic GardensRenew 180L-Arginine Note: free form50 mgper 1 Capsule(s)DSLD:46961
- Indiana Botanic GardensUltra Kidney Complex200 mgper 2 Capsule(s)DSLD:47008
- InfoWars LifeVitamin Mineral Fusion Fruit Punch FlavorL-Arginine Hydrochloride · L-Arginine (Form: as L-Arginine HCl)100 mgper 8.02 Gram(s)DSLD:218950
- InfoWars M.DNitric Boostbase400 mgper 2 Capsule(s)DSLD:307122
- Innovus PharmaVesele500 mgper 2 Capsule(s)DSLD:270105
- Innovus PharmaceuticalsCardiotek500 mgper 2 Capsule(s)DSLD:270222
- Innovus PharmaceuticalsRecalMax250 mgper 1 Capsule(s)DSLD:182007
- Innovus PharmaceuticalsVaricoLess1,000 mgper 4.2 Gram(s)DSLD:270359
- Innovus PharmaceuticalsVesele500 mgper 2 Capsule(s)DSLD:304744
- Innovus PharmaceuticalsVitaros500 mgper 2 Capsule(s)DSLD:270363
- Integrative TherapeuticsHDL RXL-Arginine Hydrochloride · L-Arginine (Form: from L-Arginine HCl)153 mgper 2 Tablet(s)DSLD:184909
- Integrative TherapeuticsVasophil Sour Apple Flavored3 Gram(s)per 0.3 Ounce(s)DSLD:222859
- Integrative TherapeuticsVasophil Sour Apple Flavored3 Gram(s)per 0.29 Ounce(s)DSLD:242439
- Integrative TherapeuticsVasophil Sour Apple Flavored3 Gram(s)per 0.29 Ounce(s)DSLD:270086
- Integrative TherapeuticsVasophil Sour Apple Flavored3 Gram(s)per 0.29 Packet(s)DSLD:65276
- Integrity ProductsRam It Horny Goat Weedbase20 mgper 1 Capsule(s)DSLD:316456
- Integrity ProductsTo The Moonbase20 mgper 1 Capsule(s)DSLD:316457
- Iron Brothers SupplementsNitric Oxide Booster1.1 Gram(s)per 4 Capsule(s)DSLD:263523
- Irwin NaturalsActive-Male L-Arginine MAX3 + Horny Goat WeedL-Arginine Hydrochloride167 mgper 1 Liquid Softgel(s)DSLD:323274
- Irwin NaturalsL-Arginine + Horny Goat WeedL-Arginine Hydrochloride167 mgper 1 Liquid Softgel(s)DSLD:323286
- Irwin NaturalsLibido-Max for Active MenL-Arginine Hydrochloride150 mgper 2 Liquid Softgel(s)DSLD:292077
- Irwin NaturalsOptimum-Strength Testosterone UP PRO-GrowtHL-Arginine Hydrochloride500 mgper 3 Liquid Soft-Gel(s)DSLD:323290
- Irwin NaturalsSteel-LibidoL-Arginine Hydrochloride · L-Arginine (Form: as L-Arginine Hydrochloride)167 mgper 1 Liquid Soft-Gel(s)DSLD:292088
- Irwin NaturalsSteel-LibidoL-Arginine Hydrochloride167 mgper 1 Liquid Soft-Gel(s)DSLD:323292
- IVL Institute For Vibrant LivingL-Arginine500 mgper 1 Vegetarian Capsule(s)DSLD:15485
- Jacked FactoryN.O. XTsourced from66.7 mgper 3 Capsule(s)DSLD:319463
- Jarrow FormulasArginine 1000 mgL-Arginine Hydrochloride1,000 mgper 1 Tablet(s)DSLD:307553
- JJJ DistributorsKH-610.86 mgper 6 Tablet(s)DSLD:26749
- Julian BakeryPegan Thin Seed Protein 20 g Triple Chocolate1,100 mgper 44 Gram(s)DSLD:296710
- JunpMegMan Performance Booster150 mgper 1 Capsule(s)DSLD:267072
- Just Ripe NutritionT-Thrive250 mgper 2 Tablet(s)DSLD:337132
- KALL-Arginine 500 mg L-Ornithine 500 mg500 mgper 1 Tablet(s)DSLD:254606
- KALLean Amino 7-Keto DHEA1,000 mgper 2 Tablet(s)DSLD:47296
- KALMagnesium 500 mg100 mgper 1 Tablet(s)DSLD:286787
- KaraMDBoost NXT350 mgper 2 Veggie Capsule(s)DSLD:243877
- KirkmanAmino Support Powder110 mgper 1 tspDSLD:23882
- KirkmanMushroom Energy & Endurance182 mgper 2 Capsule(s)DSLD:297232
- KirkmanPhenol Assist Companion40 mgper 1 Capsule(s)DSLD:25254
- KyolicKyolic Formula 108200 mgper 2 Capsule(s)DSLD:326210
- L.A. NaturalsMale Virility20 mgper 1 mLDSLD:34912
- Labrada NutritionA2 Pump1,590 mgper 3 Capsule(s)DSLD:41012
- Leading Edge HealthGenFX200 mgper 1 Capsule(s)DSLD:336110
- Leading Edge HealthHyperGH 14x520 mgper 2 Tablet(s)DSLD:339437
- Leading Edge HealthSemenax250 mgper 4 Capsule(s)DSLD:336130
- Leading Edge HealthTestosil250 mgper 4 Capsule(s)DSLD:313010
- Leading Edge HealthVigRX Max Volume100 mgper 4 Capsule(s)DSLD:306920
- Lee Haney's Nutritional Support SystemsCompetitive MassWhey Protein643 mgper 65 Gram(s)DSLD:12990
- LidtkeLiver Clean & BuildL-Arginine Note: base, USP300 mgper 2 Capsule(s)DSLD:257232
- Life ExtensionArginine Ornithine Powder2.25 Gram(s)per 3.1 Gram(s)DSLD:328281
- Life ExtensionGH Pituitary Support Day FormulaL-Arginine Alpha-Ketoglutarate · L-Arginine (Form: as Alpha-Ketoglutarate)800 mgper 4 Tablet(s)DSLD:59067
- Life ExtensionL-Arginine Caps 700 mg700 mgper 1 Capsule(s)DSLD:328509
- Life PriorityMuscle Memory6 Gram(s)per 13.2 Gram(s)DSLD:334608
- Life's FortuneCardio Cherry Flavor5,000 mgper 15.9 Gram(s)DSLD:255986
- Life's FortuneCardio Mixed Berry Flavor5,000 mgper 15.9 Gram(s)DSLD:260083
- LifeLinkL-Arginine 500500 mgper 1 Capsule(s)DSLD:11774
- LifeSeasonsSensitivi-T500 mgper 3 Capsule(s)DSLD:217385
- LifeSeasons TherapeuticsWomen's Vitali-T500 mgper 3 Capsule(s)DSLD:310537
- LiveGoodEssential Aminos Delicious Fruit Punch Flavor500 mgper 10.14 Gram(s)DSLD:339347
- Logos NutritionalsNitro Complex15 mgper 3 Tablet(s)DSLD:335726
- Longevity PremierHorny Goat Weed Maxbase20 mgper 2 Capsule(s)DSLD:277542
- LuckyVitaminArginine 500 mg & Citrulline 250 mgfree-form500 mgper 1 Veg Capsule(s)DSLD:283100
- LuckyVitaminL-Arginine 1,000 mg1,000 mg1 Gram(s)per 1 Tablet(s)DSLD:283204
- LumidayLumiday Youth Rejuvenator Lavender Lemon FlavorArginine L-Pyroglutamate · L-Arginine (Form: from L-Arginine Pyroglutamate)1,500 mgper 13.1 Gram(s)DSLD:250023
- MacroLife NaturalsMacroMeal Ultimate ChocolateAmino acids1,204.5 mgper 45 Gram(s)DSLD:295312
- MacroLife NaturalsMacroMeal Ultimate Chocolate2,409 mgper 22.5 Gram(s)DSLD:295313
- MacroLife NaturalsMacroMeal Ultimate Chocolate Protein PowderAmino acidsamount not statedper 45 Gram(s)DSLD:288254
- MacroLife NaturalsMacroMeal Ultimate Chocolate Protein PowderAmino acidsamount not statedper 22.5 Gram(s)DSLD:293340
- MacroLife NaturalsMacroMeal Ultimate Chocolate Protein Powderamount not statedper 22.5 Gram(s)DSLD:293341
- MacroLife NaturalsMacroMeal Ultimate Chocolate Protein PowderAmino acidsamount not statedper 22.5 Gram(s)DSLD:293342
- MacroLife NaturalsMacroMeal Ultimate VanillaAmino acidsamount not statedper 40 Gram(s)DSLD:292749
- MacroLife NaturalsMacroMeal Ultimate Vanilla Protein PowderAmino acidsamount not statedper 40 Gram(s)DSLD:288255
- MacroLife NaturalsMacroMeal Ultimate Vanilla Protein PowderAmino acidsamount not statedper 41 Gram(s)DSLD:288256
- MacroLife NaturalsMacroMeal Ultimate Vanilla Protein PowderAmino acids1,514 mgper 40 Gram(s)DSLD:292747
- MacroLife NaturalsMacroMeal Ultimate Vanilla Protein PowderAmino acidsamount not statedper 40 Gram(s)DSLD:292748
- MacroLife NaturalsMacroMeal Ultimate Vanilla Protein PowderAmino acidsamount not statedper 41 Gram(s)DSLD:292755
- MacroLife NaturalsMacroMeal Ultimate Vanilla Protein PowderAmino acids2,392 mgper 41 Gram(s)DSLD:292756
- MacroLife NaturalsMacroMeal Ultimate Vanilla Protein PowderAmino acidsamount not statedper 41 Gram(s)DSLD:292757
- MajorL-Arginine 500 mg500 mgper 1 Tablet(s)DSLD:201853
- MalemaxMale Enhancement250 mgper 2 Tablet(s)DSLD:233616
- manMEDPerformaxL-Arginine Hydrochloride200 mgper 1 Capsule(s)DSLD:323196
- MannatechCardio Balance333 mgper 1 Capsule(s)DSLD:37112
- MannatechOSPL-Arginine Hydrochloride · L-Arginine (Form: as L-Arginine HCl)200 mgper 1 Packet(s)DSLD:40682
- MannatechPLUSL-Arginine Hydrochloride · L-Arginine (Form: as L-Arginine HCl)95 mgper 1 Caplet(s)DSLD:34898
- Martin Avenue PharmacyAmino Acids Formula39 mgper 1 Tablet(s)DSLD:18766
- Martin Avenue PharmacyHyper Rx Depletion50 mgper 1 Capsule(s)DSLD:19440
- Mason NaturalL-Arginine 500 mg500 mgper 1 Capsule(s)DSLD:244889
- Mason NaturalVein Erect with L-Arginine & Maca2,500 mgper 4 Capsule(s)DSLD:244894
- Max Drive NutritionExtreme NO2400 mgper 2 Capsule(s)DSLD:215048
- Maxi HealthMaxi Mens Formula400 mgper 4 Capsule(s)DSLD:323794
- MBi NutraceuticalsArginine - 700 Capsules700 mgper 3 Capsule(s)DSLD:231372
- MBi NutraceuticalsBio-Aminos85 mgper 2 Capsule(s)DSLD:231378
- Medix SelectVENTRICORE1.5 Gram(s)per 2 Capsule(s)DSLD:273278
- Meijer HerbalHorny Goat Weed with Maca40 mgper 2 Capsule(s)DSLD:271844
- Met-RXNuclear X Strawberry LemonadeL-Arginine Alpha-Ketoglutarate · Arginine (Form: from L-Arginine Alpha-Ketoglutarate, and L-Arginine) Note: 1.5 g1,500 mgper 12 Gram(s)DSLD:66317
- MET-RxNuclear X Citrus SurgeL-Arginine Alpha-Ketoglutarate · Arginine (Form: from L-Arginine Alpha-Ketoglutarate, and L-Arginine) Note: 3 g3,000 mgper 6 Gram(s)DSLD:38580
- MET-RxNuclear X Radioactive PunchL-Arginine Alpha-Ketoglutarate · Arginine (Form: from L-Arginine Alpha-Ketoglutarate, and L-Arginine) Note: 3 g3,000 mgper 6 Gram(s)DSLD:38444
- MET-RxPre-Workout Nuclear X Citrus SurgeL-Arginine Alpha-Ketoglutarate · Arginine (Form: from L-Arginine Alpha-Ketoglutarate, and L-Arginine) Note: 3 g3,000 mgper 12 Gram(s)DSLD:66357
- MET-RxPre-Workout Nuclear X Radioactive PunchL-Arginine Alpha-Ketoglutarate · Arginine (Form: from L-Arginine Alpha-Ketoglutarate, and L-Arginine) Note: 3 g3,000 mgper 12 Gram(s)DSLD:66359
- MET-RxPre-Workout Nuclear X Sour AppleL-Arginine Alpha-Ketoglutarate · Arginine (Form: from L-Arginine Alpha-Ketoglutarate, and L-Arginine) Note: 3 g3,000 mgper 12 Gram(s)DSLD:66354
- MET-RxPre-Workout Nuclear X WatermelonL-Arginine Alpha-Ketoglutarate · Arginine (Form: from L-Arginine Alpha-Ketoglutarate, and L-Arginine) Note: 3 g3,000 mgper 12 Gram(s)DSLD:66360
- Metabolic MaintenanceL-Arginine500 mgper 1 Capsule(s)DSLD:24883
- Metabolic MaintenanceL-Arginine750 mgper 1 Capsule(s)DSLD:24885
- Metabolic MaintenanceL-Arginine 750 mg750 mgper 1 Capsule(s)DSLD:274043
- MetagenicsArginine Plus1.5 Gram(s)per 2 Tablet(s)DSLD:295630
- MetagenicsUltraClear Renew Berry70 mgper 36 Gram(s)DSLD:323339
- MetagenicsUltraClear Renew Chai70 mgper 36 Gram(s)DSLD:323341
- MetagenicsUltraClear Renew Natural Berry Flavor70 mgper 18 Gram(s)DSLD:295876
- MetagenicsUltraClear Renew Natural Chai Flavor70 mgper 36 Gram(s)DSLD:265595
- MetagenicsUltraClear Renew Vanilla70 mgper 36 Gram(s)DSLD:323343
- MetagenicsUltraClear Renew Vanilla Flavor70 mgper 9 Gram(s)DSLD:265519
- MH Michael's Health Naturopathic ProgramsArginine CitrullineL-Arginine Hydrochloride2,250 mgper 1 Tablet(s)DSLD:303372
- MH Michael's Health Naturopathic ProgramsArginine CitrullineArginine Hydrochloride2,250 mgper 1 Tablet(s)DSLD:303373
- MH Michael's Health Naturopathic ProgramsArginine Citrulline PowderL-Arginine Hydrochloride750 mgper 2.9 Gram(s)DSLD:332987
- MHPTrac Grape4 gper 17 Gram(s)DSLD:5720
- MHPTrac Orange4 gper 17 Gram(s)DSLD:5721
- Micro IngredientsL-Arginine 1500 mg1,500 mgper 1500 mgDSLD:256801
- MillecorL-Argininebase400 mgper 2 Capsule(s)DSLD:317786
- MM Sports NutritionQuadra Cuts Extreme500 mgper 1 Time-Release Tablet(s)DSLD:38124
- MMUSAAlpha ATP Cherry LemonadeL-Arginine Hydrochloride250 mgper 10.4 Gram(s)DSLD:327365
- Monster TestGold Monster Test Concentrated Testosterone Booster250 mgper 2 Tablet(s)DSLD:294601
- Monster TestMonster Test Extreme N.O. Boost Nitric Oxide Booster500 mgper 2 Capsule(s)DSLD:264401
- MontiffAll- Basic 677 MilligramsL-Arginine Hydrochlorideamount not statedper 1 Capsule(s)DSLD:42000
- MontiffPure L-Arginine HClL-Arginine HCl Note: elemental500 mgper 1 Capsule(s)DSLD:42046
- MontiffSuper-SportsL-Arginine baseamount not statedper 1 Capsule(s)DSLD:237087
- MontiffSuper-Sports 750 MilligramsL-Arginine baseamount not statedper 1 Capsule(s)DSLD:293563
- MontiffSuper-Sports 750 MilligramsL-Arginine baseamount not statedper 1 Capsule(s)DSLD:42099
- MRMChoLESStat With Flaphenol CCM600 mgper 1 Vegetarian Capsule(s)DSLD:46300
- MRM NutritionTribest 750750 mgper 2 Vegan Capsule(s)DSLD:262719
- Mt. Angel VitaminsFabulously Female500 mgper 2 Vegetarian Capsule(s)DSLD:258347
- Mt. CapraCaprotein222 mgper 10 Gram(s)DSLD:4743
- Mt. CapraDouble Bonded Protein Chocolate732 mgper 33.5 Gram(s)DSLD:19314
- MTN OPSEnduro Pink Lemonade5,000 mgper 11 Gram(s)DSLD:277897
- MTN OPSIgnite Blue Raspberry Lemonade5 Gram(s)per 13 Gram(s)DSLD:327385
- MTN OPSIGNITE Peach Zing Flavor5 Gram(s)per 11.8 Gram(s)DSLD:268700
- MTN OPSYeti Blue Raspberry5 Gram(s)per 14.7 Gram(s)DSLD:277898
- MTN OPSYeti Blue Raspberry5 Gram(s)per 15 Gram(s)DSLD:327387
- Muscle EmpireL-Arginine 3000 mg Unflavoredamount not statedper 3 Gram(s)DSLD:71667
- Musclegen Performance NutritionAnabolismL-Arginine · L-Arginine (Form: L-Arginine Base)400 mgper 1 Packet(s)DSLD:213507
- Musclegen Performance NutritionPsychosis X Limeaide Fizz750 mgper 5.85 Gram(s)DSLD:213573
- Musclegen Performance NutritionPsychosis X Limeaide Fizz750 mgper 11.7 Gram(s)DSLD:249713
- Musclegen Performance NutritionZ-TropinL-Arginine Note: as free form400 mgper 2 Capsule(s)DSLD:213610
- MuscleGen Performance NutritionAnabolismL-Arginine · L-Arginine (Form: L-Arginine Base)400 mgper 1 Packet(s)DSLD:211546
- My Stellar LifestyleWonder PillBase20 mgper 2 Capsule(s)DSLD:278456
- Naked NutritionNaked Energy1 Gram(s)per 4.8 Gram(s)DSLD:325648
- NatrolChromeMate50 mgper 1 Capsule(s)DSLD:55215
- NatrolL-Arginine 1000 mg1,000 mgper 1 Tablet(s)DSLD:78056
- NatrolL-Arginine 3,000 mg3,000 mgper 3 Tablet(s)DSLD:230650
- Natural ClinicianClinical Libido1,000 mgper 2 Capsule(s)DSLD:18637
- Natural FactorsL-Arginine 1000 mgL-Arginine Hydrochloride · L-Arginine (Form: L-Arginine Hydrochloride) Note: pharmaceutical grade1,000 mgper 1 Tablet(s)DSLD:75695
- Natural FactorsL-Arginine 500 mgL-Arginine Hydrochloride · L-Arginine (Form: L-Arginine Hydrochloride) Note: pharmaceutical grade1,000 mgper 2 Vegetarian Capsule(s)DSLD:75789
- Natural FactorsL-Arginine 500 mgL-Arginine Hydrochloride · L-Arginine (Form: L-Arginine Hydrochloride) Note: pharmaceutical grade1,000 mgper 2 Vegetarian Capsule(s)DSLD:75829
- Natural FactorsSex Vitality2,000 mgper 6 Capsule(s)DSLD:76198
- Natural Factors WS WomenSenseSexEssentials1,000 mgper 3 Vegetarian Capsule(s)DSLD:76543
- Natural Grocers by Vitamin CottageL-Arginine 500 mg500 mgper 1 Capsule(s)DSLD:337986
- naturaltreasuresHorny Goat Weed Spray2 mgper 0.25 tspDSLD:206951
- Nature's AnswerMale CompleteL-Arginine Hydrochloride · L-Arginine (Form: as L-Arginine HCl) Note: 1,000 mg1 Gram(s)per 4 Veg Capsule(s)DSLD:208471
- Nature's BountyL-Arginine 1000 mgL-Arginine Hydrochloride · L-Arginine (Form: as L-Arginine Hydrochloride) Note: 1 g1,000 mgper 1 Tablet(s)DSLD:61960
- Nature's BountyL-Arginine 500 mg1,000 mgper 2 Capsule(s)DSLD:26577
- Nature's CraftFertility BoosterL-Arginine Hydrochloride450 mgper 3 Capsule(s)DSLD:296796
- Nature's CraftHorny Goat Weed 1000 mgL-Arginine Hydrochloride20 mgper 2 Capsule(s)DSLD:322552
- Nature's CraftMale Fertility SupportL-Arginine Hydrochloride450 mgper 3 Capsule(s)DSLD:299237
- Nature's CraftMale Fertility SupportL-Arginine Hydrochloride450 mgper 3 Capsule(s)DSLD:321685
- Nature's CraftT-EnhanceL-Arginine Hydrochloride20 mgper 2 Capsule(s)DSLD:296790
- Nature's HarmonyL-Arginine 500 mgL-Arginine HCl Note: synthetic500 mgper 4 Capsule(s)DSLD:21857
- Nature's LabL-Arginine HCl 1,500 mg1,500 mgper 2 Capsule(s)DSLD:205256
- Nature's NutritionAdvanced Heart Health 1648 mg150 mgper 1 Capsule(s)DSLD:271187
- Nature's SunshineFree Amino Acids22 mgper 2 Tablet(s)DSLD:255231
- Nature's SunshineSolstic Cardio Natural Strawberry Lemonade Flavor5 Gram(s)per 10.8 Gram(s)DSLD:255478
- Nature's WayHDL AssistL-Arginine Hydrochloride · L-Arginine (Form: from L-Arginine HCl)153 mgper 2 Tablet(s)DSLD:212280
- Natures CraftHorny Goat WeedL-Arginine Hydrochloride20 mgper 2 Capsule(s)DSLD:228724
- Natures CraftN.O.400 mgper 2 Capsule(s)DSLD:256529
- Natures CraftN.O. Rush L-Arginine400 mgper 2 Capsule(s)DSLD:256571
- NaturesPlusGH MALEfree form amino acid140 mgper 2 Capsule(s)DSLD:303941
- NaturesPlusPro Creation Male Fertility Supportfree form amino acid100 mgper 2 Capsule(s)DSLD:298598
- NeoLife SportBio-Tone900 mgper 4 Tablet(s)DSLD:303252
- NeurobiologixMale Support Formulabase20 mgper 2 Capsule(s)DSLD:327680
- New AgeL-Arginine Capsulesbase400 mgper 2 Capsule(s)DSLD:268711
- New Health LabsNeuroEase Plus100 mgper 1 Capsule(s)DSLD:247209
- New SunHorny Goat Weed Combination (Passion +)336 mgper 2 Capsule(s)DSLD:11644
- New SunL-Arginine1,000 mgper 2 Capsule(s)DSLD:204021
- New SunL-ArginineL-Arginine Note: (free-form) (1,000 mg)1 Gram(s)per 2 Capsule(s)DSLD:244873
- NewtonEverettAminoForce18 mgper 1 Capsule(s)DSLD:292148
- NewtonEverettHGH-R Isotropin 1500 mg400 mgper 1 Capsule(s)DSLD:49931
- NewtonEverettNoxadrene Extreme15 mgper 7 Tablet(s)DSLD:213154
- NewtonEverettSenstra 700 mgL-Arginine Hydrochloride · L-Arginine (Form: as L-Arginine HCl)200 mgper 2 Capsule(s)DSLD:35282
- Nobi NutritionPremium Horny Goat WeedL-Arginine Hydrochloride20 mgper 2 Capsule(s)DSLD:242490
- Nova NutritionsL-Arginine Double Strength 1000 mgL-Arginine Hydrochloride · L-Arginine (Form: as L-Arginine Hydrochloride)1,000 mgper 1 Tablet(s)DSLD:229340
- Nova NutritionsL-Arginine L-Citrulline 1000 mgL-Arginine Hydrochloride · L-Arginine (Form: as L-Arginine HCl)750 mgper 1 Tablet(s)DSLD:229307
- NOWAir Defensefree-form25 mgper 2 Veg Capsule(s)DSLD:335205
- NOWAwe Slim!500 mgper 1 fl. Oz.DSLD:15064
- NOWDouble Strength L-Arginine 1000 mg1,000 mg, from1 Gram(s)per 1 Tablet(s)DSLD:314282
- NOWL-Arginine 500 mgL-Arginine Note: (free-form) (1,000 mg)1 Gram(s)per 2 Veg Capsule(s)DSLD:244343
- NOWL-Arginine 500 mgL-Arginine Note: (free-form) (1,000 mg)1 Gram(s)per 2 Veg Capsule(s)DSLD:244345
- NOWL-Arginine 700 mgL-Arginine Note: free-form700 mgper 1 Veg Capsule(s)DSLD:245900
- NOWTri-AminoL-Arginine Note: free-form550 mgper 2 Capsule(s)DSLD:204714
- NOWTri-AminoL-Arginine Note: free-form600 mgper 2 Capsule(s)DSLD:56818
- NOW SportsAmino Power Pre-Workout Natural RaspberryL-Arginine Note: (free form) (1,000 mg)1 Gram(s)per 18 Gram(s)DSLD:205171
- NOW SportsArginine & Citrulline 500 mg / 250 mgL-Arginine Note: free form500 mgper 1 Veg Capsule(s)DSLD:314238
- NOW SportsArginine & Citrulline 500 mg / 250 mgL-Arginine Note: free form500 mgper 1 Veg Capsule(s)DSLD:314239
- NOW SportsArginine & Citrulline PowderL-Arginine Note: (free-form) (1,500 mg)1.5 Gram(s)per 3 Gram(s)DSLD:314240
- NOW SportsArginine & Ornithine 500 mg / 250 mgL-Arginine Note: (free-form) (1,000 mg)1 Gram(s)per 2 Capsule(s)DSLD:314242
- NOW SportsArginine & Ornithine 500 mg / 250 mgL-Arginine Note: (free form) (1,000 mg)1 Gram(s)per 2 Veg Capsule(s)DSLD:335337
- NOW SportsArginine Power Super StackL-Arginine Hydrochloride · L-Arginine (Form: from L-Arginine HCl)600 mgper 3 Capsule(s)DSLD:12854
- NOW SportsArginine Stack Tropical PunchL-Arginine Note: free-form600 mgper 20 Gram(s)DSLD:205158
- NOW SportsDouble Strength L-Arginine 1000 mg1,000 mg1 Gram(s)per 1 Tablet(s)DSLD:303937
- NOW SportsDouble Strength L-Arginine 1000 mg1,000 mg1 Gram(s)per 1 Tablet(s)DSLD:303938
- NOW SportsElectro Endurance Natural Orange FlavorL-Arginine Note: free-form500 mgper 45 Gram(s)DSLD:205226
- NOW SportsElectro Endurance Orange FlavorL-Arginine Note: free-form500 mgper 45 Gram(s)DSLD:13117
- NOW SportsL-Arginine Powderfree-form, 6,000 mg6 Gram(s)per 6 Gram(s)DSLD:314470
- NOW SportsL-Arginine Powderfree-form, 6,000 mg6 Gram(s)per 6 Gram(s)DSLD:314471
- NOW SportsPro-GH Fruit Punch Flavor1.5 Gram(s)per 18 Gram(s)DSLD:210369
- NPB Natures Pure BlendNitric Oxide Flow500 mgper 2 Capsule(s)DSLD:335682
- NugenixGH-Boost Tea-Berry BlastArginine L-Pyroglutamate · L-Arginine (Form: from L-Arginine Pyroglutamate)1,500 mgper 13 Gram(s)DSLD:252329
- NugenixNugenix GH-Boost Tea-Berry BlastArginine L-Pyroglutamate · L-Arginine (Form: from L-Arginine Pyroglutamate)1,500 mgper 12.5 Gram(s)DSLD:249996
- Number One NutritionBlood Circulation50 mgper 1 Capsule(s)DSLD:335947
- NuMedicaL-Arginine 750 mg1,500 mgper 2 Capsule(s)DSLD:323551
- NusaPureHorny Goat Weed with Maca RootL-Arginine Hydrochloride20 mgper 2 Capsule(s)DSLD:307328
- NusaPureL-Arginine HCL 1000 mg1,000 mgper 2 Veggie Capsule(s)DSLD:307338
- NutraBio100% Pure L-ArginineL-Arginine Note: Kyowa Quality1,500 mgper 1.5 Gram(s)DSLD:50830
- NutraBio100% Pure L-ArginineL-Arginine Note: Kyowa Quality1,500 mgper 1.5 Gram(s)DSLD:50835
- NutraBio100% Pure L-Arginine 1500 Milligrams1,500 mgper 2 Vegetable Capsule(s)DSLD:50906
- NutraBioAEE3,000 mgper 3 Gram(s)DSLD:51069
- NutraBioAEE 3000 Milligrams3,000 mgper 5 Capsule(s)DSLD:51060
- NutraBioL-Argininefermented1.5 Gram(s)per 1.5 Gram(s)DSLD:329428
- NutraBioL-Arginine 750 mgL-Arginine (Form: Kyowa Quality) Note: HPLC L-Arginine Note: (Kyowa Quality) (HPLC)1,500 mgper 2 Vegetable Capsule(s)DSLD:248237
- NutraChampsHorny Goat WeedL-Arginine Hydrochloride · L-Arginine (Form: as L-Arginine HCl)100 mgper 2 Capsule(s)DSLD:228762
- NutraChampsL-Arginine500 mgper 2 Capsule(s)DSLD:228814
- NutraChampsNitric Charge1,200 mgper 4 Capsule(s)DSLD:228954
- NutraChampsNitric Charge1,000 mgper 5 Capsule(s)DSLD:338140
- NutracraftAlphaFlowbase400 mgper 2 Capsule(s)DSLD:329246
- NutraPro (Neutraceutical Corp.)Healthy Heart150 mgper 3 Capsule(s)DSLD:253174
- Nutrex ResearchNIOX Ultraamount not statedper 3 Liquid Capsule(s)DSLD:36836
- Nutri-WestAR-G50 mgper 1 Tablet(s)DSLD:27541
- Nutri-WestCore Level Zinc25 mgper 1 Tablet(s)DSLD:27758
- Nutri-WestDSF-Herbal1 mgper 1 Tablet(s)DSLD:27685
- Nutri-WestTotal Arginine500 mgper 1 Tablet(s)DSLD:28295
- Nutri-WestTotal Brain5 mgper 1 Tablet(s)DSLD:28326
- Nutri-WestTotal Heart50 mgper 1 Tablet(s)DSLD:28492
- Nutri-WestTotal Systemic D-Tox3.33 mgper 1 Capsule(s)DSLD:29063
- NutriCologyL-Arginine500 mgper 1 Capsule(s)DSLD:235204
- NutriCologyL-Arginine500 mgper 1 Capsule(s)DSLD:235387
- NutriCologyNO Cofactors125 mgper 3 Capsule(s)DSLD:234773
- NutriCologySuper Immuno Complex62 mgper 1 Packet(s)DSLD:183928
- NutricostL-Arginine + L-Citrulline 750 mg500 mgper 1 Capsule(s)DSLD:306238
- NutricostL-Arginine + L-Ornithine 750 mg500 mgper 1 Capsule(s)DSLD:306239
- NutricostL-Arginine 1,000 mg1,000 mgper 1 Tablet(s)DSLD:270513
- NutricostL-Arginine 5 g Unflavored5 Gram(s)per 5 Gram(s)DSLD:269649
- NutricostL-Arginine 5 g Unflavored5 Gram(s)per 5 Gram(s)DSLD:269651
- NutricostL-Arginine 5 g Unflavored5 Gram(s)per 5 Gram(s)DSLD:306240
- NutricostL-Arginine 5 g Unflavored5 Gram(s)per 5 Gram(s)DSLD:311730
- NutricostL-Arginine 500 mg500 mgper 1 Capsule(s)DSLD:306241
- NutricostL-Arginine 500 mg & L-Citrulline 250 mg500 mgper 1 Capsule(s)DSLD:311945
- Nutricost PerformanceNitric Oxide Booster500 mgper 3 Capsule(s)DSLD:270613
- Nutrients for HealthAndroBoostL-Arginine Hydrochloride · L-Arginine (Form: as L-Arginine HCl)5 mgper 2 Caplet(s)DSLD:204180
- Nutrients for HealthErexalin V-Power Max150 mgper 1 Capsule(s)DSLD:181012
- Nutrients for HealthProstate Health ComplexL-Arginine Hydrochloride · L-Arginine (Form: as L-Arginine HCl)50 mgper 1 Capsule(s)DSLD:181022
- Nutrients for Health V-Power PlusL-Arginine Hydrochloride25 mgper 1 Tablet(s)DSLD:272624
- NutriFlairHorny Goat Weed 1000 mgL-Arginine HCl Note: Base20 mgper 2 Capsule(s)DSLD:268832
- NutriONNCirculation Support50 mgper 1 Capsule(s)DSLD:308889
- NutriRiseAdvanced Strength Circulation Support50 mgper 1 Capsule(s)DSLD:257145
- NutriSuppzN.O Blast400 mgper 2 Capsule(s)DSLD:268881
- Nutrition EssentialsAlphaMan XLL-Arginine Hydrochloride20 mgper 2 Capsule(s)DSLD:271772
- OL Olympian LabsArginine & Ornithine500 mgper 1 Capsule(s)DSLD:175751
- OL Olympian LabsESR500 mgper 1 Capsule(s)DSLD:53139
- OmniLifePowerMaker24 Gram(s)per 10 Gram(s)DSLD:208655
- ONL Osyris Nutrition LabBull Boost500 mgper 2 Tablet(s)DSLD:321720
- ONL Osyris Nutrition LabRed WolfL-Arginine Hydrochloride25 mgper 1 Tablet(s)DSLD:321747
- Ormus MineralsRay's Secret Male Blend 445 mgamount not statedper 1 Capsule(s)DSLD:269195
- Orphic NutritionL-Argininebase400 mgper 2 Capsule(s)DSLD:285531
- OweliFemale Libido Enhancerbase100 mgper 2 Capsule(s)DSLD:314842
- Parrillo PerformanceUltimate Amino Formula38 mgper 2 Capsule(s)DSLD:322532
- Patient One 1 MediNutritionalsArginine as Real-AKGReal-AKG Arginine Alpha-Ketoglutarate · Arginine (Form: as Real-AKG(TM) Arginine Alpha-Ketoglutarate)1,000 mgper 2 Capsule(s)DSLD:47834
- Patient One MediNutritionalsArginine 750 mgL-Arginine Note: free form750 mgper 1 Capsule(s)DSLD:181901
- Peak HerbalsNitroRise600 mgper 2 Capsule(s)DSLD:278430
- Performance InspiredJoint Support Plus25 mgper 2 Tablet(s)DSLD:272234
- PerformixSupercharged Pump Redberry150 mgper 2 Capsule(s)DSLD:328387
- Perricone MD NutriceuticalsPerricone Super Antioxidant50 mgper 2 Caplet(s)DSLD:209856
- PharmaxL-Glutamine Powder (with Arginine)985 mgper 1 Gram(s)DSLD:55322
- Pharmaxa LabsVirectin LoadedL-Arginine Hydrochloride300 mgper 3 Capsule(s)DSLD:306942
- Pharmaxa LabsVirectin LoadedL-Arginine Hydrochloride300 mgper 3 Capsule(s)DSLD:307908
- Pharmaxa LabsZenofem250 mgper 3 Capsule(s)DSLD:306943
- PhytAge LabsLeptiCellbase100 mgper 2 Capsule(s)DSLD:330111
- PhytAge LabsTurbo Boost 91150 mgper 2 Capsule(s)DSLD:330114
- Potent SeaMarine Aminos93 mgper 2 Capsule(s)DSLD:17197
- Precision EngineeredAmino 1000140 mgper 2 Caplet(s)DSLD:2461
- Precision EngineeredLiquid Aminos Wild Cherry Flavor1,197 mgper 2 TbspDSLD:21045
- Precision EngineeredSyntha Phase ChocolateL-Arginine Note: 1.5 g1,539 mgper 46 Gram(s)DSLD:63133
- Precision EngineeredSyntha Phase Cookies & CreamL-Arginine Note: 1.5 g1,539 mgper 46 Gram(s)DSLD:63134
- Precision EngineeredSyntha Phase VanillaL-Arginine Note: 1.5 g1,539 mgper 46 Gram(s)DSLD:63063
- Precision Engineered Bio-LogicalGreen Monster Cherry Cola1.5 Gram(s)per 6 Gram(s)DSLD:66032
- Precision Engineered Bio-LogicalGreen Monster Lemon Berry Iced Tea1.5 Gram(s)per 6 Gram(s)DSLD:66033
- Primal PharmBLAST Base400 mgper 2 Vegetable Capsule(s)DSLD:276394
- PrimeSecretagogue3 Gram(s)per 17.7 Gram(s)DSLD:204063
- Priority One Nutritional SupplementsUrinary TranquilityL-Arginine Monohydrochloride500 mgper 3 Vegetarian Capsule(s)DSLD:277426
- ProCapsEssential Amino Protein125 mgper 4 Capsule(s)DSLD:331548
- Professional BotanicalsCardioPlex4 Gram(s)per 13 Gram(s)DSLD:193195
- ProgeneProgene Daily Complex1,000 mgper 2 Tablet(s)DSLD:71699
- ProgeneProgene Daily Complex1,000 mgper 2 Tablet(s)DSLD:71707
- ProgeneProgene Daily Complex1,000 mgper 2 Tablet(s)DSLD:71710
- ProgeneProgene Daily Complex1,000 mgper 2 Tablet(s)DSLD:71712
- ProgeneProgene Daily Complex1,000 mgper 2 Tablet(s)DSLD:71720
- Progressive Professional from Progressive LaboratoriesAmino Blend138 mgper 3 Capsule(s)DSLD:261202
- Progressive Professional from Progressive LaboratoriesHerbal Arouse-M225 mgper 3 Capsule(s)DSLD:261777
- Protocol For Life BalanceArginine 500 mg & Citrulline 250 mgfree-form500 mgper 1 Veg Capsule(s)DSLD:258628
- Protocol For Life BalanceL-Arginine 1000 mg1,000 mg, from1 Gram(s)per 1 Tablet(s)DSLD:337818
- Protocol For Life BalanceL-Arginine 500 mgL-Arginine Note: (free-form) (1,000 mg)1 gper 2 Capsule(s)DSLD:14866
- PS ProSuppsHyde Max Pump Cherry LimeadeNO3-T1,000 mgper 11.2 Gram(s)DSLD:295373
- PureL-Arginine1,060 mgper 2 Capsule(s)DSLD:248685
- Pure EncapsulationsAmino RepleteL-Arginine Hydrochloride · L-Arginine (Form: from L-Arginine HCl) Note: free-form250 mgper 9 Gram(s)DSLD:184274
- Pure EncapsulationsAmino Repletefree-form250 mgper 4 Gram(s)DSLD:293886
- Pure EncapsulationsAmino-NRL-Arginine HCl Note: free-form68 mgper 3 Capsule(s)DSLD:245985
- Pure EncapsulationsAmino-NRFree-form68 mgper 3 Capsule(s)DSLD:293887
- Pure EncapsulationsGrowth Hormone Support1,000 mgper 2 Capsule(s)DSLD:277701
- Pure EncapsulationsGrowth Hormone Support1,000 mgper 2 Capsule(s)DSLD:277702
- Pure EncapsulationsL-Arginine1,400 mgper 2 Capsule(s)DSLD:293991
- Pure EncapsulationsL-Arginine1,400 mgper 2 Capsule(s)DSLD:295518
- Pure EncapsulationsNitri Oxide SupportArginine Alpha-Ketoglutarate · 2:12,050 mgper 5.4 Gram(s)DSLD:277959
- Pure Label NutritionL-Arginine 2110 mgFree form50 mgper 3 Vcap(s)DSLD:266459
- Pure NaturalsL-Arginine 120 500 mg500 mgper 1 Capsule(s)DSLD:323855
- Pure NaturalsL-Arginine 500 mgfree form500 mgper 1 Capsule(s)DSLD:323856
- Pure PowerEndurance Berry Blast2 Gram(s)per 8.6 Gram(s)DSLD:327160
- PureBulk.comL-Arginine Base (Vegan)750 mgper 750 mgDSLD:23134
- PureBulk.comL-Arginine Ethyl Ester2,400 mgper 2400 mgDSLD:23135
- PureBulk.comL-Arginine MalateL-Arginine Malate Note: 2:15,000 mgper 2500 mgDSLD:23137
- PureBulk.comL-Arginine-HCLL-Arginine Hydrochloride · L-Arginine (Form: as L-Arginine HCl)1,245 mgper 750 mgDSLD:23132
- PureBulk.comL-Arginine-HCL (Vegan)L-Arginine Hydrochloride · L-Arginine (Form: as L-Arginine HCl)1,245 mgper 750 mgDSLD:23133
- PureBulk.comL-Arginine-HCL L-Ornithine-HCL1,000 mgper 1500 mgDSLD:23131
- Purely OptimalTestosterone Booster Extra StrengthL-Arginine Hydrochloride · L-Arginine (Form: as L-Arginine HCl)50 mgper 2 Capsule(s)DSLD:244063
- PureMax Labs YummyViteBlood Circulation Support50 mgper 1 Capsule(s)DSLD:318885
- PureMax Labs YummyViteHeart Health150 mgper 1 Capsule(s)DSLD:315442
- PureMax Labs YummyViteHorny Goat Weed Extra Strength BlendL-Arginine Hydrochloride20 mgper 2 Capsule(s)DSLD:318894
- PureMax Labs YummyViteHorny Goat Weed Extra Strength BlendL-Arginine Hydrochloride20 mgper 2 Capsule(s)DSLD:319634
- PureMax Labs YummyViteHorny Goat Weed Extra Strength Herbal BlendL-Arginine Hydrochloride20 mgper 2 Capsule(s)DSLD:319635
- Puritan's PrideL-Arginine 1000 mgL-Arginine Hydrochloride · L-Arginine (Form: L-Arginine HCl) Note: (free form) (1 g)1,000 mgper 1 Caplet(s)DSLD:242377
- Puritan's PrideL-Arginine 1000 mgL-Arginine Hydrochloride · 1 Gram, free-form L-Arginine1,000 mgper 1 Caplet(s)DSLD:286178
- Puritan's PrideL-Arginine 1000 mg1 g, Free Form1,000 mgper 1 Capsule(s)DSLD:318288
- Puritan's PrideL-Arginine L-Ornithine L-Lysine Complex1.4 g Free Form1,447 mgper 4 Caplet(s)DSLD:286177
- Puritan's PrideUltra Man MaxL-Arginine Hydrochloride50 mgper 2 Caplet(s)DSLD:318336
- Puritan's Pride PremiumL-Arginine 1000 mgL-Arginine Note: (Free Form) (1 g)1,000 mgper 1 Capsule(s)DSLD:26063
- Puritan's Pride PremiumL-Arginine 500 mgL-Arginine Free Form500 mgper 1 Capsule(s)DSLD:25980
- Purus LabsL-ArginineHC2 Gram(s)per 4 Veggie Capsule(s)DSLD:326484
- Q-Leap NutraceuticalsNeuropaquell800 mgper 2 Capsule(s)DSLD:279106
- QualiaQualia Nootropic Energy Triple Berry FlavornooLVL · Inositol-Enhanced Bonded Arginine Silicate (Form: as nooLVL)800 mgper 2 fl. Oz.DSLD:239683
- Radiance SelectMen's MultipleL-Arginine Hydrochloride · L-Arginine (Form: as L-Arginine Hydrochloride)50 mgper 2 Tablet(s)DSLD:2893
- Redcon1Fade Out GrapeL-Arginine Monohydrochloride · Arginine (Form: as L-Arginine Monohydrochloride)1 Gram(s)per 11 Gram(s)DSLD:237102
- RegimeHair Intensity25 mgper 1 Capsule(s)DSLD:227895
- REVSCIRegainsL-Arginine400 mgper 2 Capsule(s)DSLD:289168
- REVSCIRegains Max Muscle Mango1,500 mgper 10.5 Gram(s)DSLD:288809
- Rise-N-ShineBedtime Weight LossL-Arginine200 mgper 1 Capsule(s)DSLD:313437
- Rise-N-ShineCirculation Support50 mgper 1 Capsule(s)DSLD:297109
- Rise-N-ShineHorny Goat WeedL-Arginine Hydrochloride20 mgper 2 Capsule(s)DSLD:297067
- Rise-N-ShineSnooze & LoseL-Arginine200 mgper 1 Capsule(s)DSLD:297125
- RunFit NutritionRunner's Performance Mix Fruit Punch Flavor1,000 mgper 10 Gram(s)DSLD:286060
- RysePre-Workout Candy Watermelon1 Gram(s)per 16.4 Gram(s)DSLD:264520
- Ryse Up Sports NutritionPre-Workout Electric Lemonade1 Gram(s)per 16.4 Gram(s)DSLD:244022
- Ryse Up Sports NutritionPre-Workout Pink Blast1 Gram(s)per 16.4 Gram(s)DSLD:244013
- S J PharmaceuticalsCardiotek-Rx Tablets500 mgper 1 Tablet(s)DSLD:264187
- S SculptNight KitL-Arginine · L-Arginine (Form: L-Arginine Base)200 mgper 1 Capsule(s)DSLD:236801
- Scientific Nutrition For Advanced Conditioning SNACPED Performance Energy Drink Raspberry Lemonade1,000 mgper 9.2 Gram(s)DSLD:14627
- Seeking HealthOptimal Amino Blend18 mgper 1 Capsule(s)DSLD:210883
- Sheer Strength LabsN.O.+ Nitric Oxide Booster1,100 mgper 4 Capsule(s)DSLD:261359
- Sheer Strength LabsSheer N.O.1,100 mgper 4 Capsule(s)DSLD:219024
- SigmaCeuticalCirculation & Vein Formula50 mgper 1 Capsule(s)DSLD:321751
- SigmaCeuticalLibido Enhancement & SupportL-Arginine Hydrochloride20 mgper 2 Capsule(s)DSLD:255967
- Signature SupplementsCirculation Improve50 mgper 2 Capsule(s)DSLD:338657
- Signature SupplementsL-Arginine 400 mg800 mgper 1 Capsule(s)DSLD:338803
- Signature SupplementsMuscle Recovery100 mgper 2 Capsule(s)DSLD:338853
- Simply SupplementsHigh Strength Prostaform PlusL-Arginine HCl Note: providing120 mgper 1 Capsule(s)DSLD:70785
- Simply SupplementsSuper Strength L-Arginine 500 mg604 mgper 1 Capsule(s)DSLD:70387
- SimplyBestProstamex Gold10 mgper 1 Tablet(s)DSLD:22076
- SimplyBestVitaMen Plus1 mgper 1 Tablet(s)DSLD:22587
- SimplySupplementsL-Arginine 500 mgL-Arginine HCl Note: providing605 mgper 1 Capsule(s)DSLD:22033
- SimplySupplementsL-Arginine 500 mgL-Arginine HCl Note: providing605 mgper 1 Capsule(s)DSLD:22410
- SimplySupplementsProstaform PlusL-Arginine HCl Note: providing120 mgper 1 Capsule(s)DSLD:22464
- SirenLabsShock'd Grapeamount not statedper 6.5 Gram(s)DSLD:45206
- SkinnyBeanBooty Boost250 mgper 2 Tablet(s)DSLD:334282
- SkinnyBeanEstrogen Enhancement100 mgper 2 Capsule(s)DSLD:334283
- SNAC NutritionAerobitine1,000 mgper 2 Capsule(s)DSLD:258093
- SNAC NutritionProglycosyn Orange Cream1 Gram(s)per 59 Gram(s)DSLD:211842
- SNAC NutritionProglycosyn Vanilla Cream1 Gram(s)per 59 Gram(s)DSLD:211849
- SNAC NutritionXPedite Green Apple1,000 mgper 13.2 Gram(s)DSLD:292302
- SNAC NutritionXPedite Raspberry Lemonade1,000 mgper 13.2 Gram(s)DSLD:292303
- SNAPNitric Oxide PreWorkout Organic Beets240 mgper 8.2 Gram(s)DSLD:296742
- SolgarL-Arginine 1000 mgL-Arginine Hydrochloride · L-Arginine (Form: as L-Arginine HCl) Note: (free form) (1 g)1,000 mgper 1 Tablet(s)DSLD:63262
- SolgarL-Arginine 500 mgL-Arginine Note: free form500 mgper 1 Vegetable Capsule(s)DSLD:200511
- SolgarL-Arginine 500 mgL-Arginine Note: free form500 mgper 1 Vegetarian Capsule(s)DSLD:217340
- SolgarL-Arginine 500 mgL-Arginine Note: free form500 mgper 1 Vegetarian Capsule(s)DSLD:217342
- SolgarPomegranate Complex750 mgper 3 Vegetarian Capsule(s)DSLD:214792
- SomaLifeYouth Formula1,302 mgper 6 Capsule(s)DSLD:16517
- SomaLife InternationalgHP Sport1,302 mgper 6 Capsule(s)DSLD:16512
- Sonora NutritionMultivitamin for Men100 mgper 3 Capsule(s)DSLD:247436
- Soto SupplementsGFC 200+amount not statedper 10 Drop(s)DSLD:209984
- Source NaturalsBlood Pressure ResponseL-Arginine Hydrochloride · L-Arginine (Form: as L-Arginine HCl)1.44 Gram(s)per 3 Tablet(s)DSLD:214394
- Source NaturalsBlood Pressure ResponseL-Arginine Hydrochloride · L-Arginine (Form: as L-Arginine HCl)1.44 Gram(s)per 3 Tablet(s)DSLD:214396
- Source NaturalsBlood Pressure ResponseL-Arginine Hydrochloride · L-Arginine (Form: as L-Arginine HCl)1.44 Gram(s)per 3 Tablet(s)DSLD:214397
- Source NaturalsBlood Pressure ResponseL-Arginine Hydrochloride · L-Arginine (Form: as L-Arginine HCl)1.44 Gram(s)per 5 Tablet(s)DSLD:214719
- Source NaturalsCholestrexL-Arginine Hydrochloride · L-Arginine (Form: as L-Arginine HCl)66 mgper 2 Tablet(s)DSLD:185154
- Source NaturalsCholestrexL-Arginine Hydrochloride · L-Arginine (Form: as L-Arginine HCl)66 mgper 2 Tablet(s)DSLD:185161
- Source NaturalsCholestrexL-Arginine Hydrochloride · L-Arginine (Form: as L-Arginine HCl)66 mgper 2 Tablet(s)DSLD:185187
- Source NaturalsCholestrexL-Arginine Hydrochloride · L-Arginine (Form: as L-Arginine HCl)66 mgper 2 Tablet(s)DSLD:185212
- Source NaturalsHeart Science500 mgper 3 Tablet(s)DSLD:274660
- Source NaturalsIntimate Response98 mgper 1 Tablet(s)DSLD:213854
- Source NaturalsIntimate Response98 mgper 1 Tablet(s)DSLD:213861
- Source NaturalsL-Arginine 1,000 mgL-Arginine Hydrochloride · L-Arginine (Form: as L-Arginine HCl)1 Gram(s)per 1 Tablet(s)DSLD:273431
- Source NaturalsL-Arginine 1,000 mgL-Arginine Hydrochloride · L-Arginine (Form: as L-Arginine HCl)1 Gram(s)per 1 Tablet(s)DSLD:295932
- Source NaturalsL-Arginine 500 mg1 Gram(s)per 2 Capsule(s)DSLD:274749
- Source NaturalsL-Arginine 500 mgfree form1 Gram(s)per 2 Capsule(s)DSLD:295933
- Source NaturalsL-Arginine L-Citrulline ComplexL-Arginine Hydrochloride · L-Arginine (Form: as L-Arginine HCl)750 mgper 1 Tablet(s)DSLD:273701
- Source NaturalsL-Arginine L-Citrulline ComplexL-Arginine Hydrochloride · L-Arginine (Form: as L-Arginine HCl)750 mgper 1 Tablet(s)DSLD:274744
- Source NaturalsL-Arginine L-Citrulline Complex 1,000 mgL-Arginine Hydrochloride750 mgper 1 Tablet(s)DSLD:295935
- Source NaturalsMale NitroL-Arginine Hydrochloride750 mgper 1 Tablet(s)DSLD:274905
- Source NaturalsMale NitroL-Arginine Hydrochloride750 mgper 1 Tablet(s)DSLD:295980
- Source NaturalsMale ResponseL-Arginine Pyroglutamate300 mgper 1 Tablet(s)DSLD:295981
- Source NaturalsMale ResponseL-Arginine Pyroglutamate300 mgper 1 Tablet(s)DSLD:295982
- Source NaturalsWellness ImmuNitricL-Arginine Hydrochloride2,400 mgper 7.4 Gram(s)DSLD:296387
- Source NaturalsWellness ImmuNitricL-Arginine Hydrochloride2,250 mgper 3 Tablet(s)DSLD:296388
- Source NaturalsWellness ImmuNitricL-Arginine Hydrochloride2,250 mgper 3 Tablet(s)DSLD:296389
- SP Standard ProcessSP Detox Balance1,300 mgper 37 Gram(s)DSLD:340373
- Spring ValleyHorny Goat Weed Complex40 mgper 2 Vegetarian Capsule(s)DSLD:244528
- Spring ValleyL-Arginine500 mgper 1 Capsule(s)DSLD:178389
- Spring ValleyL-Arginine500 mgper 1 Capsule(s)DSLD:178404
- Spring ValleyL-Arginine 500 mgL-Arginine Note: 1,000 mg1 Gram(s)per 2 Capsule(s)DSLD:73374
- SteelRested-AF Lemon Ginger1 Gram(s)per 13 Gram(s)DSLD:277716
- SteelVeg-Pro Vanilla Cream Pie1.42 Gram(s)per 1 Scoop(s)DSLD:218137
- Success ChemistryExtreme Horny GoatBase20 mgper 2 Capsule(s)DSLD:334290
- Success ChemistryLibido BoostBase100 mgper 2 Capsule(s)DSLD:334301
- SundownL-Arginine 500 mgL-Arginine Note: 1 g1,000 mgper 2 Capsule(s)DSLD:212440
- Sundown NaturalistL-Arginine 500 mgL-Arginine Note: 1g1,000 mgper 2 Capsule(s)DSLD:63498
- SuperSmartProsexual Booster Formula1,500 mgper 4 Tablet(s)DSLD:332484
- SuperSmartProsexual Formula Man1,600 mgper 6 Capsule(s)DSLD:332485
- Supplement SpotMaxoMan500 mgper 2 Tablet(s)DSLD:328359
- SwansonGHR FormulaL-Arginine Base620 mgper 2 Capsule(s)DSLD:203270
- SwansonL-Arginine & L-OrnithineL-Arginine base500 mgper 1 Capsule(s)DSLD:181354
- SwansonL-Arginine 500 mgFree-Form Amino Acid500 mgper 1 Capsule(s)DSLD:308640
- SwansonL-Arginine 500 mgFree-Form Amino Acid500 mgper 1 Capsule(s)DSLD:337849
- SwansonL-Arginine 850 mg Maximum Strength850 mgper 1 Capsule(s)DSLD:203212
- SwansonSuper Vitality ReleaserAjiPure L-Arginine150 mgper 2 Veggie Capsule(s)DSLD:206871
- SwansonUltimate Women's Intimate Performance33.3 mgper 1 Tablet(s)DSLD:309296
- SwansonVitality Renewal Formula1.5 mcgper 12 Drop(s)DSLD:206865
- Swole AFEscobar Tropical Paradise500 mgper 5.5 Gram(s)DSLD:262194
- SyntraxMatrix 1.0 Milk ChocolateArginine Note: Important Nonessential Amino Acid2.5 Gram(s)per 31 Gram(s)DSLD:228586
- Systemic FormulasAccell Therapeutic680 mgper 30 Gram(s)DSLD:22284
- Systemic FormulasEpic LQ Metabolic NO-ONOO Micro Antioxidantamount not statedper 0.5 Dropper(s)DSLD:22500
- Systemic FormulasEventa LQamount not statedper 0.5 Dropper(s)DSLD:22400
- Taylor MD FormulationsAmino Restore Natural Choclate Flavor2.48 Gram(s)per 15 Gram(s)DSLD:263101
- Ten PerformancePro Workout0.5 Gram(s)per 8.2 Gram(s)DSLD:287126
- TerraVita Premium CollectionL-Arginine 450 mg450 mgper 1 Capsule(s)DSLD:285842
- TerraVita Premium CollectionL-Arginine Powder1,000 mgper 0.25 Teaspoon(s)DSLD:283785
- TerraVita Premium CollectionL-Arginine Powder1,000 mgper 0.25 Teaspoon(s)DSLD:287830
- TestomenixTestomenix250 mgper 1 Capsule(s)DSLD:278485
- The Enclare NutritionA6BurnL-Arginine200 mgper 1 Capsule(s)DSLD:276196
- The Enclare NutritionStaminaL-Arginine HCl20 mgper 2 Capsule(s)DSLD:276199
- The Genius BrandGenius L-Arginine Natural Lemon5 Gram(s)per 8 Gram(s)DSLD:305643
- The Genius BrandGenius Pre Grape Limeade1 Gram(s)per 8.45 Gram(s)DSLD:305644
- The Health GuardianCardio for Life Grape Flavor5,000 mgper 1 Level Scoop(s)DSLD:260033
- The Professional SeriesHyper Ten Support50 mgper 1 Capsule(s)DSLD:10737
- The Vitamin ShoppeArginine & Ornithine 2000 mgL-Arginine base Note: free form amino acid1,250 mgper 2 Capsule(s)DSLD:217739
- The Vitamin ShoppeArginine & Ornithine 2000 mgL-Arginine base Note: free form amino acid1,250 mgper 2 Capsule(s)DSLD:217742
- The Vitamin ShoppeL-Arginine 500 mgArginine, Powder · L-Arginine (Form: as Arginine powder base)500 mgper 1 Capsule(s)DSLD:183407
- The Vitamin ShoppeL-Arginine 500 mgArginine, Powder · L-Arginine (Form: as Arginine powder base)500 mgper 1 Capsule(s)DSLD:183411
- The Vitamin ShoppeL-Arginine HCl Tropical Flavor6 Gram(s)per 8.1 Gram(s)DSLD:204475
- ThorneL-ArginineL-Arginine complexed with Time-Sorb Note: A time-release matrix.1 Gram(s)per 2 Capsule(s)DSLD:336345
- ThorneL-Arginine PlusTime-Sorb1 Gram(s)per 3 Capsule(s)DSLD:336346
- Thymely SolutionsMale Virility20 mgper 1 mLDSLD:211913
- TN Trusted NutrientsL-Arginine 1000 mgArginine Hydrochloride · L-Arginine (Form: as Arginine Hydrochloride)1,000 mgper 1 Tablet(s)DSLD:70367
- Tokkyo NutritionMass Stackamount not statedper 1 Capsule(s)DSLD:180556
- Tokkyo NutritionTrenavar Extremeamount not statedper 1 Capsule(s)DSLD:180655
- Totally ProductsForzaL-Arginine Hydrochloride20 mgper 2 Capsule(s)DSLD:294217
- Totally ProductsHGH-Up Hormone SupportL-Arginine400 mgper 2 Capsule(s)DSLD:294183
- Totally ProductsHorny Goat ComplexL-Arginine Hydrochloride20 mgper 2 Capsule(s)DSLD:294241
- Totally ProductsHorny Goat ComplexL-Arginine Hydrochloride20 mgper 2 Capsule(s)DSLD:321264
- Totally ProductsPM Total TestL-Arginine200 mgper 1 Capsule(s)DSLD:294211
- Totally ProductsTotal ManL-Arginine Hydrochloride20 mgper 2 Capsule(s)DSLD:294248
- Totally ProductsTotal TestL-Arginine Hydrochloride20 mgper 2 Capsule(s)DSLD:294261
- TriVitaLeanology ChocolateArginine Note: Essential Amino Acids (amount in 30.3g of powder)1,383 mgper 30.3 Gram(s)DSLD:33082
- TruehopeAminopowerplusL-Arginine Hydrochloride · Arginine (Form: as L-Arginine Hydrochloride)88.8 mgper 4 Veggie Capsule(s)DSLD:32348
- Twinlab100% Whey Protein Fuel Chocolate Surge600 mgper 35 Gram(s)DSLD:4265
- Twinlab100% Whey Protein Fuel Strawberry Smash600 mgper 34 Gram(s)DSLD:3623
- Twinlab100% Whey Protein Fuel Vanilla Slam600 mgper 33 Gram(s)DSLD:3624
- TwinlabAmino Fuel 100086 mgper 4 Tablet(s)DSLD:3625
- TwinlabAmino Fuel 100086 mgper 4 Tablet(s)DSLD:73907
- TwinlabL-ArginineL-Arginine500 mgper 1 Capsule(s)DSLD:268467
- TwinlabMale Fuel1,400 mgper 3 Capsule(s)DSLD:43928
- TwinlabMale Fuel1,400 mgper 3 Capsule(s)DSLD:43938
- Ultimate Nutrition Platinum SeriesArginine Ornithine Lysine750 mgper 3 Capsule(s)DSLD:293448
- Ultimate Nutrition Platinum SeriesArginine Power 800 mg800 mgper 1 Capsule(s)DSLD:293449
- Ultra PrimeSecretagogue3 Gram(s)per 17.7 Gram(s)DSLD:217972
- UnicityRenew1,714 mgper 7 Capsule(s)DSLD:240040
- UniversalAmino 1000280 mgper 5 Capsule(s)DSLD:64048
- UniversalAmino 1900130 mgper 4 Tablet(s)DSLD:246059
- UniversalAmino 1900130 mgper 4 Tablet(s)DSLD:274619
- UniversalAmino 1900140 mgper 4 Tablet(s)DSLD:64049
- UniversalAmino 225083 mgper 2 Tablet(s)DSLD:37728
- UniversalAmino 225083 mgper 2 Tablet(s)DSLD:64054
- UniversalAmino 225083 mgper 2 Tablet(s)DSLD:64059
- UniversalAmino 2700145 mgper 3 Tablet(s)DSLD:37770
- UniversalAmino 2700145 mgper 3 Tablet(s)DSLD:65618
- UniversalUniversal Amino 2700140 mgper 3 Tablet(s)DSLD:247363
- Universal NutritionUniversal Amino 2700140 mgper 3 Tablet(s)DSLD:274726
- VAXAParasitin40 mgper 4 Capsule(s)DSLD:277609
- Vega SportRecovery Apple Berry Flavored407 mgper 27 Gram(s)DSLD:282416
- Vega SportRecovery Tropical Flavored407 mgper 27 Gram(s)DSLD:282418
- VerVitaReGenerZyme Heart50 mgper 3 Tablet(s)DSLD:207060
- Vibrant HealthGlycemic Vibrance H50 mgper 3 Capsule(s)DSLD:38288
- Vibrant HealthGlycemic Vibrance H Natural Orange-Mango Flavor200 mgper 4 Gram(s)DSLD:40381
- Village VitalityMale Virility20 mgper 1 mLDSLD:310267
- ViMultiAnti-Aging ComplexL-Arginine · L-Arginine (Form: L-Arginine Base)400 mgper 2 Capsule(s)DSLD:231118
- ViMultiP.M. Weight LossL-Arginine · L-Arginine (Form: L-Arginine Base)200 mgper 1 Capsule(s)DSLD:231010
- ViMultiT SupportL-Arginine Hydrochloride25 mgper 1 Tablet(s)DSLD:53001
- ViMultiViMulti A.M.250 mgper 1 Capsule(s)DSLD:329715
- ViMultiVitality XR500 mgper 2 Capsule(s)DSLD:230955
- ViMultiXXX500 mgper 2 Capsule(s)DSLD:53132
- ViMulti Beautiful MeSkinny DreamsL-Arginine · L-Arginine (Form: L-Arginine Base)200 mgper 1 Capsule(s)DSLD:230866
- VinsicSea Cucumber & Oysters300 mgper 3 Tablet(s)DSLD:335764
- VISPURAMaca1,800 mgper 4 Capsule(s)DSLD:322229
- VitabaseHGH Complexl-arginine base400 mgper 2 Capsule(s)DSLD:329278
- VitabaseL-Arginine 500 mgL-Arginine Note: Free form L-Arginine.500 mgper 1 Vegetarian Capsule(s)DSLD:7146
- VitaCeutical LabsL-Arginine & L-Ornithine Complex500 mgper 2 Capsule(s)DSLD:53659
- VitaCeutical LabsL-Arginine 500 mg500 mgper 1 Capsule(s)DSLD:6401
- Vital NutrientsArginine 1500 mgL-Arginine · pure 100% L-Arginine base, L-Form1,500 mgper 1 Vegetarian CapsulesDSLD:304942
- Vital PerformancePRE Lemon GrapeNO3-T1.5 Gram(s)per 26 Gram(s)DSLD:245669
- Vital PerformancePRE Passion FruitNO3-T1.5 Gram(s)per 26 Gram(s)DSLD:245668
- Vital PerformancePRE Watermelon BlueberryNO3-T1.5 Gram(s)per 26 Gram(s)DSLD:245664
- Vital PerformancePRE Yuzu ClementineNO3-T1.5 Gram(s)per 27 Gram(s)DSLD:245650
- Vital ProteinsVitality Immune Booster Clementine500 mgper 15 Gram(s)DSLD:254297
- Vital ProteinsVitality Immune Booster Clementine500 mgper 15 Gram(s)DSLD:302836
- Vital ProteinsVitality Immune Booster Grape Citrus500 mgper 13 Gram(s)DSLD:302874
- VitaliboostLoad Boost400 mgper 3 Capsule(s)DSLD:303526
- VitalsPremium Female Enhancementbase100 mgper 2 Capsule(s)DSLD:316168
- Vitamin WorldBi-Amino ComplexL-Arginine Note: (1 g) (Free Form)1,000 mgper 2 Capsule(s)DSLD:20960
- Vitamin WorldL-Arginine 500 mgL-Arginine Note: (1 g) (Free Form)1,000 mgper 2 Capsule(s)DSLD:60474
- Vitamin WorldMaximum Strength L-Arginine 1000 mgL-Arginine Note: (1 g) (Free Form)1,000 mgper 1 Capsule(s)DSLD:20896
- Vitamin WorldMaximum Strength L-Arginine 1000 mgL-Arginine Note: (Free Form) (1 g)1,000 mgper 1 Capsule(s)DSLD:62797
- Vitamin WorldMaximum Strength L-Arginine 1000 mg Free FormL-Arginine Hydrochloride · L-Arginine (Form: L-Arginine HCl) Note: (free form) (1 g)1,000 mgper 1 Caplet(s)DSLD:62384
- Vitamin WorldTri-Amino ComplexL-Arginine HCl Free Form Note: 1.4 g1,447 mgper 4 Caplet(s)DSLD:20845
- Vitamin WorldUltra Man 50 Plus Daily Multi-PacksArginine Hydrochloride · L-Arginine (Form: as Arginine HCl) Note: 1 g1,000 mgper 1 Packet(s)DSLD:72414
- Vitamin WorldUltra Man Max Daily MultiL-Arginine Hydrochloride · L-Arginine (Form: as L-Arginine Hydrochloride)50 mgper 2 Caplet(s)DSLD:21154
- Vitamin WorldUltra Man Max Daily MultiL-Arginine Hydrochloride · L-Arginine (Form: as L-Arginine Hydrochloride)50 mgper 2 Caplet(s)DSLD:21270
- Vitamin WorldUltra Man Max Daily MultiL-Arginine Hydrochloride · L-Arginine (Form: as L-Arginine Hydrochloride)50 mgper 2 Caplet(s)DSLD:240125
- Vitamin WorldUltra Vita Man 50+L-Arginine Hydrochloride · L-Arginine (Form: as L-Arginine Hydrochloride)100 mgper 2 Tablet(s)DSLD:3275
- Vitamins DirectProstate Health Complex50 mgper 1 Capsule(s)DSLD:28994
- VitanicaBladder Ease750 mgper 3 Capsule(s)DSLD:302782
- Viva VitaminsL-Arginine 500 mgL-Arginine Note: free form500 mgper 1 Vegetarian CapsulesDSLD:238753
- ViviscalHair Therapy Post-Baby Light Vanilla Flavor100 mgper 0.07 Ounce(s)DSLD:246406
- VolDox HeartLifeAllicin100 mgper 2 Capsule(s)DSLD:335635
- Wholesome StoryMale Fertility SupportL-Arginine Hydrochloride200 mgper 3 Capsule(s)DSLD:335612
- WindmillL-Arginine HCl 500 mg500 mgper 1 Capsule(s)DSLD:180928
- Windmill Health ProductsNature's Aphrodisiac For Women250 mgper 2 Caplet(s)DSLD:7619
- Wonder LaboratoriesArginine Ornithine & Lysine1,447 mgper 4 Tablet(s)DSLD:260418
- Wonder LaboratoriesFormula MS50 mgper 2 Vegetable Capsule(s)DSLD:262302
- Wonder LaboratoriesFormula MS100 mgper 2 Tablet(s)DSLD:262304
- Wonder LaboratoriesFormula MS50 mgper 2 Vegetable Capsule(s)DSLD:325853
- Wonder LaboratoriesL-Arginine 1000 mgArginine Hydrochloride · L-Arginine (Form: as Arginine Hydrochloride)1,000 mgper 1 Tablet(s)DSLD:215314
- Wonder LaboratoriesL-Arginine 1000 mgArginine Hydrochloride · L-Arginine (Form: as Arginine Hydrochloride)1,000 mgper 1 Tablet(s)DSLD:262073
- Wonder LaboratoriesL-Arginine 500 mg500 mgper 1 Capsule(s)DSLD:215312
- Wonder LaboratoriesL-Arginine 500 mg500 mgper 1 Capsule(s)DSLD:215313
- Wonder LaboratoriesL-Arginine 500 mg500 mgper 1 Capsule(s)DSLD:262696
- Wonder LaboratoriesL-Arginine 500 mg500 mgper 1 Capsule(s)DSLD:262730
- Wonder LaboratoriesTriple-Aminos1,450 mgper 5 Capsule(s)DSLD:215699
- Wonder LaboratoriesTriple-Aminos1,450 mgper 5 Capsule(s)DSLD:260419
- Wonder LaboratoriesTriple-Aminos1,450 mgper 5 Capsule(s)DSLD:262130
- Wonder LabsAmino Acid Complex115.5 mgper 1 Tablet(s)DSLD:214914
- Wonder LabsAmino Acid Complex115.5 mgper 1 Tablet(s)DSLD:260733
- Woodstock VitaminsL-Arginine 500 mg500 mgper 1 Capsule(s)DSLD:263065
- XtendlifeCardio-Klenz250 mgper 6 Tablet(s)DSLD:17014
- XtendlifeMale Rejuvenator800 mcgper 6 Tablet(s)DSLD:318034
- XtendlifeNatural Energy70 mgper 3 Capsule(s)DSLD:283389
- XtendlifeTotal Balance Children's25 mgper 3 Tablet(s)DSLD:318023
- XtendlifeTotal Balance Men's Premium90 mgper 7 Tablet(s)DSLD:331309
- XtendlifeTotal Balance Unisex Premium90 mgper 6 Tablet(s)DSLD:283408
- XtendlifeTotal Balance Women's Premium90 mgper 7 Tablet(s)DSLD:331312
- XYMOGENAngiNOX Elite Natural Fruit Punch Flavor500 mgper 4.5 Gram(s)DSLD:335420
- XYMOGENMax Brain5 mgper 1 Capsule(s)DSLD:50373
- XYMOGENMaX Heart50 mgper 2 Capsule(s)DSLD:50060
- XYMOGENXymoBolX Natural Lemon Flavor405 mgper 6.8 Gram(s)DSLD:335572
- Zen NutrientsNeuraZenx25 mgper 2 Capsule(s)DSLD:277223
- Zen NutrientsWoundVite25 mgper 2 Capsule(s)DSLD:277222
- ZHOUHorny Goat Weed20 mgper 2 Vegetable Capsule(s)DSLD:286213
- ZHOUN.O. Pro with Beet Root1,200 mgper 4 Vegetable Capsule(s)DSLD:250096
Label record: NIH Office of Dietary Supplements · CC0
Registered, and not reported
- Source
- ClinicalTrials.gov
- Intervention
- L-arginine
- Status
- Completed, terminated or suspended
- Results posted
- No
Trials without posted results
418 trials
418 registered trials without posted results · Overdue (FDAAA 801): 99 · Showing 120 of 418
99 past the window21 within it, or no actual date
- NCT05616624terminated— Polaris has decided to close to accrual due to low enrollment2026-07-22a university or hospital
- NCT04036409completed2026-07-08a university or hospital
- NCT04040634completed2026-07-08a university or hospital
- NCT05477134completed2026-06-18a university or hospital
- NCT05712694terminated— Lack of Efficacy, no safety concern.2026-05-25industry
- NCT04278768suspended— Dosing completed in all cohorts. Planning underway for potential additional patient cohorts.expected 2026-04-01industry
- NCT06460948completed2026-03-17a university or hospital
- NCT06790771completed2026-03-15a university or hospital
- NCT07466758completed2026-03-04a university or hospital
- NCT06439875completed2026-02-16a university or hospital
- NCT06426407terminated— The study was terminated due to lack of feasibility.2026-02-01a university or hospital
- NCT07673432completed2026-01-15industry
Show the remaining 406
- NCT07020754completed2026-01-01a university or hospital
- NCT05069402completed2025-12-31a university or hospital
- NCT07653737completed2025-12-31a university or hospital
- NCT07134231completed2025-12-11industry
- NCT05190744completed2025-12-08a university or hospital
- NCT06248359completed2025-12-01a university or hospital
- NCT06771128completed2025-12-01a university or hospital
- NCT07257042completed2025-11-04industry
- NCT07149376completed2025-10-14industrypast the reporting window
- NCT07084948completed2025-10-10an individualpast the reporting window
- NCT07292753completed2025-10-10a university or hospitalpast the reporting window
- NCT03573310completed2025-09-25industrypast the reporting window
- NCT07038044completed2025-09-18a university or hospitalpast the reporting window
- NCT04487756completed2025-09-08a university or hospitalpast the reporting window
- NCT06542198completed2025-07-22a university or hospitalpast the reporting window
- NCT06002269completed2025-07-08a university or hospitalpast the reporting window
- NCT06728644completed2025-07-04a university or hospitalpast the reporting window
- NCT07506187completed2025-06-30a university or hospitalpast the reporting window
- NCT07347509completed2025-06-12a university or hospitalpast the reporting window
- NCT07548541completed2025-05-15a university or hospitalpast the reporting window
- NCT06960148completed2025-05-13industrypast the reporting window
- NCT06732518completed2025-04-24industrypast the reporting window
- NCT06781489completed2025-03-20a university or hospitalpast the reporting window
- NCT06778759completed2025-03-12a university or hospitalpast the reporting window
- NCT05616273completed2025-01-28a university or hospitalpast the reporting window
- NCT05706493completed2025-01-01a university or hospitalpast the reporting window
- NCT06947265completed2025-01-01a university or hospitalpast the reporting window
- NCT05293041completed2024-12-06a university or hospitalpast the reporting window
- NCT05412160completed2024-12-01a university or hospitalpast the reporting window
- NCT04307550completed2024-10-27a university or hospitalpast the reporting window
- NCT05651555completed2024-10-23a university or hospitalpast the reporting window
- NCT05470998completed2024-10-01a university or hospitalpast the reporting window
- NCT04329975completed2024-09-25industrypast the reporting window
- NCT06954779completed2024-09-20industrypast the reporting window
- NCT04725071terminated— Slow accrual2024-09-09a university or hospitalpast the reporting window
- NCT06216262completed2024-08-23a university or hospitalpast the reporting window
- NCT06977854completed2024-07-27industrypast the reporting window
- NCT06772584completed2024-07-01a university or hospitalpast the reporting window
- NCT07191665completed2024-06-30industrypast the reporting window
- NCT06764420completed2024-06-20a university or hospitalpast the reporting window
- NCT04786873completed2024-06-13industrypast the reporting window
- NCT06704815completed2024-06-12industrypast the reporting window
- NCT03684213completed2024-05-15a university or hospitalpast the reporting window
- NCT06938126completed2024-05-15a university or hospitalpast the reporting window
- NCT06753526completed2024-04-30a university or hospitalpast the reporting window
- NCT05514457completed2024-03-15a university or hospitalpast the reporting window
- NCT04950270completed2024-02-26a university or hospitalpast the reporting window
- NCT06135792completed2024-02-13a university or hospitalpast the reporting window
- NCT04549662completed2024-02-12a university or hospitalpast the reporting window
- NCT06125730completed2024-02-10industrypast the reporting window
- NCT05765487completed2024-01-26industrypast the reporting window
- NCT05952349completed2023-12-31a university or hospitalpast the reporting window
- NCT05653895completed2023-12-30a university or hospitalpast the reporting window
- NCT06182267completed2023-12-22industrypast the reporting window
- NCT05954923completed2023-12-20a university or hospitalpast the reporting window
- NCT06140784completed2023-12-10industrypast the reporting window
- NCT05764317completed2023-11-30industrypast the reporting window
- NCT05822518completed2023-11-30a university or hospitalpast the reporting window
- NCT05988099completed2023-07-28industrypast the reporting window
- NCT03679780completed2023-07-26a university or hospitalpast the reporting window
- NCT04474808completed2023-06-30a university or hospitalpast the reporting window
- NCT05507476completed2023-06-01a government bodypast the reporting window
- NCT06004375completed2023-05-30a university or hospitalpast the reporting window
- NCT05806502completed2023-04-30a university or hospitalpast the reporting window
- NCT06726486completed2023-04-30a university or hospitalpast the reporting window
- NCT03101826terminated— Insufficient resources2023-03-08a university or hospitalpast the reporting window
- NCT03922880completed2023-01-20a university or hospitalpast the reporting window
- NCT03389412completed2023-01-03a university or hospitalpast the reporting window
- NCT06020456completed2023-01-01a university or hospitalpast the reporting window
- NCT06197555completed2022-12-24a university or hospitalpast the reporting window
- NCT06973148completed2022-12-19a university or hospitalpast the reporting window
- NCT05706714completed2022-12-13a university or hospitalpast the reporting window
- NCT01791816completed2022-12a university or hospitalpast the reporting window
- NCT05656495completed2022-11-22a university or hospitalpast the reporting window
- NCT05958251completed2022-11-02a university or hospitalpast the reporting window
- NCT03878381completed2022-10-29a university or hospitalpast the reporting window
- NCT03572166completed2022-09-30a university or hospitalpast the reporting window
- NCT04935814completed2022-08-02a university or hospitalpast the reporting window
- NCT05140278completed2022-07-29a university or hospitalpast the reporting window
- NCT03455140completed2022-07-22a university or hospitalpast the reporting window
- NCT05333315completed2022-07-01a university or hospitalpast the reporting window
- NCT03566524completed2022-06-30a university or hospitalpast the reporting window
- NCT03696121completed2022-06-30a university or hospitalpast the reporting window
- NCT05152849completed2022-06-21industrypast the reporting window
- NCT03711903completed2022-06-16a university or hospitalpast the reporting window
- NCT04923555completed2022-06-07a university or hospitalpast the reporting window
- NCT03204266completed2022-05-25a university or hospitalpast the reporting window
- NCT04591808terminated— for strategic reasons2022-04-08a university or hospitalpast the reporting window
- NCT05448976completed2022-04-06a university or hospitalpast the reporting window
- NCT03489525completed2022-03-21industrypast the reporting window
- NCT05560945completed2022-03-12industrypast the reporting window
- NCT03998800completed2022-01-01a university or hospitalpast the reporting window
- NCT04782999completed2022-01a university or hospitalpast the reporting window
- NCT05461911completed2021-12-01a research networkpast the reporting window
- NCT04394117completed2021-11-14a university or hospitalpast the reporting window
- NCT04463849completed2021-10-31a university or hospitalpast the reporting window
- NCT05568316completed2021-10-30a university or hospitalpast the reporting window
- NCT05061797completed2021-10-11industrypast the reporting window
- NCT03928587completed2021-10-08industrypast the reporting window
- NCT02850367completed2021-09a university or hospitalpast the reporting window
- NCT05536934completed2021-09a university or hospitalpast the reporting window
- NCT04626375completed2021-08-01a university or hospitalpast the reporting window
- NCT02936687completed2021-07-01a university or hospitalpast the reporting window
- NCT02838030suspended— COVID-19 pandemicexpected 2021-07a university or hospital
- NCT05470764completed2021-06-28industrypast the reporting window
- NCT04875000completed2021-06-20a university or hospitalpast the reporting window
- NCT05464745completed2021-06-09industrypast the reporting window
- NCT03876119completed2021-05-31a university or hospitalpast the reporting window
Where it reaches
10 systems, 24 regions, 102 tissues, 123 transporter routes — routes, not measurements: transporters known to carry L-arginine are expressed there, and no source reports it arriving.
Loading the model…
Papers screened
2,186 papers
- Compound
- L-arginine
- Screened
- 2,186
- Admitted
- 13
- Discarded
- 1,056
- Not read
- 1,117
- Showing
- 200 of 2,186
Read and discarded1,056 papers
- PMID:7003021cited by PMID:20042191; not about the subject it would be filed under2026-10-12
- PMID:7517833cited by PMID:20042191; not about the subject it would be filed under2026-10-12
- PMID:7884538cited by PMID:20042191; not about the subject it would be filed under2026-10-12
- PMID:8561065cited by PMID:20042191; not about the subject it would be filed under2026-10-12
- PMID:8602586cited by PMID:20042191; not about the subject it would be filed under2026-10-12
- PMID:9082032cited by PMID:20042191; not about the subject it would be filed under2026-10-12
- PMID:9247501cited by PMID:20042191; not about the subject it would be filed under2026-10-12
- PMID:9734729cited by PMID:20042191; not about the subject it would be filed under2026-10-12
- PMID:10204828cited by PMID:20042191; not about the subject it would be filed under2026-10-12
- PMID:10395594cited by PMID:20042191; not about the subject it would be filed under2026-10-12
- PMID:10799368cited by PMID:20042191; not about the subject it would be filed under2026-10-12
- PMID:11208932cited by PMID:20042191; not about the subject it would be filed under2026-10-12
and 1,044 more.
Not read yet1,117 papers
- PMID:94483002026-10-15
- PMID:112572272026-10-13
- PMID:146995052026-10-13
- PMID:191366292026-10-13
- PMID:11108692026-10-13
- PMID:95677542026-10-12
- PMID:104987512026-10-12
- PMID:107371512026-10-12
- PMID:109351532026-10-12
- PMID:157237382026-10-12
- PMID:31552912026-10-12
- PMID:68117072026-10-12
and 1,105 more.
Measured, not recorded
- Compound
- L-arginine
- Endpoints measured
- 997 endpoints
- Recorded as a finding
- No
Show what was measured
24-hour ambulatory systolic blood pressure
decreases, GTN lowered 24 hour ambulatory systolic blood pressure by 7.9 mmHg (95% CI 0.1, 15.8), n = 127
GTN lowered 24 hour ambulatory systolic blood pressure by 7.9 mmHg (95% CI 0.1, 15.8) and increased heart rate (WMD 6.2 beats per minute, 95% CI 2.7, 9.8).
PMID:12519542 · both readings recorded this
24 hour ambulatory systolic blood pressure
decreases, GTN lowered 24 hour ambulatory systolic blood pressure by 7.9 mmHg (95% CI 0.1, 15.8)
GTN lowered 24 hour ambulatory systolic blood pressure by 7.9 mmHg (95% CI 0.1, 15.8) and increased heart rate (WMD 6.2 beats per minute, 95% CI 2.7, 9.8).
PMID:12519542 · both readings recorded this
death, combined death or deterioration, end-of-trial death, combined death or dependency, combined death or institutionalisation
no effect
Treatment with GTN was not associated with statistically significant effects on end-of-treatment death, or combined death or deterioration, or end-of-trial death, combined death or dependency, or combined death or institutionalisation.
PMID:12519542 · one of two readings recorded this
end-of-treatment death, combined death or deterioration, end-of-trial death, combined death or dependency, combined death or institutionalisation
no effect
Treatment with GTN was not associated with statistically significant effects on end-of-treatment death, or combined death or deterioration, or end-of-trial death, combined death or dependency, or combined death or institutionalisation.
PMID:12519542 · one of two readings recorded this
heart rate
increases, WMD 6.2 beats per minute (95% CI 2.7, 9.8)
GTN lowered 24 hour ambulatory systolic blood pressure by 7.9 mmHg (95% CI 0.1, 15.8) and increased heart rate (WMD 6.2 beats per minute, 95% CI 2.7, 9.8).
PMID:12519542 · both readings recorded this
Type 2 diabetes risk associated with carrying the Gly972Arg variant of the IRS-1 gene, pooled risk ratio across 27 case-control studies
increases, summary risk ratio 1.25 (95% CI 1.05-1.48)
Not recorded as a finding: subject_absent
The summary risk ratio, based on 3408 cases and 5419 control cases from 27 studies, was 1.25 (95% CI 1.05-1.48).
PMID:12819898 · one of two readings recorded this
Type 2 diabetes risk in carriers vs non-carriers of the IRS-1 Gly972Arg variant
increases, summary risk ratio 1.25 (95% CI 1.05-1.48)
The summary risk ratio, based on 3408 cases and 5419 control cases from 27 studies, was 1.25 (95% CI 1.05-1.48).
PMID:12819898 · one of two readings recorded this
Type 2 diabetes risk (summary risk ratio) associated with the IRS-1 Gly972Arg genotype
increases, summary risk ratio 1.25 (95% CI 1.05-1.48)
Not recorded as a finding: subject_absent
The summary risk ratio, based on 3408 cases and 5419 control cases from 27 studies, was 1.25 (95% CI 1.05-1.48).
PMID:12819898 · one of two readings recorded this
Type 2 diabetes risk (summary risk ratio) by IRS-1 Gly972Arg genotype
increases, summary risk ratio 1.25 (95% CI 1.05-1.48)
The summary risk ratio, based on 3408 cases and 5419 control cases from 27 studies, was 1.25 (95% CI 1.05-1.48).
PMID:12819898 · one of two readings recorded this
Blood urea nitrogen
increases, p = 0.01
blood urea nitrogen increased (p = .01) with HMB, arginine, and glutamine supplementation
PMID:15080599 · one of two readings recorded this
Hemoglobin
increases, p = 0.05
increased red blood cells, hemoglobin, hematocrit, lymphocytes, and eosinophils (p < .05)
PMID:15080599 · one of two readings recorded this
Blood creatinine
no effect
Blood creatinine levels were not changed
PMID:15080599 · one of two readings recorded this
Emotional profile
increases, p = 0.05
HMB, arginine, and glutamine supplementation was associated with an improvement in emotional profile (p = .05)
PMID:15080599 · one of two readings recorded this
Eosinophils
increases, p = 0.05
increased red blood cells, hemoglobin, hematocrit, lymphocytes, and eosinophils (p < .05)
PMID:15080599 · one of two readings recorded this
Feeling of weakness
decreases, p = 0.03
a decreased feeling of weakness (p = .03)
PMID:15080599 · one of two readings recorded this
Hematocrit
increases, p = 0.05
increased red blood cells, hemoglobin, hematocrit, lymphocytes, and eosinophils (p < .05)
PMID:15080599 · one of two readings recorded this
Lymphocytes
increases, p = 0.05
increased red blood cells, hemoglobin, hematocrit, lymphocytes, and eosinophils (p < .05)
PMID:15080599 · one of two readings recorded this
Red blood cells
increases, p = 0.05
increased red blood cells, hemoglobin, hematocrit, lymphocytes, and eosinophils (p < .05)
PMID:15080599 · one of two readings recorded this
necrotising enterocolitis (any stage) incidence
decreases, RR 0.24 (95% CI 0.10, 0.61), RD -0.21 (95% CI -0.32, -0.09)
There was a statistically significant reduction in the risk of developing NEC (any stage) in the arginine group compared with the placebo group (RR 0.24 [95% CI 0.10, 0.61], RD -0.21 [95% CI -0.32, -0.09]).
PMID:15495101 · both readings recorded this
side effects attributable to arginine
no effect
Not recorded as a finding: The paper never states whether the single included trial administered arginine enterally or parenterally, and the supplement-adverse-event-incidence node is defined only for orally/enterally administered supplements, so the route requirement could not be confirmed.
No significant side effects directly attributable to arginine were observed.
PMID:15495101 · one of two readings recorded this
side effects attributable to arginine
no effect
No significant side effects directly attributable to arginine were observed.
PMID:15495101 · one of two readings recorded this
Change from baseline in systolic blood pressure, 0 to 6 h
increases, p = 0.047
There was a small but significant difference in the mean change from baseline for SBP from 0 to 6 h after NMI 861 treatment compared with placebo (0.8 +/- 1.4 vs-4.1 +/- 2.1 mmHg, respectively; 95% CI 0.0, 9.8 mmHg (P = 0.047))
PMID:15606445 · one of two readings recorded this
Diastolic blood pressure and pulse rate, three studied time periods
no effect
There was no significant difference in DBP or pulse between NMI 861 and placebo treatments for the three studied time periods
PMID:15606445 · one of two readings recorded this
Maximum change in systolic blood pressure during GTN infusion
no effect, p = 0.46
The mean maximum changes from baseline during GTN infusion for subjects administered with either NMI 861 or placebo were a decrease of 16.9 +/- 3.4 vs 13.6 +/- 2.4 mmHg (mean difference between treatments -3.3 mmHg, 95% CI -12.7, 6.0 mmHg (P = 0.460)) for SBP
PMID:15606445 · one of two readings recorded this
systolic and diastolic blood pressure and pulse rate after oral NMI 861; hypotensive response to intravenous nitroglycerine; L-arginine Cmax and tmax
no effect, no significant difference in DBP or pulse between NMI 861 and placebo
Not recorded as a finding: the intervention held more than the compound
There was no significant difference in DBP or pulse between NMI 861 and placebo treatments for the three studied time periods.
PMID:15606445 · one of two readings recorded this
systolic and diastolic blood pressure, pulse rate and hypotensive response to intravenous nitroglycerine after a single oral dose of NMI 861 in healthy men
no effect, no significant difference in hypotensive response to GTN between NMI 861 and placebo
Not recorded as a finding: the intervention held more than the compound
There was no significant difference in the hypotensive response induced by GTN between the NMI 861 and placebo treatments.
PMID:15606445 · one of two readings recorded this
Systolic blood pressure, 6-12 h and 12-24 h periods
no effect
There was no significant difference in SBP between treatments for the studied periods 6-12 h and 12-24 h
PMID:15606445 · one of two readings recorded this
adverse outcomes at follow-up (updated review)
no effect
Not recorded as a finding: sentence reports the finding via 'this trial' rather than naming arginine, so it does not support a claim on its own; the primary side-effects sentence naming arginine was extracted instead
In this updated version, follow up data from this trial were available that revealed no statistically significant difference in the adverse outcomes.
PMID:17636753 · one of two readings recorded this
adverse outcomes at longer follow-up
no effect
Not recorded as a finding: The only sentence reporting this later-timepoint update is agentless ('this trial'), never naming arginine, so it cannot anchor a claim on its own; the earlier same-paper sentence naming arginine covers only the immediate side-effects finding.
In this updated version, follow up data from this trial were available that revealed no statistically significant difference in the adverse outcomes.
PMID:17636753 · one of two readings recorded this
necrotising enterocolitis (any stage) incidence
decreases, RR 0.24 (95% CI 0.10, 0.61), RD -0.21 (95% CI -0.32, -0.09)
There was a statistically significant reduction in the risk of developing NEC (any stage) in the arginine group compared with the placebo group [RR 0.24 (95% CI 0.10, 0.61), RD -0.21 (95% CI -0.32, -0.09)].
PMID:17636753 · both readings recorded this
side effects attributable to arginine
no effect
Not recorded as a finding: The paper never states whether the single included trial administered arginine enterally or parenterally, and the supplement-adverse-event-incidence node is defined only for orally/enterally administered supplements, so the route requirement could not be confirmed.
No significant side effects directly attributable to arginine were observed.
PMID:17636753 · one of two readings recorded this
side effects attributable to arginine
no effect
No significant side effects directly attributable to arginine were observed.
PMID:17636753 · one of two readings recorded this
Arginine de novo synthesis
no effect
Arginine de novo synthesis was not affected by the APF intake
PMID:18590940 · one of two readings recorded this
Arginine oxidation
decreases
However, arginine oxidation was significantly decreased
PMID:18590940 · one of two readings recorded this
Citrulline, leucine and urea fluxes
no effect
There were no significant differences for citrulline, leucine or urea fluxes
PMID:18590940 · one of two readings recorded this
Plasma arginine flux, fed state
decreases
During the 4-week APF, plasma arginine fluxes for the fed state, were significantly reduced
PMID:18590940 · one of two readings recorded this
Fasting flow-mediated dilation (net change)
increases, p = 0.01, n = 492
In an overall pooled estimate, l-arginine significantly increased FMD (WMD: 1.98%; 95% CI: 0.47, 3.48; P = 0.01)
PMID:19056561 · one of two readings recorded this
Fasting flow-mediated dilation (net change)
increases, p = 0.003
A subgroup analysis suggested that l-arginine supplementation significantly increased FMD when the baseline FMD levels were <7% (WMD: 2.56%; 95% CI: 0.87, 4.25; P = 0.003)
PMID:19056561 · one of two readings recorded this
Meta-regression of effect size on baseline FMD
decreases, p = 0.016
Meta-regression analysis indicated that the baseline FMD was inversely related to effect size (regression coefficient = -0.55; 95% CI: -1.00, -0.1; P = 0.016)
PMID:19056561 · one of two readings recorded this
Prealbumin
increases, p = 0.037
prealbumin values were low in every group, but this parameter was improved after the nutritional protocol only in the immunonutrition group (13.64+/-8.83 vs 15.98+/-8.66, P=0.037)
PMID:19152452 · one of two readings recorded this
Lymphocyte subpopulations (CD4+, CD8+, CD16+/56+, CD69) after nutrition protocols
no effect, n = 42
After nutritional protocols, none of the groups had an increase in their lymphocyte subpopulations
PMID:19152452 · one of two readings recorded this
Postoperative complications and postoperative hospital stay
no effect, n = 42
Also, groups did not differ in terms of postoperative complications and postoperative durations of hospital stay
PMID:19152452 · one of two readings recorded this
prealbumin, lymphocyte subpopulations (CD4+, CD8+, CD16+/56+, CD69), postoperative complications and postoperative hospital stay after 7 days of preoperative immunonutrition
no effect, groups did not differ in postoperative durations of hospital stay
Not recorded as a finding: the intervention held more than the compound
Also, groups did not differ in terms of postoperative complications and postoperative durations of hospital stay.
PMID:19152452 · one of two readings recorded this
prealbumin; lymphocyte subpopulations (CD4+, CD8+, CD16+/56+, CD69); postoperative complications; postoperative duration of hospital stay in gastrointestinal tumour patients
no effect, groups did not differ in postoperative complications and postoperative duration of hospital stay
Not recorded as a finding: the intervention held more than the compound
Also, groups did not differ in terms of postoperative complications and postoperative durations of hospital stay.
PMID:19152452 · one of two readings recorded this
Body weight, BMI, waist:hip ratio, systolic and diastolic blood pressure
no effect, n = 30
There were no significant differences in body weight, BMI, waist:hip ratio, or systolic and diastolic blood pressure at the end of the two diet phases (Table 3)
PMID:20042191 · one of two readings recorded this
Cholesterol fractional synthesis rate (FSR)
no effect, n = 30
Similarly, cholesterol FSR was not significantly altered by the Lys:Arg ratio of the diet
PMID:20042191 · one of two readings recorded this
Endogenous LCAT and CETP activities
no effect, n = 30
Endogenous LCAT and CETP activities were not significantly different at the end of the two diet phases
PMID:20042191 · one of two readings recorded this
Energy intake
no effect, n = 30
The mean energy intake (mean ± SD) of the participants was 2617 ± 468 kcal when consuming the low Lys:Arg ratio diet and 2662 ± 490 kcal when consuming the high Lys:Arg ratio diet
PMID:20042191 · one of two readings recorded this
Fasting adiponectin
increases, p = 0.035, n = 30
Compared to the high Lys:Arg ratio diet, the low Lys:Arg ratio diet resulted in a modestly lower apo AI (3%, P=0.003) and higher adiponectin concentration (7%; P=0.035)
PMID:20042191 · one of two readings recorded this
Fasting apo AI
decreases, p = 0.003, n = 30
Compared to the high Lys:Arg ratio diet, the low Lys:Arg ratio diet resulted in a modestly lower apo AI (3%, P=0.003) and higher adiponectin concentration (7%; P=0.035)
PMID:20042191 · one of two readings recorded this
Fasting glycated albumin and immunoreactive insulin
no effect, n = 30
There were no significant differences in fasting concentrations of glycated albumin or immunoreactive insulin at the end of the two experimental diet phases
PMID:20042191 · one of two readings recorded this
Fasting hsCRP
decreases, p = 0.02, n = 30
Relative to the high Lys:Arg ratio diet, the low Lys:Arg ratio diet resulted in 23% lower fasting hsCRP concentrations (P=0.020)
PMID:20042191 · one of two readings recorded this
Fasting Lp(a) and apo B concentrations
no effect, n = 30
At the end of the two diet phases there were no significant differences in Lp(a) or apo B concentrations
PMID:20042191 · one of two readings recorded this
Fasting total, LDL, VLDL, HDL and sdLDL cholesterol, RemLC, triglycerides and total cholesterol:HDL ratio
no effect, n = 30
Consumption of the two experimental diets resulted in no significant differences in fasting total, LDL, VLDL, HDL and sdLDL cholesterol, RemLC or triglyceride concentrations and the total cholesterol:HDL cholesterol ratio (Table 4)
PMID:20042191 · one of two readings recorded this
flow mediated dilation and peripheral artery tonometry; fasting and postprandial lipids, hsCRP, adiponectin on low versus high dietary Lys:Arg ratio diets
no effect, vascular reactivity not significantly different between the low and high Lys:Arg diets
Not recorded as a finding: the comparison was against another active treatment
Vascular reactivity was not significantly different at the end of the two experimental diet phases as measured by flow mediated dilation or peripheral artery tonometry.
PMID:20042191 · one of two readings recorded this
Postprandial apo AI
decreases, p = 0.018, n = 30
the low Lys:Arg ratio diet resulted in modestly lower postprandial apo AI (3%, P=0.018) and lower hsCRP concentrations (29%, P=0.020)
PMID:20042191 · one of two readings recorded this
Postprandial hsCRP
decreases, p = 0.02, n = 30
the low Lys:Arg ratio diet resulted in modestly lower postprandial apo AI (3%, P=0.018) and lower hsCRP concentrations (29%, P=0.020)
PMID:20042191 · one of two readings recorded this
Postprandial Lp(a) and apo B concentrations
no effect, n = 30
There were no significant differences in Lp(a) or apo B concentrations at the end of the two diet phases
PMID:20042191 · one of two readings recorded this
Postprandial total cholesterol:HDL cholesterol ratio
decreases, p = 0.05, n = 30
the total cholesterol:HDL cholesterol ratio was marginally lower after participants consumed the low Lys:Arg ratio diet compared to the high Lys:Arg ratio diet (−1.5%; P=0.05)
PMID:20042191 · one of two readings recorded this
Postprandial total, LDL and HDL cholesterol
no effect, n = 30
In the postprandial state, consumption of the two experimental diets resulted in no significant differences in total, LDL, and HDL cholesterol concentrations (Table 5)
PMID:20042191 · one of two readings recorded this
Postprandial triglycerides
decreases, p = 0.001, n = 30
postprandial serum VLDL cholesterol and triglyceride concentrations were 24% (P=0.001) and 23% (P=0.001) lower, respectively, following the low Lys:Arg ratio diet phase
PMID:20042191 · one of two readings recorded this
Postprandial VLDL cholesterol
decreases, p = 0.001, n = 30
postprandial serum VLDL cholesterol and triglyceride concentrations were 24% (P=0.001) and 23% (P=0.001) lower, respectively, following the low Lys:Arg ratio diet phase
PMID:20042191 · one of two readings recorded this
Vascular reactivity (flow mediated dilation and peripheral artery tonometry)
no effect, n = 30
Vascular reactivity was not significantly different at the end of the two experimental diet phases as measured by flow mediated dilation or peripheral artery tonometry
PMID:20042191 · one of two readings recorded this
Between-group difference in changes of weight, BMI, LBM and RMR
no effect, n = 30
However, when comparing these changes between the two groups, no statistical significance was observed
PMID:20953883 · one of two readings recorded this
BMI change after gastric bypass, all subjects
decreases, p = 0.0001, n = 30
At 8 weeks, weight, BMI, LBM, and RMR significantly decreased by 15.7±2.5 kg, 6.0±1.0 kg/m2, 7.8±4.0 kg, and 290.6±234.9 kcal/day, respectively (P<0.0001 for each variable)
PMID:20953883 · one of two readings recorded this
lean body mass by DXA and resting metabolic rate by indirect calorimetry after laparoscopic gastric bypass
no effect, no statistically significant difference in changes between groups
Not recorded as a finding: the intervention held more than the compound
However, when comparing these changes between the two groups, no statistical significance was observed.
PMID:20953883 · one of two readings recorded this
lean body mass by DXA and resting metabolic rate by indirect calorimetry, weight and BMI, after laparoscopic gastric bypass
no effect, changes compared between groups, no statistical significance observed
Not recorded as a finding: the intervention held more than the compound
However, when comparing these changes between the two groups, no statistical significance was observed.
PMID:20953883 · one of two readings recorded this
Lean body mass (LBM) change after gastric bypass, all subjects
decreases, p = 0.0001, n = 30
At 8 weeks, weight, BMI, LBM, and RMR significantly decreased by 15.7±2.5 kg, 6.0±1.0 kg/m2, 7.8±4.0 kg, and 290.6±234.9 kcal/day, respectively (P<0.0001 for each variable)
PMID:20953883 · one of two readings recorded this
Resting metabolic rate (RMR) change after gastric bypass, all subjects
decreases, p = 0.0001, n = 30
At 8 weeks, weight, BMI, LBM, and RMR significantly decreased by 15.7±2.5 kg, 6.0±1.0 kg/m2, 7.8±4.0 kg, and 290.6±234.9 kcal/day, respectively (P<0.0001 for each variable)
PMID:20953883 · one of two readings recorded this
Weight change after gastric bypass, all subjects
decreases, p = 0.0001, n = 30
At 8 weeks, weight, BMI, LBM, and RMR significantly decreased by 15.7±2.5 kg, 6.0±1.0 kg/m2, 7.8±4.0 kg, and 290.6±234.9 kcal/day, respectively (P<0.0001 for each variable)
PMID:20953883 · one of two readings recorded this
plasma L-arginine concentration, relative decrease
decreases
which is a relative decrease of 41%
PMID:21150584 · one of two readings recorded this
plasma L-arginine concentration
decreases, p = 0.001
mean plasma L-arginine concentration was 33.9 μmol/L (95% confidence interval, 41.2-26.6) lower in sepsis patients than in concurrent nonseptic controls (p < .001)
PMID:21150584 · one of two readings recorded this
development of pre-eclampsia/eclampsia (incidence) in pregnant women at high risk
decreases, absolute risk reduction 0.17 (95% CI 0.12 to 0.21) for L-arginine plus antioxidant vitamins versus placebo
Not recorded as a finding: this platform holds no node for the endpoint
The incidence of pre-eclampsia was reduced significantly (χ(2) = 19.41; P < 0.001) in women randomised to L-arginine plus antioxidant vitamins compared with placebo (absolute risk reduction 0.17 (95% confidence interval 0.12 to 0.21).
PMID:21596735 · one of two readings recorded this
incidence of pre-eclampsia/eclampsia in high-risk pregnancy
decreases, absolute risk reduction 0.17 (95% CI 0.12 to 0.21) for L-arginine plus antioxidant vitamins vs placebo
Not recorded as a finding: the intervention held more than the compound
The incidence of pre-eclampsia was reduced significantly (χ(2) = 19.41; P < 0.001) in women randomised to L-arginine plus antioxidant vitamins compared with placebo (absolute risk reduction 0.17 (95% confidence interval 0.12 to 0.21).
PMID:21596735 · one of two readings recorded this
Incidence of pre-eclampsia/eclampsia
no effect, p = 0.052
Antioxidant vitamins alone showed an observed benefit, but this effect was not statistically significant compared with placebo (χ(2) = 3.76; P = 0.052; absolute risk reduction 0.07, 0.005 to 0.15)
PMID:21596735 · one of two readings recorded this
Incidence of pre-eclampsia/eclampsia
decreases, p = 0.001
The incidence of pre-eclampsia was reduced significantly (χ(2) = 19.41; P < 0.001) in women randomised to L-arginine plus antioxidant vitamins compared with placebo (absolute risk reduction 0.17 (95% confidence interval 0.12 to 0.21)
PMID:21596735 · one of two readings recorded this
Incidence of pre-eclampsia/eclampsia
decreases, p = 0.004
L-arginine plus antioxidant vitamins compared with antioxidant vitamins alone resulted in a significant effect (P = 0.004; absolute risk reduction 0.09, 0.05 to 0.14)
PMID:21596735 · one of two readings recorded this
diastolic blood pressure
decreases, p = 0.001
diastolic BP by 2.66 mm Hg (95% CI -3.77 to -1.54, P < .001)
PMID:22137067 · one of two readings recorded this
net change in systolic BP versus baseline systolic BP (meta-regression)
no effect, p = 0.13
an inverse, though insignificant (P = .13), relation between baseline systolic BP and net change in systolic BP
PMID:22137067 · one of two readings recorded this
systolic blood pressure
decreases, p = 0.001
L-arginine intervention significantly lowered systolic BP by 5.39 mm Hg (95% CI -8.54 to -2.25, P = .001)
PMID:22137067 · one of two readings recorded this
diastolic blood pressure
decreases, p = 0.004
a mean decrease of 3.07 mmHg (p = 0.004) for diastolic blood pressure
PMID:22957482 · one of two readings recorded this
gestation age at delivery
increases, p = 0.002
a mean increase of 1.23 weeks (p = 0.002) for gestation age at delivery
PMID:22957482 · one of two readings recorded this
systolic blood pressure
no effect, p = 0.19
did not reduce systolic BP (p = 0.19)
PMID:22957482 · one of two readings recorded this
Arginine and citrulline flux
increases, n = 12
Whereas subjects had increased arginine and citrulline flux with high-dose arginine therapy, the glutamine flux was not different between the two treatment arms
PMID:23040521 · one of two readings recorded this
Glutamine flux
no effect, n = 12
Whereas subjects had increased arginine and citrulline flux with high-dose arginine therapy, the glutamine flux was not different between the two treatment arms
PMID:23040521 · one of two readings recorded this
Plasma argininosuccinate
increases, p = 0.03, n = 12
Subjects had significantly increased levels of argininosuccinate (P<0.03) and AST levels (P<0.01) after treatment with high-dose arginine
PMID:23040521 · one of two readings recorded this
plasma aspartate aminotransferase (AST), alanine aminotransferase (ALT) and synthetic liver function tests in argininosuccinic aciduria
increases, AST significantly increased after high-dose arginine versus low-dose arginine plus sodium phenylbutyrate
Not recorded as a finding: the comparison was against another active treatment
Subjects had significantly increased levels of argininosuccinate (P<0.03) and AST levels (P<0.01) after treatment with high-dose arginine.
PMID:23040521 · one of two readings recorded this
Plasma aspartate aminotransferase (AST)
increases, p = 0.01, n = 12
Subjects had significantly increased levels of argininosuccinate (P<0.03) and AST levels (P<0.01) after treatment with high-dose arginine
PMID:23040521 · one of two readings recorded this
Plasma AST and ALT
increases
In the subset of subjects with elevated AST or ALT, treatment with high-dose of arginine was associated with further increases in plasma levels of both aminotransferases
PMID:23040521 · one of two readings recorded this
Synthetic liver function (prothrombin time, INR, coagulation factor levels)
no effect, n = 12
The synthetic liver functions as assessed by prothrombin time, INR, and coagulation factor levels were not different between the HDA and LDA arms
PMID:23040521 · one of two readings recorded this
Dentine hypersensitivity on three stimuli, baseline to Day-28
decreases
The 8% Arginine-CaCO₃ group exhibited statistically significant reduction in DH on three stimuli at baseline to Day-28
PMID:23229241 · one of two readings recorded this
Dentine hypersensitivity (tactile, air-blast and thermal stimuli), 8% Arginine-CaCO3 versus 1.23% NaF gel
decreases
Sensitivity score differences between the groups were statistically significant at Day-28
PMID:23229241 · one of two readings recorded this
diastolic blood pressure
decreases
diastolic pressure (MD 4.86; 95% CL 4.19, 5.52)
PMID:23435582 · one of two readings recorded this
neonatal weight
no effect
increased neonatal weight (MD 256.24; 95% CL -28.66, 541.13)
PMID:23435582 · one of two readings recorded this
preeclampsia or eclampsia incidence
decreases
L-arginine was more effective in reducing preeclampsia or eclampsia incidence (odds ratio 0.384; 95% confidence limits 0.25, 0.58) than the placebo
PMID:23435582 · one of two readings recorded this
prolongation of pregnancy
increases
L-arginine could prolong pregnancy weeks (MD 11.54; 95% CL 5.23, 17.85) than placebo
PMID:23435582 · one of two readings recorded this
systolic blood pressure
no effect
systolic pressure (MD 3.20; 95% CL -1.54, 7.94)
PMID:23435582 · one of two readings recorded this
Hospital length of stay
no effect, p = 0.34, n = 38
hospital length of stay (4.1 ± 01.8 versus 4.8 ± 2.5 days, P=0.34)
PMID:23645695 · one of two readings recorded this
Correlation of total opioid use with duration of admission
increases, p = 0.0001
total opioid use was strongly correlated with the duration of the admission (r=0.86, P<0.0001)
PMID:23645695 · one of two readings recorded this
pain score at discharge, instrument not named in abstract
decreases, 1.9 ± 2.4 versus 3.9 ± 2.9, p = 0.01
Not recorded as a finding: instrument not stated; cannot map to vas-pain or nrs-pain
A significant reduction in total parenteral opioid use by 54% (1.9 ± 2.0 mg/kg versus 4.1 ± 4.1 mg/kg, P=0.02) and lower pain scores at discharge (1.9 ± 2.4 versus 3.9 ± 2.9, P=0.01) were observed in the treatment arm compared to the placebo one.
PMID:23645695 · one of two readings recorded this
pain score at discharge, instrument not stated in the abstract
decreases, 1.9 ± 2.4 versus 3.9 ± 2.9, p = 0.01
Not recorded as a finding: instrument not stated; vas-pain and nrs-pain nodes are instrument-bound
A significant reduction in total parenteral opioid use by 54% (1.9 ± 2.0 mg/kg versus 4.1 ± 4.1 mg/kg, P=0.02) and lower pain scores at discharge (1.9 ± 2.4 versus 3.9 ± 2.9, P=0.01) were observed in the treatment arm compared to the placebo one.
PMID:23645695 · one of two readings recorded this
Pain score at discharge
decreases, p = 0.01, n = 38
lower pain scores at discharge (1.9 ± 2.4 versus 3.9 ± 2.9, P=0.01)
PMID:23645695 · one of two readings recorded this
total parenteral opioid use, mg/kg
decreases, 1.9 ± 2.0 mg/kg versus 4.1 ± 4.1 mg/kg, 54% reduction, p = 0.02
Not recorded as a finding: no outcome node for opioid consumption
A significant reduction in total parenteral opioid use by 54% (1.9 ± 2.0 mg/kg versus 4.1 ± 4.1 mg/kg, P=0.02) and lower pain scores at discharge (1.9 ± 2.4 versus 3.9 ± 2.9, P=0.01) were observed in the treatment arm compared to the placebo one.
PMID:23645695 · both readings recorded this
Total parenteral opioid use
decreases, p = 0.02, n = 38
A significant reduction in total parenteral opioid use by 54% (1.9 ± 2.0 mg/kg versus 4.1 ± 4.1 mg/kg, P=0.02)
PMID:23645695 · one of two readings recorded this
Body mass index
no effect, p = 0.882
BMI (kg/m2) | 36.8 ± 6.3 | 36.1 ± 4.9 | 36.6 ± 6.1 | 35.8 ± 5.0 | 0.518 | 0.220 | 0.882
PMID:23708056 · one of two readings recorded this
Triglycerides
no effect, p = 0.438
TG (mmol/L) | 2.2 ± 1.6 | 2.0 ± 0.9 | 2.1 ± 1.3 | 2.0 ± 0.7 | 0.509 | 0.229 | 0.438
PMID:23708056 · one of two readings recorded this
Glucose
no effect, p = 0.138
Glucose (mmol/L) | 5.1 ± 0.7 | 5.0 ± 0.5 | 4.8 ± 0.6 | 4.9 ± 0.5 | 0.998 | 0.018 | 0.138
PMID:23708056 · one of two readings recorded this
Body fat content
no effect, p = 0.528
FAT (%) | 37.0 ± 9.7 | 35.6 ± 9.8 | 35.6 ± 9.8 | 35.5 ± 8.6 | 0.665 | 0.435 | 0.528
PMID:23708056 · one of two readings recorded this
Correlation, change in zinc with change in body fat percentage
unclear, p = 0.05
ΔZn/Δ%FAT | −0.38 | <0.05
PMID:23708056 · one of two readings recorded this
Correlation, change in zinc with change in insulin sensitivity M
unclear, p = 0.01
ΔZn/ΔM | 0.80 | <0.01
PMID:23708056 · one of two readings recorded this
Correlation, serum copper with triglycerides after treatment
unclear, p = 0.05
Cu/TG | 0.47 | <0.05
PMID:23708056 · one of two readings recorded this
Correlation, serum magnesium with body fat percentage after treatment
unclear, p = 0.05
Mg/%FAT | −0.38 | <0.05
PMID:23708056 · one of two readings recorded this
Correlation, serum zinc with BMI after treatment
unclear, p = 0.05
Zn/BMI | −0.51 | <0.05
PMID:23708056 · one of two readings recorded this
Correlation, serum zinc with body fat percentage after treatment
unclear, p = 0.05
Zn/%FAT | −0.49 | <0.05
PMID:23708056 · one of two readings recorded this
Correlation, serum zinc with insulin sensitivity M after treatment
unclear, p = 0.01
Zn/M | 0.62 | <0.01
PMID:23708056 · one of two readings recorded this
Dietary arginine intake during study
the average arginine intake was 43.3 mg/kg body weight
PMID:23708056 · one of two readings recorded this
High-sensitivity C-reactive protein
no effect, p = 0.418
hs-CRP (mg/l) | 2.8 ± 1.2 | 2.9 ± 1.0 | 2.6 ± 1.4 | 2.8 ± 1.0 | 0.516 | 0.055 | 0.418
PMID:23708056 · one of two readings recorded this
insulin sensitivity by euglycemic hyperinsulinemic clamp (M value, mg/kg/min) and serum zinc by flame atomic absorption spectrometry, 9 g L-arginine three times daily vs placebo for 6 months in obese adults
increases, p = 0.001
Not recorded as a finding: this platform holds no node for the endpoint
Statistically significant interaction between treatment and time factors (with both factors statistically significant) was observed for insulin sensitivity (P = 0.001) and zinc concentration (P < 0.001): The increase in insulin sensitivity and zinc level was significantly higher in l-arginine group compared to placebo group.
PMID:23708056 · one of two readings recorded this
Insulin sensitivity (M value, euglycemic clamp)
increases, p = 0.001
M (mg/kg/min) | 3.2 ± 1.8 | 3.4 ± 1.7 | 4.3 ± 2.1 | 3.0 ± 1.6 | 0.043 | 0.008 | 0.001
PMID:23708056 · one of two readings recorded this
insulin sensitivity (M value), euglycemic hyperinsulinemic clamp, whole-body glucose uptake in mg/kg/min
increases, interaction P = 0.001; increase higher in the l-arginine group than placebo, p = 0.001
Not recorded as a finding: no outcome node for clamp-derived insulin sensitivity; HOMA-IR requires a fasting insulin and glucose calculation
Statistically significant interaction between treatment and time factors (with both factors statistically significant) was observed for insulin sensitivity (P = 0.001) and zinc concentration (P < 0.001): The increase in insulin sensitivity and zinc level was significantly higher in l-arginine group compared to placebo group.
PMID:23708056 · one of two readings recorded this
Insulin
no effect, p = 0.228
Insulin (μUI/Ml) | 29.2 ± 13.9 | 28.6 ± 16.4 | 25.5 ± 12.7 | 26.8 ± 14.7 | 0.903 | 0.048 | 0.228
PMID:23708056 · one of two readings recorded this
Serum calcium
no effect, p = 0.088
Ca (mmol/L) | 2.4 ± 0.4 | 2.7 ± 0.4 | 2.6 ± 0.3 | 2.6 ± 0.3 | 0.140 | 0.066 | 0.088
PMID:23708056 · one of two readings recorded this
Serum copper
decreases, p = 0.003
Cu (mmol/L) | 14.0 ± 2.3 | 13.9 ± 2.6 | 13.0 ± 1.7 | 14.1 ± 2.1 | 0.111 | 0.049 | 0.003
PMID:23708056 · one of two readings recorded this
Serum iron
no effect, p = 0.055
Fe (mmol/L) | 14.9 ± 4.0 | 15.3 ± 3.2 | 17.7 ± 5.3 | 16.7 ± 3.5 | 0.139 | 0.056 | 0.055
PMID:23708056 · one of two readings recorded this
Serum magnesium
no effect, p = 0.078
Mg (mmol/L) | 0.8 ± 0.1 | 0.9 ± 0.2 | 0.9 ± 0.1 | 0.9 ± 0.1 | 0.293 | 0.069 | 0.078
PMID:23708056 · one of two readings recorded this
Serum zinc, time by treatment interaction (text)
increases, p = 0.001
Statistically significant interaction between treatment and time factors (with both factors statistically significant) was observed for insulin sensitivity (P = 0.001) and zinc concentration (P < 0.001)
PMID:23708056 · one of two readings recorded this
Serum zinc
increases
Zn (mmol/L) | 10.7 ± 1.1 | 10.5 ± 1.2 | 12.2 ± 1.6 | 10.7 ± 1.4 | 0.007 | 0.000 | 0.000
PMID:23708056 · one of two readings recorded this
Total cholesterol
no effect, p = 0.976
TC (mmol/L) | 5.7 ± 1.2 | 5.5 ± 1.0 | 5.6 ± 1.0 | 5.4 ± 0.7 | 0.282 | 0.137 | 0.976
PMID:23708056 · one of two readings recorded this
CD4+ T cells
increases
On postoperative day 7, CD4(+) T cells, NK cells, IgM and IgG levels of the arginine-supplemented group increased prominently and were significantly higher than those of the control group and those on preoperative day 1
PMID:23812551 · one of two readings recorded this
Immunoglobulin G
increases
On postoperative day 7, CD4(+) T cells, NK cells, IgM and IgG levels of the arginine-supplemented group increased prominently and were significantly higher than those of the control group and those on preoperative day 1
PMID:23812551 · one of two readings recorded this
Immunoglobulin M
increases
On postoperative day 7, CD4(+) T cells, NK cells, IgM and IgG levels of the arginine-supplemented group increased prominently and were significantly higher than those of the control group and those on preoperative day 1
PMID:23812551 · one of two readings recorded this
Natural killer cells
increases
On postoperative day 7, CD4(+) T cells, NK cells, IgM and IgG levels of the arginine-supplemented group increased prominently and were significantly higher than those of the control group and those on preoperative day 1
PMID:23812551 · one of two readings recorded this
overall survival and progression-free survival in months after gastric cancer surgery; serum total protein, albumin, proalbumin, transferrin; CD4+ and CD8+ T cells, NK cells, IgM, IgG
increases, overall survival 41 vs 30.5 months and progression-free survival 18 vs 11.5 months, arginine-enriched versus standard enteral nutrition, p = 0.03
Not recorded as a finding: this platform holds no node for the endpoint
The group receiving arginine-enriched nutrition had a significantly better OS (P = 0.03, 41 vs. 30.5 months) and better PFS (P = 0.02, 18 vs. 11.5 months).
PMID:23812551 · one of two readings recorded this
overall survival, median months, arginine-supplemented enteral nutrition (9.0 g/L) vs the same product without arginine after gastric cancer surgery; also progression-free survival, CD4+ T cells, NK cells, IgM, IgG
increases, median OS 41 vs 30.5 months, p = 0.03
Not recorded as a finding: this platform holds no node for the endpoint
The group receiving arginine-enriched nutrition had a significantly better OS (P = 0.03, 41 vs. 30.5 months) and better PFS (P = 0.02, 18 vs. 11.5 months).
PMID:23812551 · one of two readings recorded this
Overall survival
increases, p = 0.03
The group receiving arginine-enriched nutrition had a significantly better OS (P = 0.03, 41 vs. 30.5 months)
PMID:23812551 · one of two readings recorded this
Progression-free survival
increases, p = 0.02
better PFS (P = 0.02, 18 vs. 11.5 months)
PMID:23812551 · one of two readings recorded this
Serum total protein, albumin, proalbumin and transferrin
no effect
There is no significant difference in the serum total protein, albumin, proalbumin, and transferrin levels between the two arms
PMID:23812551 · one of two readings recorded this
dentin hypersensitivity (DH), by tactile and air blast assessment
decreases
Not recorded as a finding: this platform holds no node for the endpoint
Current available clinical evidence suggests that arginine-containing toothpastes are associated with the reduction of DH compared to both placebo and positive control toothpastes.
PMID:23878846 · one of two readings recorded this
dentin hypersensitivity (DH), tactile and air blast assessment
decreases, better overall effects than placebo, potassium salt-containing, and strontium-containing toothpastes (P < .05 for each comparison)
Not recorded as a finding: this platform holds no node for the endpoint
We found that arginine-containing toothpastes had better overall effects in comparison with placebo toothpastes (P < .05), potassium salt-containing toothpastes (P < .05), and strontium-containing toothpastes (P < .05).
PMID:23878846 · one of two readings recorded this
dentin hypersensitivity (DH), tactile and air blast assessment
decreases, better overall effects than placebo (P < .05), potassium salt-containing toothpastes (P < .05), and strontium-containing toothpastes (P < .05)
We found that arginine-containing toothpastes had better overall effects in comparison with placebo toothpastes (P < .05), potassium salt-containing toothpastes (P < .05), and strontium-containing toothpastes (P < .05).
PMID:23878846 · one of two readings recorded this
dentin hypersensitivity, tactile and air blast assessment
decreases, better overall effects than placebo toothpastes (P < .05)
We found that arginine-containing toothpastes had better overall effects in comparison with placebo toothpastes (P < .05), potassium salt-containing toothpastes (P < .05), and strontium-containing toothpastes (P < .05).
PMID:23878846 · one of two readings recorded this
blood lactate clearance; endothelial NO bioavailability by reactive hyperemia peripheral arterial tonometry (RH-PAT index)
no effect, no effect on lactate clearance or RH-PAT index
Not recorded as a finding: this platform holds no node for the endpoint
There was no effect on lactate clearance or RH-PAT index.
PMID:23922746 · one of two readings recorded this
Endothelial NO bioavailability (RH-PAT index)
no effect
There was no effect on lactate clearance or RH-PAT index
PMID:23922746 · one of two readings recorded this
lactate clearance and endothelial NO bioavailability by reactive hyperemia peripheral arterial tonometry (RH-PAT index) after IV L-arginine hydrochloride 12 g over 8 h vs saline in severe falciparum malaria
no effect
Not recorded as a finding: this platform holds no node for the endpoint
There was no effect on lactate clearance or RH-PAT index.
PMID:23922746 · one of two readings recorded this
Lactate clearance
no effect
There was no effect on lactate clearance or RH-PAT index
PMID:23922746 · one of two readings recorded this
Maximal decrease in systolic blood pressure
decreases
although a transient but clinically unimportant mean maximal decrease in SBP of 14 mmHg was noted
PMID:23922746 · one of two readings recorded this
Mean maximal decrease in bicarbonate
decreases
with transient mean maximal increases in plasma potassium of 0.3 mmol/L, and mean maximal decreases in blood glucose of 0.8 mmol/L and bicarbonate of 2.3 mEq/L following L-arginine administration
PMID:23922746 · one of two readings recorded this
Mean maximal decrease in blood glucose
decreases
with transient mean maximal increases in plasma potassium of 0.3 mmol/L, and mean maximal decreases in blood glucose of 0.8 mmol/L and bicarbonate of 2.3 mEq/L following L-arginine administration
PMID:23922746 · one of two readings recorded this
Mean maximal increase in plasma potassium
increases
with transient mean maximal increases in plasma potassium of 0.3 mmol/L, and mean maximal decreases in blood glucose of 0.8 mmol/L and bicarbonate of 2.3 mEq/L following L-arginine administration
PMID:23922746 · one of two readings recorded this
Mean systolic and diastolic blood pressure and other vital signs
no effect
There were no changes in mean systolic (SBP) and diastolic blood pressure (DBP) or other vital signs with L-arginine
PMID:23922746 · one of two readings recorded this
Arginine appearance (whole-body rate of appearance)
increases, p = 0.012, n = 18
increased arginine appearance (PE-formula: 248 ± 114 μmol · kg(-1) · h(-1); S-formula: 130 ± 53 μmol · kg(-1) · h(-1); P = 0.012)
PMID:23945723 · one of two readings recorded this
Citrulline production
no effect, n = 18
whereas citrulline production and plasma arginine concentrations were unaffected
PMID:23945723 · one of two readings recorded this
Nitric oxide synthesis
increases, p = 0.003, n = 18
NO synthesis (PE-formula: 1.92 ± 0.99 μmol · kg(-1) · h(-1); S-formula: 0.84 ± 0.36 μmol · kg(-1) · h(-1); P = 0.003)
PMID:23945723 · one of two readings recorded this
Plasma arginine concentration
no effect, n = 18
whereas citrulline production and plasma arginine concentrations were unaffected
PMID:23945723 · one of two readings recorded this
6-minute walk test increase
increases
A greater increase in 6MWT occurred in participants in L-arginine vs. L-arginine-placebo groups, but this may be explained by the baseline difference between these groups in 6MWT (Table 2)
PMID:23967066 · one of two readings recorded this
Composite clinical score at week 8
no effect, p = 0.81, n = 168
Mean (SD) | 6.9 (1.9) | 6.9 (1.9) | 6.8 (2.0) | 0.81 | 6.9 (2.0) | 6.8 (1.9) | 0.68
PMID:23967066 · one of two readings recorded this
Composite clinical score at week 8
no effect, p = 0.68, n = 168
Mean (SD) | 6.9 (1.9) | 6.9 (1.9) | 6.8 (2.0) | 0.81 | 6.9 (2.0) | 6.8 (1.9) | 0.68
PMID:23967066 · one of two readings recorded this
Composite clinical score at week 8
no effect, p = 0.73
We found no evidence of interaction between the interventions (week 4 culture conversion: p = 0.44; clinical score: p = 0.73)
PMID:23967066 · one of two readings recorded this
Composite clinical score at week 8
no effect, p = 0.65
HIV− | 6.9 (6.6–7.3) | 7.0 | 6.8 | 0.65 | 6.9 | 6.9 | 0.86
PMID:23967066 · one of two readings recorded this
Composite clinical score at week 8
no effect, p = 0.79
HIV+ | 6.7 (5.8–7.6) | 6.6 | 6.9 | 0.79 | 6.7 | 6.5 | 0.81
PMID:23967066 · one of two readings recorded this
Composite clinical score at week 8
no effect, p = 0.83
Non-Papuan | 6.5 (6.1–6.9) | 6.5 | 6.5 | 0.83 | 6.3 | 6.7 | 0.38
PMID:23967066 · one of two readings recorded this
Composite clinical score at week 8
no effect, p = 0.55
Papuan | 7.3 (6.9–7.8 | 7.5 | 7.2 | 0.55 | 7.7 | 7.1 | 0.09
PMID:23967066 · one of two readings recorded this
Cough worse or same at week 8
no effect, p = 0.21
Worse/same | 15 (9) | 6 (7) | 9 (10) | 0.21 | 6 (7) | 9 (10) | 0.42
PMID:23967066 · one of two readings recorded this
FEV1 fall of 10% or more at week 8
no effect, p = 0.1
≥10% fall in FEV1 | 17 (10) | 4 (5) | 13 (14) | 0.10 | 11 (13) | 6 (7) | 0.38
PMID:23967066 · one of two readings recorded this
Fractional exhaled nitric oxide (FENO) after 6.0 g L-arginine
no effect
we detected no overall rise in FENO after active L-arginine administration (median ΔFENO −2 and −1ppB at first and second time points respectively), nor difference compared with those administered placebo
PMID:23967066 · one of two readings recorded this
Haemoptysis present at week 8
no effect, p = 0.61
Haemoptysis present: no.(%) | 3 (2) | 2 (2) | 1 (1) | 0.61 | 1 (1) | 2 (2) | 1.00
PMID:23967066 · one of two readings recorded this
Mean ionised calcium, enrolment to week 2
increases, p = 0.001
A small increase in mean iCa2+ was observed among all study participants between enrolment (1.21 mmol/L) and week 2 (1.24), p<0.001
PMID:23967066 · one of two readings recorded this
Sputum culture negative at week 4
no effect, p = 0.76, n = 155
Culture negative at week 4: no.(%) | 96/155 (61.9) | 48/76 (63.2) | 48/79 (60.8) * | 0.76 | 44/75 (58.7) | 52/80 (65.0) † | 0.42
PMID:23967066 · one of two readings recorded this
Sputum culture negative at week 4
no effect, p = 0.42, n = 155
Culture negative at week 4: no.(%) | 96/155 (61.9) | 48/76 (63.2) | 48/79 (60.8) * | 0.76 | 44/75 (58.7) | 52/80 (65.0) † | 0.42
PMID:23967066 · one of two readings recorded this
Sputum culture negative at week 4
no effect, p = 0.44
We found no evidence of interaction between the interventions (week 4 culture conversion: p = 0.44; clinical score: p = 0.73)
PMID:23967066 · one of two readings recorded this
Sputum culture negative at week 4
no effect
In those who received L-arginine plus vitamin D, week 4 culture conversion occurred in 57% (21/37), compared to 61% (25/41) of participants who received neither (risk difference 4%, 95% CI −18 to 27)
PMID:23967066 · one of two readings recorded this
Sputum culture negative at week 4
no effect, p = 0.8, n = 112
HIV− | 68/112 (60.7) | 31/50 (62.0) | 37/62 (59.7) | 0.80 | 27/47 (57.5) | 41/65 (63.1) | 0.55
PMID:23967066 · one of two readings recorded this
Sputum culture negative at week 4
no effect, p = 0.63, n = 19
HIV+ | 11/19 (57.9) | 6/12 (50.0) | 5/7 (71.4) | 0.63 | 9/15 (60.0) | 2/4 (50) | 0.57
PMID:23967066 · one of two readings recorded this
Sputum culture negative at week 4
no effect, p = 0.6, n = 80
Non-Papuan | 51/80 (63.8) | 26/39 (66.7) | 25/41 (61.0) | 0.60 | 24/39 (61.5) | 27/41 (65.9) | 0.69
PMID:23967066 · one of two readings recorded this
Sputum culture negative at week 4
no effect, p = 0.93
Papuan | 45/47 (60) | 22/37 (59.5) | 23/38 (60.5) | 0.93 | 20/36 (55.6) | 25/39 (64.1) | 0.45
PMID:23967066 · one of two readings recorded this
Sputum culture negative at week 4
no effect, p = 0.55, n = 112
HIV− | 68/112 (60.7) | 31/50 (62.0) | 37/62 (59.7) | 0.80 | 27/47 (57.5) | 41/65 (63.1) | 0.55
PMID:23967066 · one of two readings recorded this
Sputum culture negative at week 4
no effect, p = 0.57, n = 19
HIV+ | 11/19 (57.9) | 6/12 (50.0) | 5/7 (71.4) | 0.63 | 9/15 (60.0) | 2/4 (50) | 0.57
PMID:23967066 · one of two readings recorded this
Sputum culture negative at week 4
no effect, p = 0.69, n = 80
Non-Papuan | 51/80 (63.8) | 26/39 (66.7) | 25/41 (61.0) | 0.60 | 24/39 (61.5) | 27/41 (65.9) | 0.69
PMID:23967066 · one of two readings recorded this
Sputum culture negative at week 4
no effect, p = 0.45
Papuan | 45/47 (60) | 22/37 (59.5) | 23/38 (60.5) | 0.93 | 20/36 (55.6) | 25/39 (64.1) | 0.45
PMID:23967066 · one of two readings recorded this
Sputum culture negative at week 8
no effect, p = 0.94, n = 123
Culture negative at week 8: no. (%) | 97/123 (78.9) | 44/56 (79) | 53/67 (79) | 0.94 | 44/59 (75) | 53/64 (83) | 0.26
PMID:23967066 · one of two readings recorded this
Sputum culture negative at week 8
no effect, p = 0.26, n = 123
Culture negative at week 8: no. (%) | 97/123 (78.9) | 44/56 (79) | 53/67 (79) | 0.94 | 44/59 (75) | 53/64 (83) | 0.26
PMID:23967066 · one of two readings recorded this
Sputum culture negative at week 8
no effect, p = 0.88, n = 91
HIV− | 69/91 (76) | 27/36 (75) | 42/55 (76) | 0.88 | 24/37 (65) | 45/54 (83) | 0.05
PMID:23967066 · one of two readings recorded this
Sputum culture negative at week 8
no effect, p = 1, n = 14
HIV+ | 13/14 (93) | 8/9 (89) | 5/5 (100) | 1.00 | 11/12 (92) | 2/2 (100) | 1.00
PMID:23967066 · one of two readings recorded this
Sputum culture negative at week 8
decreases, p = 0.05, n = 91
HIV− | 69/91 (76) | 27/36 (75) | 42/55 (76) | 0.88 | 24/37 (65) | 45/54 (83) | 0.05
PMID:23967066 · one of two readings recorded this
Sputum present at week 8
no effect, p = 0.89
Sputum present: no.(%) | 131 (72) | 63 (73) | 68 (72) | 0.89 | 62 (70) | 69 (75) | 0.51
PMID:23967066 · one of two readings recorded this
St George's Respiratory Questionnaire fall
decreases
A greater fall in SGRQ by 8.3 units occurred in participants who did not receive vitD compared with those who did
PMID:23967066 · one of two readings recorded this
Time to sputum smear negativity
no effect, p = 0.85
Time to smear negativity: Median weeks (IQR) | 5 (2–8) | 4 (2–8) | 5 (2–8) | 0.85 | 5 (2–8) | 4 (2–8) | 0.45
PMID:23967066 · one of two readings recorded this
Time to sputum smear negativity
no effect, p = 0.45
Time to smear negativity: Median weeks (IQR) | 5 (2–8) | 4 (2–8) | 5 (2–8) | 0.85 | 5 (2–8) | 4 (2–8) | 0.45
PMID:23967066 · one of two readings recorded this
Weight change category at week 8 (<5% weight gain)
no effect, p = 0.74
<5% weight gain | 98 (54) | 49 (57) | 49 (52) | 0.74 | 47 (53) | 51 (55) | 0.80
PMID:23967066 · one of two readings recorded this
arginine deiminase system activity in plaque and saliva, ammonia production from arginine by Nessler assay; plaque microbial composition by qRT-PCR and HOMIM
increases, p = 0.026
Not recorded as a finding: the comparison was against another active treatment
Among the CA subjects, only those making use of Arg had a statistically significant increase in plaque ADS activity (P = 0.026).
PMID:24289808 · one of two readings recorded this
arginine deiminase system activity of dental plaque and saliva, ammonia production from arginine quantified by Nessler's reagent; plaque microbial composition by qRT-PCR and HOMIM
increases, plaque ADS activity increased in caries-active subjects using the arginine toothpaste; comparator was a fluoride toothpaste, p = 0.026
Not recorded as a finding: this platform holds no node for the endpoint
Among the CA subjects, only those making use of Arg had a statistically significant increase in plaque ADS activity (P = 0.026).
PMID:24289808 · one of two readings recorded this
Baseline plaque taxa differing between CA and CF after Benjamini-Hochberg correction
no effect, p = 0.05
no significant difference in bacteria taxa was found (adjusted P-value > 0.05)
PMID:24289808 · one of two readings recorded this
Number of bacterial taxa in plaque, Arg versus F
decreases
a greater reduction in the numbers of bacterial species was observed in plaque samples of CA subjects treated with Arg compared to those treated with F
PMID:24289808 · one of two readings recorded this
Number of bacterial taxa in plaque at baseline, caries-active versus caries-free
increases, p = 0.046
a significantly higher average number of bacterial taxa was detected in the plaque of CA (99.7 ± 8.3) compared to those of CF (81.9 ± 8.2) subjects (P = 0.046)
PMID:24289808 · one of two readings recorded this
Plaque ADS activity after treatment
increases, p = 0.026
Among the CA subjects, only those making use of Arg had a statistically significant increase in plaque ADS activity (P = 0.026)
PMID:24289808 · one of two readings recorded this
Plaque ADS activity after treatment
increases, p = 0.042
a statistically significant difference in the levels of ADS activity was observed only among those treated with F (P = 0.042)
PMID:24289808 · one of two readings recorded this
Plaque ADS activity at baseline, caries-free versus caries-active
increases, p = 0.048
While significantly higher ADS activity levels were observed in plaque samples from CF (0.32 ± 0.28) compared to those of CA subjects (0.27 ± 0.33; P = 0.048)
PMID:24289808 · one of two readings recorded this
Plaque proportions of S. sanguinis, S. gordonii and S. mutans by qRT-PCR
no effect
Multiple regression analyses revealed no correlation between the frequency of these specific bacterial species and the treatment used and/or the caries group
PMID:24289808 · one of two readings recorded this
Saliva ADS activity after test toothpastes
no effect
There were no statistically significant differences in saliva ADS activity levels among the caries groups after the use of the test toothpastes
PMID:24289808 · one of two readings recorded this
Saliva ADS activity at baseline, caries-free versus caries-active
no effect
there were no statistically significant difference in the saliva ADS activity between the caries groups at baseline
PMID:24289808 · one of two readings recorded this
Sources cited
20 papers
- Subject
- L-arginine
- Findings
- 33
- Papers
- 20
Arginine therapy in sickle cell disease: A systematic review and meta-analysis of clinical outcomes.record2026PMID:415346221 finding
Assessment of the effectiveness and safety of two-month oral supplementation with L-arginine depending on the type of lipid metabolism disorder in patients with atherosclerotic lower limb ischemia.record2025PMID:413641691 finding
Arginine on immune function and post-operative obstructions in colorectal cancer patients: a meta-analysis.record2024PMID:392234661 finding
L-arginine impact on inflammatory and cardiac markers in patients undergoing coronary artery bypass graft: a systematic review and meta-analysis of randomized controlled trials.record2024PMID:395381802 findings
Effect of l-Arginine Supplementation on Blood Pressure in Adults: A Systematic Review and Dose-Response Meta-analysis of Randomized Clinical Trials.record2022PMID:349678402 findings
Effects of Chronic Supplementation of L-Arginine on Physical Fitness in Water Polo Players.record2021PMID:338156571 finding
Effects of tree nut and groundnut consumption compared with those of l-arginine supplementation on fasting and postprandial flow-mediated vasodilation: Meta-analysis of human randomized controlled trials.record2021PMID:329801861 finding
The effect of L-arginine supplementation on maximal oxygen uptake: A systematic review and meta-analysis.record2021PMID:335873271 finding
The effect of L-arginine supplementation on obesity-related indices: A systematic review and meta-analysis of randomized clinical trials.record2021PMID:309824452 findings
Effects of l-arginine supplementation on glycemic profile: Evidence from a systematic review and meta-analysis of clinical trials.record2020PMID:325613572 findings
Effect of L-arginine on energy metabolism, skeletal muscle and brown adipose tissue in South Asian and Europid prediabetic men: a randomised double-blinded crossover study.record2019PMID:303777123 findings
Effect of l-arginine supplementation on C-reactive protein and other inflammatory biomarkers: A systematic review and meta-analysis of randomized controlled trials.record2019PMID:317800283 findings
Effect of L-Arginine supplementation on lipid profiles and inflammatory markers: A systematic review and meta-analysis of randomized controlled trials.record2019PMID:314425775 findings
L-Arginine Inhibited Inflammatory Response and Oxidative Stress Induced by Lipopolysaccharide via Arginase-1 Signaling in IPEC-J2 Cells.record2019PMID:309790401 finding
Arginine supplementation for improving maternal and neonatal outcomes in hypertensive disorder of pregnancy: a systematic review.record2014PMID:234355822 findings
Arginine supplementation in prevention of necrotizing enterocolitis in the premature infant: an updated systematic review.record2014PMID:252050071 finding
Effect of L-arginine on immune function: a meta-analysis.record2014PMID:251644441 finding
A randomized, placebo-controlled trial of arginine therapy for the treatment of children with sickle cell disease hospitalized with vaso-occlusive pain episodes.record2013PMID:236456951 finding
Arginine supplementation for prevention of necrotising enterocolitis in preterm infants.record2007PMID:176367531 finding
Arginine supplementation for prevention of necrotising enterocolitis in preterm infants.record2004PMID:154951011 finding
Other names
8 names
Resolves to: L-arginine
- Also called
- (2S)-2-amino-5-(carbamimidamido)pentanoic acid(2S)-2-amino-5-guanidinopentanoic acid(S)-2-amino-5-guanidinopentanoic acid(S)-2-Amino-5-guanidinovaleric acidArgarginineL-(+)-arginineL-Arg